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ABSTRACT 
Broccoli is a nutritious food containing many macro- and micro-nutrients. Most consumers 
prefer cooked broccoli (CB); unfortunately, the enzyme myrosinase is inactivated by heat, 
resulting in the failure of glucoraphanin (GRP) hydrolysis to sulforaphane (SF), the potent anti-
cancer compound in broccoli. Certain unknown bacteria in the gut microbiota also have 
myrosinase-like activities that can hydrolyze GRP and release bioactive SF. However, the activity 
from bacteria is low compared to that from plant. The overall objective of this study is to identify 
ways to improve SF formation and absorption (bioavailability) from CB, through better 
understanding the mechanism. Our first hypothesis was that frequent intake of CB would enrich 
the bacteria that contain myrosinase-like activity, therefore enhancing SF bioavailability and 
bioactivity. Our data show that no less than 4 days of CB diet greatly alters the cecal microbiota 
composition in rats, and increases the myrosinase-like activity of cecal microbiota ex vivo. 
Increased colonocyte NAD(P)H: quinone oxidoreductase 1 activity (one marker of SF bioactivity) 
in rats fed with no less than 7 days of a CB diet also indicates enhanced SF bioactivity by frequent 
intake of CB. The myrosinase-like activity of cecal microbiota is lost when the 4 day CB diet was 
switched back to a control diet for an additional 3 days, suggesting that the increase in SF 
bioavailability requires intake of CB on a daily basis. Whether the myrosinase-like activity or the 
abundance of the myrosinase-containing bacteria is induced by a CB diet remains unknown and 
needs to be further investigated. In the next study, we compared the effect of frequent intake of 
CB and raw broccoli (RB) in prevention of dextran sulfate sodium (DSS)-induced colitis in mice. 
Our data show that frequent intake of a CB diet is as effective as a RB diet in lessening damage 
by DSS, evidenced by a decreased disease activity index, attenuated colon length shrinkage, less 
endotoxin (lipopolysaccharide) leakage into blood, and less severe colon lesions as assessed by 
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histopathology. Intriguingly, mRNA expression of pro-inflammatory cytokines indicated that 
broccoli anti-inflammatory action may be through inhibition of the IL-6 trans-signaling pathway, 
as evidenced by reversal of the DSS-increased expression of IL-6, CCR2 and vascular cell 
adhesion molecule 1 (VCAM-1). Our next hypothesis was that the quercetin-3-O-sophoroside 
(QS), the major flavonoid in broccoli, could improve the bioavailability of SF from CB, by 
modifying the gut microbiota composition. Because no literature existed on health-related 
properties of QS, we considered that it was essential to first understand the disposition of QS per 
se. Our data show that QS is absorbed intact in the small intestine and partly methylated to 
isorhamnetin sophoroside (methylated QS). No quercetin aglycone or its typical phase II 
metabolites were observed. With this important piece of information about where and how QS is 
absorbed and metabolized, future studies will be able to study whether the intact QS improves SF 
bioavailability from CB and whether this effect, if present, is dependent on gut microbiota. 
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CHAPTER 1: Introduction 
1.1 Introduction 
Broccoli and other crucifers are well appreciated as important anti-cancer and anti-
inflammation vegetables.  Whereas most consumers prefer cooked broccoli (CB), the enzyme 
myrosinase is inactivated by heat, resulting in the failure of glucoraphanin (GRP) hydrolysis to 
sulforaphane (SF), the potent anti-cancer compound in broccoli. Therefore, the overall objective 
of this study was to investigate potential ways to improve SF formation and absorption 
(bioavailability) from CB.  
Due to heat destruction of myrosinase, SF formation in CB is considered absent. However, 
research shows the presence of a little SF in plasma and urine after CB consumption (Conaway et 
al. 2000). Further study then unveiled that SF was being formed by gut bacteria (Shapiro et al. 
1998).  However, SF formation by the bacteria is poor, compared to that from the plant myrosinase 
in raw broccoli (RB) (Angelino and Jeffery 2014; Li et al. 2011). Our first aim was to determine 
whether frequent intake of CB would enrich any specific bacteria in the gut that might contain 
myrosinase-like activity and therefore enhance SF formation. Our hypothesis was that frequent 
intake of CB would enrich the SF-forming bacteria and consequently enhance SF bioavailability. 
Inflammation is considered a possible mechanism for aggravation of many chronic diseases, 
such as cancers. Accumulating evidence suggests that broccoli is able to mitigate gut inflammation 
(Hubbard et al. 2017; Paturi et al. 2012). However, only RB was investigated whereas no such 
study using CB had been conducted. Therefore, our second aim was to compare frequent intake of 
CB and RB in possible protection of the host against colitis (gut inflammation) in a mouse model. 
Our hypothesis was that frequent intake of CB would be as effective as RB in protecting the host 
from gut inflammation. 
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Emerging evidence in multiple fields of nutritional research has shown extensive interactions 
between food components. Recent studies suggest synergism in anti-cancer activity between 
quercetin (the major flavonoid in broccoli) and SF (Zhou et al. 2010). This raises the possibility 
that quercetin might improve SF bioavailability. The quercetin occurs in broccoli mainly as 
quercetin-3-O-sophoroside (QS). However, unlike glucoraphanin (the precursor of SF in broccoli), 
whose disposition in vivo (absorption, distribution, metabolism, and excretion) has been well 
studied and documented, the study of QS remains blank. In order to understand whether quercetin 
interacts with SF and improve its bioavailability, it is essential to know where quercetin is absorbed 
in relation to SF and how it is metabolized. Our third aim was therefore to investigate the 
absorption and metabolism of QS. 
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CHAPTER 2: Literature Review 
2.1 Broccoli Composition 
Macronutrients and micronutrients 
Broccoli belongs to the species Brassica oleracea, family Brassicaceae (previously referred as 
Cruciferae), and genus Brassica. This family includes other common foods such as cabbage, kale, 
Brussels sprouts, cauliflower, etc. A whole mature broccoli plant includes floret, leaves, stem, root, 
and seeds. The composition varies greatly across different parts (Fahey et al. 1997). For instance, 
the compound glucoraphanin is present at highest level in the seed, compared to the other parts. 
Usually broccoli floret is the part consumed. Fresh broccoli florets contain approximately 90% 
water. In terms of macronutrient composition, broccoli florets contain an average of 6.64 g /100g 
fresh weight (FW) carbohydrate, with a fiber content of 2.60 g/100g FW. Broccoli contains only 
trace amount of protein (2.82 g/100g FW) and very little fat (0.37 g/100g FW). Broccoli contains 
a diverse distribution of vitamins. It is an excellent source for vitamins C and K (107% of Daily 
Value (DV) and 97% DV, per 100g FW, respectively). Broccoli is also a good source for vitamin 
B (B1, B2, B3, B5, B6 and B9, 10-19% DV/ 100g FW). Besides, broccoli contains a small amount 
of vitamins A and E as well. In terms of minerals, broccoli florets contain a moderate level of 
manganese (10% DV/100g FW) and phosphorus (9% DV). They also contain a small amount of 
potassium (7%), iron (6%), magnesium (6%), calcium (5%), zinc (4%), and sodium (2%) (All the 
data above are cited from USDA National Nutrient Database for Standard Reference 28, slightly 
revised May 2016 Software v.3.7 2017-02-01). 
Glucosinolates in broccoli 
In particular, broccoli has a significant amount of glucosinolates (GSL), which are  unique 
components in plants of the order Capparales, comprising the families Capparaceae, Brassicaceae 
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(Cruciferae), Koeberliniaceae, Moringaceae, Resedaceae and Tovariaceae (Rodman et al. 1998). 
GSL are secondary plant metabolites (phytochemicals) derived from amino acids, bearing an N-
sulfate and an S-glucose moiety (Jeffery and Araya 2009). The GSLs in broccoli include 
glucoraphanin (GRP), glucobrassicin, 4-Methoxyglucobrassicin, glucoiberin, neoglucobrassicin, 
glucoerucin, and glucoalysin (Tian et al. 2005).  Among them, GRP is the most abundant one, the 
main hydrolysis products of which is sulforaphane (SF). The GSL composition and amount in 
broccoli vary substantially, affected by type of cultivar, climate, harvest season, growing 
conditions, and different plant parts (Jeffery et al. 2003).  
Phenolic compounds in broccoli 
Phenolic compounds are another big group of secondary metabolites in broccoli. Depending on 
the structure, phenolic compounds can be classified into flavonoids, hydroxycinnamic acid 
derivatives, phenolic acids, and simple phenols. Flavonoids are the most extensively studied 
among these phenolic compounds, which are further classified into flavone, isoflavone, flavonol, 
flavanone, flavan-3-ol, and anthocyanidin (Del Rio et al. 2013) . 
Broccoli contains a large number of flavonoids, principally flavonols. Quercetin sophorosides, 
kaempferol sophorosides and their derivatives in combination with hydroxycinnamic acids are the 
most abundant phenolic compounds in broccoli (Cartea et al. 2010). Compared with kaempferol, 
quercetin contains one more hydroxyl group, and its bioactivity is more extensively studied. 
Therefore, we are particularly interested in quercetin and its derivatives in broccoli.  
2.2 Broccoli and Health 
Broccoli and cancer 
Brassicas are well appreciated to decrease cancer risk. The unique isothiocyanates (ITCs, the 
main hydryolysis products of GSLs) in brassicas are suggested to be chemopreventive in vitro, 
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such as inducing cell apoptosis, inhibiting inflammation and mutations (Hecht 1999; Murillo and 
Mehta 2001). The whole brassica also has been shown to protect rodents against cancers (Chen et 
al. 2016). However, when the brassicas are used in clinical studies, the chemopreventive effect is 
not consistent. As a review summarizing the chemoprevention by brassicas of the top four 
prevalent cancers in US (lung, colorectal, breast, and prostate cancers) shows, some studies 
indicated a negative association between brassica intake and cancer risk, whereas other studies 
reported that there was no association between the two (Higdon et al. 2007). 
One possible explanation for this inconsistency may be attributed to genetic polymorphisms. 
For instance, researchers found that for those who have the homozygous for null GSTM1 and 
GSTT1, which genotype leads to a longer time for ITCs to circulate in the body, there was a greater 
negative association between brassica intake and lung & colon cancer risks (Higdon et al. 2007). 
Yet this was not consistently found in all studies. 
Other possible factors influencing the inconsistency of efficacy of cruciferous vegetables may 
come from the large variability in bioavailability of ITCs, which highly depends on the extent of 
hydrolysis from GSL. The highly variable composition and abundance of GSL as well as the 
different food matrices may also be responsible for the inconsistent results. For instance, one paper 
reported that there was a negative association between urinary ITCs and breast cancer risk, whereas 
there was no association between brassica intake and breast cancer risk (Fowke et al. 2003) . This 
result indicates that the bioavailability of ITCs may play an important role in the efficacy of 
brassicas.  
Broccoli and gut health 
The gastrointestinal (GI) tract in our body is not only responsible for nutrient digestion and 
absorption, but also a component of the immune system. A healthy gut barrier acts as a 
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semipermeable membrane, only allowing access of nutrients and preventing access of numerous 
bacteria and toxins. Inflammation, however, compromises the integrity of the gut barrier, resulting 
in gut leakage, which further promotes allergies, asthma, autoimmune disease, cancer and other 
diseases (Richards et al. 2016). 
Inflammatory bowel disease (IBD) is a complicated multifactorial but prevalent chronic disease 
involved with gut inflammation, the etiology of which is not fully understood yet (Kim and Cheon 
2017). The most common IBDs are Crohn’s Disease (CD) and Ulcerative Colitis (UC) (Tontini 
2015). Both of them are associated with chronic inflammation in the GI tract, but with a difference 
in the site of inflammation: CD is usually involved with the whole GI tract, whereas UC typically 
occurs in colon (Chassaing et al. 2014). Over decades, a myriad of animal models of IBD have 
been developed, with the purpose of investigating the pathogenesis of IBD, as well as evaluating 
potential therapies (Perše and Cerar 2012). Among them, Dextran sulfate sodium (DSS)-induced 
colitis, a chemical induced model is one of the most commonly used models, due to its simplicity, 
rapidity, controllability and many similarities with human ulcerative colitis (Chassaing et al. 2014).  
Accumulating evidence suggests broccoli has the effect of mitigating gut inflammation in vitro 
and in vivo. In vitro studies suggest that broccoli extract inhibited nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) pathway in lipopolysaccharide (LPS)-stimulated RAW 
264.7 cells (Hwang and Lim 2014) and protected the barrier integrity of Caco-2 cells, a widely 
used human intestinal model (Ferruzza et al. 2016). In vivo studies suggest the dietary broccoli 
mitigated the inflammation in various rodent models, including the DSS-induced colitis in rats 
(Mueller et al. 2013) and mdr1a−/− mice (a mouse model with genetic IBD; Paturi et al. 2012). In 
these studies, however, only fresh broccoli was investigated whereas it has been widely 
acknowledged that the cooking conditions for broccoli would greatly affect its efficacy. 
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2.3 Glucoraphanin and Sulforaphane 
Glucoraphanin (GRP) hydrolysis 
Glucosinolates (GSL) are secondary plant metabolites derived from amino acids, bearing an N-
sulfate and an S-glucose moiety (Jeffery and Araya 2009). They are primarily found in plants 
belonging to the family Brassicaceae (Cruciferae) including broccoli, mustard, kale, cabbage, 
Brussel sprouts, etc.  
The existence of GSLs in the plants are possibly attributed to their roles in the defense system 
(Hopkins et al. 2009). When predators chew the plant tissue, myrosinase, an enzyme that was 
originally stored separately, is freed to meet the substrate GSL. Upon hydrolysis, glucose and 
sulfate from the GSL are released and an array of hydrolysis products are formed, including ITCs, 
nitriles, thiocyanates, epithionitrile, and oxazolidine-thiones (Vaughn and Berhow 2005). 
Generally, defensive properties are considered enhanced upon hydrolysis, comparing to the parent 
compounds GSL (Halkier and Gershenzon 2006). The profile of the hydrolysis products varies 
depending on the plant species, side-chain structure, pH and iron concentration (Vaughn and 
Berhow 2005). 
 The GSLs in broccoli are primarily GRP (Tian et al 2005). As Figure 2.1 shows, the hydrolysis 
products of GRP primarily include ITCs (SF and erucin) and nitriles (SF nitrile and erucin nitrile) 
(Angelino and Jeffery 2014). Erucin is the reduced form of SF. SF nitrile and erucin nitrile are the 
nitrile derivative of corresponding ITCs, having a -C≡N group in replacement of the -N=C=S 
group (Figure 2.1).  The formation of nitriles is promoted by a modifier protein, epithiospecifier 
protein (ESP) (Matusheski et al. 2006), and is favored in low pH and in the presence of iron 
(Angelino et al. 2015). Comparing the ITCs and nitriles formed upon the hydrolysis of GRP, ITCs 
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have obtained more attention for their well-acknowledged anti-cancer bioactivity. On the contrary, 
the nitriles failed to show these chemoprotective effects (Matusheski and Jeffery 2001).  
In studies of the efficacy of SF from Brassica processed with different methods (Conaway et 
al. 2000; Shapiro et al. 2001; Shapiro et al. 2006; Clarke et al. 2011; Fahey et al. 2015), researchers  
found a small but consistent 10% of SF recovery in the urine even after consumption of cooked 
Brassica, where the myrosinase had been fully inactivated by heat. The occurrence of SF suggested 
that GRP must be hydrolyzed somewhere by unknown sources other than plant myrosinase. 
Notably, there was a 2-4 hour delay in the absorption and distribution of SF in plasma and tissues 
after consumption of cooked brassica compared with that of raw brassica (Conaway et al. 2000; 
Clarke et al. 2011; Li et al. 2013), indicating the hydrolysis of GRP to SF occurred in the lower GI 
tract, where abundant microbiota live.  
In the meantime, individual bacterial strains like Lactobacillus agilis, Bifidobacterium spp., 
Enterobacteriaceae (Llanos et al. 1995; Cheng et al. 2004; Mullaney et al. 2013; Luang-In et al. 
2014) were reported to possess myrosinase-like activity and be able to hydrolyze different GSLs 
in vitro. This evidence altogether pointed to the hypothesis that certain gut bacteria in the lower 
gut have myrosinase-like activity, although in a slow (2-4 hour delay) and low efficiency (only 
10% of SF recovery in urine) manner. The hypothesis was also supported by a study where subjects 
were given antibiotics and an enema followed by a diet containing cooked broccoli sprouts extract 
(Shapiro et al. 1998). These subjects produced even fewer urinary SF metabolites than subjects 
without the antibiotics and enema treatment, confirming the role of gut microbiota in the hydrolysis 
of GRP. 
Since that time on, researches have focused on further proving this by incubating the GRP or 
broccoli extract directly with cecal or fecal microbiota ex vivo (Lai et al. 2010; Li et al. 2011; Saha 
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et al. 2012; Angelino et al. 2015). All these studies confirmed the microbial myrosinase-like 
activity based on the occurrence of hydrolysis products or the disappearance of GRP.  
Interestingly, in both in vitro and ex vivo studies, erucin and nitriles rather than SF and ITC, were 
the predominant hydrolysis products of GRP or broccoli extract, indicating the hydrolysis by the 
gut microbiota is more complex than expected. Some researchers (Mullaney et al. 2013; Luang-In 
et al. 2014) hypothesized that the occurrence of reduced ITC (erucin, iberverin) was attributed to 
the presence of sulfoxide reductases in the bacteria, and the occurrence of the nitriles was due to 
the low pH in the medium. They excluded the possibility that the reduction of SF to erucin was 
due to the oxygen availability by observing the same amount of erucin and iberverin under both 
aerobic and anaerobic conditions.  
Bioavailability of SF 
Bioavailability is the fraction of a compound that is absorbed and reaches the circulatory 
system, therefore is an important parameter for evaluating the effectiveness of a drug or a 
phytochemical compound. In this sense, improving the bioavailability of SF is a fundamental step 
to maximize the health-promoting properties of broccoli. 
SF is generally considered to be released by hydrolysis of GRP and absorbed rapidly in the 
upper GI tract, i.e. small intestine (Barba et al. 2016).  A rodent study depicting the dynamic 
distribution of SF and SF metabolites among six different tissues, suggested that the distribution 
occurred within 0.5 hour after administration of a pre-hydrolyzed broccoli extract (Li et al. 2013). 
The consumption of cooked broccoli usually results in a 2-4 hour delayed absorption and 
distribution of SF in both human and mouse plasma and tissues (Clarke et al. 2011; Conaway et 
al. 2000; Li et al. 2013), indicating that the hydrolysis of GRP to SF occurs in the lower GI tract.  
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A myriad of studies (Clarke et al. 2011; Conaway et al. 2000; Shapiro et al. 2001; Shapiro et 
al. 2006; Fahey et al. 2015) have compared the bioavailability of SF from brassicas that were 
processed differently. Different processing methods basically lead to three forms of brassicas: raw 
brassicas, cooked brassicas and pre-hydrolyzed brassicas. Generally, the administration of pre-
hydrolyzed brassicas, where the SF has been already hydrolyzed by myrosinase in vitro, showed 
the highest urinary recovery, ranging from 40% to 80% (Shapiro et al. 2001; Shapiro et al. 2006; 
Fahey et al. 2015). The consumption of raw brassicas showed moderate urinary recovery, ranging 
from 25% to 40% (Shapiro et al. 2001; Conaway et al. 2000), depending on the chewing efficiency. 
The consumption of cooked brassicas showed the lowest urinary recovery with greatest variation 
among subjects, ranging from 10% to 20% (Conaway et al. 2000; Fahey et al. 2015; Shapiro et al. 
2001; Shapiro et al. 2006), indicating the microbial hydrolysis of GRP is less effective than plant 
myrosinase.  
Bioactivity of SF 
After absorption, SF is extensively and rapidly metabolized through the mercapturic acid 
pathway (Figure 2.2, modified from Higdon et al. 2005). The central carbon atom of the -N=C=S 
group in SF is strongly electrophilic and can react with oxygen-, sulfur- or nitrogen-centered 
nucleophiles, yielding thiocarbamates,  dithiocarbamates or thiourea derivatives, respectively 
(Zhang 2012). In liver, the carbon atom of the -N=C=S of SF reacts with the cysteine thiol of 
glutathione (GSH), forming a series of dithiocarbamates: SF-GSH, SF-cysteine-glycine, SF-
cysteine, SF-N-acetylcysteine (SF-NAC) (Figure 2.2), which are excreted in the urine, with the 
most abundant form being SF-NAC (Clarke et al. 2011; Janobi et al. 2006).  
With the conjugation to GSH, SF is highly reactive with the sulfhydryl-rich protein, Keap1 in 
the cells (Kensler et al. 2012). Keap1 is a cytosolic protein that represses Nuclear factor (erythroid-
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derived 2)-like 2 (Nrf2) signaling by promoting its proteasomal degradation (Kensler et al. 2012). 
By binding with Keap1, SF inhibits degradation of Nrf2 and allows the accumulation and 
translocation of free Nrf2 into the nucleus, leading to activation of genes involved with anti-
oxidation, anti-inflammation and phase II detoxification.  
2.4 Quercetin Glycosides and Quercetin 
Like most flavonoids, quercetin occurs as multiple quercetin glycosides (QGs) in nature. The 
major QG in broccoli is quercetin-3-O-sophoroside (QS; Price et al. 1998). In order to understand 
the disposition of QS, it is important to review the absorption of other QGs.  
A debate 
The extensive discussion on uptake and metabolism of QGs occurred during 1995-2005. Before 
that time, it was considered that the flavonoid glycosides could only be absorbed from the lower 
gut (i.e. colon) as a consequence of microbial hydrolysis and catabolism: from our perspective 30 
years later, this idea no longer holds. However, at that time, this opinion was generally held for 
two reasons. The first reason was that at that time β-glycosidase was considered present only in 
bacteria; the second reason was that no transporter system for flavonoid glycosides had been 
reported. Since flavonoid glycosides were thought unable to undergo either deglycosylation to the 
aglycone (which might then cross the membrane by passive diffusion) or absorption directly at the 
small intestine due to the lack of any known transporter systems, travel to the colon appeared 
necessary, where abundant bacteria were known to live and could break down the glycosides to 
aglycones and further to phenolic acids.  
This long-held dogma was broken by Hollman and colleagues in 1995 (Hollman et al. 1995), 
when healthy ileostomy patients were investigated. The use of ileostomy patients made it possible 
to exclude any interference from colonic metabolism. Surprisingly, researchers found the presence 
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of quercetin in the urine of subjects following ingestion of either onions (mainly quercetin-4’-O-
glucoside and quercetin-3, 4’-diglucoside) or rutin, even in the absence of the colon. This finding 
was remarkable because it clearly suggested the uptake of QGs across the small intestine. 
Unfortunately, the quercetin found in the urine was measured as total quercetin following acid 
hydrolysis. Therefore, it was unknown whether the absorbed quercetin was in the form of quercetin 
aglycone, quercetin metabolites or intact QGs.  
Two hypotheses and two approaches 
A question was then raised: in which manner do the QGs enter the circulatory system from the 
small intestine? There were two hypotheses. One hypothesis postulated by Hollman in his original 
1995 paper (Hollman et al. 1995) was that the uptake was due to the transportation of intact QGs 
by unknown transporter systems. The other hypothesis was that the uptake was due to 
deglycosylation by unknown glycosidases followed by diffusion of released quercetin aglycones 
across the membrane.  
Understanding how QGs enter the body is an essential part to understanding the bioavailability 
of quercetin from various dietary sources, as almost all dietary quercetin occur as QGs. It would 
also provide important information for studies of the bioactivity of quercetin. If intact QG is the 
predominant form of quercetin in the circulatory system, then the bioavailability and/or bioactivity 
of intact QGs should be studied, not only Q aglycone or other metabolites. 
To address the question of whether QG is absorbed intact or as the aglycone after 
deglycosylation at the small intestine, two different approaches were carried out. One approach 
was to examine the plasma or urine to see whether there was intact QG; another way was to identify 
possible transporters (supporting intact absorption) or β-glycosidase (supporting deglycosylation 
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prior to absorption). Comparing the two approaches, Approach 1 would provide direct evidence 
for the absorbed forms, and Approach 2 would provide the molecular basis and explanations.  
Approach 1 
The main objectives of Approach 1 studies were (1) whether the QGs are absorbed at the small 
intestine; (2) whether intact QGs occur in the circulation. Over decades, many Approach 1 studies 
have been carried out. However, the results are highly divergent and inconsistent. We consider 
that the inconsistency might be attributed to subject (rat or human), the study model (ex vivo, in 
situ or in vivo), the analytical method (with or without hydrolysis; type of detector following 
chromatography) and/or the nature of the glycosides under study (the type, position and numbers 
of the glycoside moieties attached to quercetin). These factors are further considered below. 
Subject and models 
The type of subject and model is the first important factor to consider for Approach 1 studies. 
Clinically, there are mainly two types of model. One model is to investigate plasma and urine of 
healthy subjects following a diet containing QGs. Blood samples are typically drawn at a series of 
time points (typically within 24h) following QG administration to obtain a kinetic curve. The 
absorption site is identified based on the time of peak occurrence. However, it is reported that the 
small intestinal transit time varies from 15min to 5h, with considerable variation among 
individuals (Kim 1968). This broad range makes this method for the determination of absorption 
site difficult and less accurate. Another model overcoming this problem is by the use of ileostomy 
patients. Because of the lack of colonic route in ileostomy patients, anything present in the 
circulation must be from the exclusive absorption at the small intestine. 
In rats, there are also two major types of model. One is the feeding study, as for humans, 
investigating the plasma and urine samples following oral administration. Besides the problem of 
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broad variation of small intestinal transit time, another problem of this model is the limited amount 
and size of blood samples. Compared to human, rats have a remarkably smaller volume of blood. 
A 200g rat that is commonly used in these studies only has a total of 12mL of blood (Lee and 
Blaufox 1985) compared to 4.7 L in adult men. Moreover, blood must be drawn at several time 
points to obtain a good kinetic curve, leading to the maximum volume of blood one could draw at 
each time even less. On the other hand, because quercetin absorption is usually low, the quercetin 
level in the peripheral circulation is extremely dilute. The low amount of blood volume and the 
low concentration of quercetin in blood therefore make the analysis extremely difficult. 
Because of these problems, ex vivo and in situ models emerged. In ex vivo studies, small 
intestinal segments (usually jejunum) are harvested freshly from rats, ligated and transferred to 
organ bath filled with warm buffer, gassed with oxygen and 5% carbon dioxide. Sometimes the 
segments are everted before ligation, called everted sac. The advantage of everted sac is that by 
everting, the mucosal side would be open to the outside. The buffer in the bath then becomes the 
mucosal fluid, easier to operate. The inside of the sac would be the serosal side, representing the 
“plasma”. Presence of any substances in the serosal fluid indicates the successful uptake across the 
epithelium. Although the ex vivo model might have the problem of viability of tissues, it has the 
advantage of overcoming the problem of a limited amount of plasma samples. 
In situ model is more like a combination of in vivo and ex vivo models; therefore, it has the 
advantages and disadvantages of both models. In in situ studies, small intestinal segments are 
ligated and remains as part of the body. Either perfusion or one-dose injection could be used for 
administration of QGs in the segments. Perfusion has the advantage of modeling the dynamic 
situation in vivo but requires a complicated instrumental system to maintain the stable flow. 
Because the rats are maintained alive during the in situ experiments, fresh blood is drawn as that 
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in in vivo models. One important advantage of the in situ model is the accessibility of blood from 
portal vein, which is the blood before joining the peripheral circulation and therefore more 
concentrated.  
Compared to in vivo models, both in situ and ex vivo models have advantages of interrogation 
of small intestine directly.  
Analytical methods 
The profiling of the forms of quercetin in the circulation relied heavily on the sensitivity and 
resolution of the analytical method. The advancement of technology has made it possible to 
differentiate, identify and quantify different quercetin forms. On the other hand, the motivation to 
identify the metabolites also facilitates progress in the analytical methods. 
Since the original paper by the Hollman and colleagues in 1995 (Hollman et al. 1995), it is now 
a long time since analysis relied on either acid hydrolysis or enzyme hydrolysis (β-glucuronidase 
and sulfatase). That method brought all different quercetin forms to one single form: the quercetin 
aglycone. Therefore, it is total quercetin that is measured. There are several reasons why the 
hydrolysis is used prevalently. The major reason is lack of standards for the various quercetin 
metabolites (even now, not all the metabolite standards are commercially available). Quercetin 
aglycone once absorbed undergoes extensive cellular metabolism (sulfation, glucuronidation and 
methylation) on one or more of the five free hydroxyl groups, resulting in dozens of possible 
metabolites. Another reason was that the metabolites usually occur in particularly low abundance, 
making quantification almost impossible. Bringing all forms into one detectable form by 
hydrolysis overcomes the problem. Later, with the advent of more sensible detectors and emerging 
standards, analysis following hydrolysis was less commonly used. 
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As mentioned above, another big evolvement in analytical methods was the type of detector 
attached to the HPLC column. In the original paper (Hollman et al. 1995), the florescence detector 
was used. This method is highly sensitive, but requires a further conversion of quercetin to a 
quercetin-aluminum complex. Later studies using UV and/or visible absorption emerged. The 
problem of UV detection is lack of specificity. With this method, retention time is typically the 
only basis for identification of compounds, which might cause false identification. For instance, it 
is reported that the retention time for quercetin-3-O-glucoside (Q3G) is very similar to that for one 
form of quercetin glucuronide (QGA), leading to the false positive identification of QGA as Q3G 
(Day and Williamson 2001). Use of electrochemical detection (ECD) overcame this problem 
(Morand et al. 2000; Sesink et al. 2001). These authors used both retention time and 
electrochemical behavior to identify compounds, which greatly enhanced the specificity and 
sensitivity. By using ECD coupled with the appropriate HPLC gradient, they were able to 
differentiate various forms of quercetin.  
More recently, LC-MS2 has begun to be widely used. By gathering information of retention 
time, molecular weight and the fragmentation pattern, MS2 has the advantage to identify different 
forms of quercetin easily. It has therefore become the most common analytical method to identify 
compounds. 
The nature of the glycosides 
Common quercetin glycosides (Figure 2.3) include quercetin-3-O-glucoside (Q3G), quercetin-
4’-O-glucoside (Q4’G), quercetin-3, 4’-O-diglucoside (Q3,4’-diG), and quercetin-3-O-rutinoside 
(rutin). Here, we would focus on Q3G and rutin. Approach 1 studies involved with Q3G and rutin 
are summarized in Tables 2.1 and 2.2, respectively.  
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As Table 2.1 shows, it is clear that Q3G is absorbed at the small intestine, despite different 
models and analytical methods used. It is also almost consistent that Q3G does not occur in the 
circulation as intact Q3G. The only exception is the study from Rice-Evans’ group (Spencer et al. 
1999), where intact Q3G, QGAs as well as quercetin aglycone were all found in the serosal fluid.  
Rutin is one of the most abundant polyphenols in black tea. The structure of rutin is a bit 
different from the other QGs (Figure 2.3), as most QGs are quercetin glucosides. The glycoside 
in rutin is rutinose, which is a glucose conjugated with a rhamnose with a β-1, 6- linkage. In 
contrast to Q3G, the results about rutin in Approach 1 studies are more complicated (Table 2.2). 
As Table 2.2 shows, different subject, model and analytical methods appear to lead to different 
results.  
In rat studies, almost half of them reported no absorption at the small intestine whereas the other 
half reported the presence of absorption. For feeding in vivo studies, the Remesy group (Manach 
et al. 1997) found no rutin absorption by 2h and little quercetin at 4h, indicating that rutin is not 
absorbed at the small intestine. In contrast, the Grant group (Carbonaro and Grant 2005) found 
intact rutin in the 1h-tail blood after rutin consumption. For ex vivo studies, both the Remesy 
(Crespy et al. 1999) and the Ader groups (Wolffram et al. 2002) found no change in rutin 
concentration in the mucosal fluid after incubation with small intestinal segments, indicating no 
absorption. However, the Grant group (Carbonaro and Grant 2005) found the disappearance of 
rutin from mucosal fluid as early as 0.5min. Studies that examined the serosal fluid, also 
consistently found that rutin was absorbed at the small intestine and that it was absorbed intact 
(Spencer et al. 1999; Andlauer et al. 2001). In the Fürst group’s study (Andlauer et al. 2001), with 
a model of 60-min perfusion of rutin in the whole small intestine, they reported the occurrence of 
rutin sulfate and rutin glucuronides in the serosal fluid, in addition to intact rutin. The presence of 
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rutin metabolites excludes the possibility of paracellular absorption of rutin due to the gut leakage, 
because sulfation and glucuronidation must occur inside the epithelial cell. 
In clinical studies however, data almost consistently show that rutin is not absorbed from the 
small intestine and that no intact rutin occurred in the circulation. For studies reporting the presence 
of absorption, the amount is tiny and it might be attributed to the hydrolytic action of stomach acid. 
The only exception is a study from Mauri and colleagues (Mauri et al. 1999). They found intact 
rutin in plasma of subjects following ingestion of rutin-containing tomato, using a sensitive and 
specific analytical method (LC-MS2), but only one plasma sample was measured and the time 
point was not given. Regardless of absorption site, this study suggests intact absorption in human. 
One possible explanation is that the rutin-containing tomato was administered for two weeks in 
this study. It is possible that the frequent rutin intake may enhance some enzyme activities such as 
membrane transporters above baseline levels, so that the result is different from a single-dose 
study. 
As shown above, the nature of the glycosides greatly affects where and how the QG is absorbed. 
Q3G is considered to be absorbed at the small intestine and not occur as intact form in the 
circulation in both rat and human models, whereas rutin appears to be not absorbed at the small 
intestine in human. In rat models, some studies suggest rutin can be absorbed intact at the small 
intestine but results are inconsistent. It is possible that the transporter system between rat and 
human might be different, such that the transporter in rats might have specificity towards rutin but 
the human transporter might lack specificity towards rutin.  
Approach 2 
Results from Approach 1 studies have shown that Q3G is absorbed in the small intestine and 
does not occur in the intact form in the circulation. However, two possibilities remain. One 
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possibility is that Q3G is absorbed intact by a “membrane-bound transporter” and deglycosylated 
by a “cytosolic β-glycosidase” inside enterocytes; another possibility is that Q3G is deglycosylated 
by a “luminal β-glycosidase” in the lumen and the released aglycone is subsequently absorbed.  
To understand which hypothesis is correct or whether the two hypotheses work together, it is 
essential to identify the key proteins in the small intestine: the unknown “membrane-bound 
transporter”, the “cytosolic β-glycosidase”, and the “luminal β-glycosidase”. The identification of 
these proteins has been the major focus of Approach 2 studies. 
Identification of cellular and luminal β-glycosidases 
In an effort to identify the β-glycosidases in the small intestine, Day and Williamson made 
enormous progress (Day et al. 1998; Day et al. 2000; Day et al. 2003). At that time, there had been 
three β-glycosidases reported at the small intestine in humans: glucocerebrosidase, the broad-
specificity cytosolic beta-glucosidase (CBG), and lactase phlorizin hydrolase (LPH, the only 
luminal β-glycosidases). However, whether these enzymes have specificity towards QGs was 
unknown. 
The first study conducted by  the Williamson group was to incubate several QGs with cell-free 
extracts from human small intestine, with the purpose to determine whether these enzymes could 
deglycosylate QGs (Day et al. 1998). They found the quercetin monoglucosides (Q3G and Q4’G) 
were deglycosylated substantially in 90-min incubation (but not the quercetin diglycosides: Q3,4’-
diG and rutin). Further, by using inhibitors of glucocerebrosidase and CBG, they demonstrated 
that the deglycosylation could be attributed to CBG. Unfortunately, the role of LPH was not 
examined in this study. In a later study (Day et al. 2000), the Williamson group used purified LPH 
isolated from lamb and showed that Q3G and Q4’G were also substrates of LPH. 
These findings successfully unveiled the unknown “cytosolic β-glycosidase” and the “luminal 
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β-glycosidase” as CBG and LPH, respectively. Located inside the enterocytes, CBG was shown 
able to cleave intracellularly any QG possibly absorbed intact, whereas LPH, present in the lumen, 
was shown able to cleave the QGs extracellularly. However, it was still unknown whether the QGs 
are absorbed intact and deglycosylated by CBG or deglycosylated by LPH and then absorbed. 
Therefore, studies to identify the “unknown membrane transporters” were carried out.  
Identification of Transporters 
Hollman and colleagues (Hollman et al. 1995) first postulated that the sodium dependent 
glucose transport protein 1 (SGLT1) was the “unknown membrane transporter” because the uptake 
appeared to be sodium dependent. Therefore, later studies have mainly focused on specificity of 
SGLT1 towards QGs. As for Approach 1 studies, SGLT1 studies are here discussed for several 
QGs, because unfortunately there are no general conclusions to date. 
(1) Q3G 
To study the specificity of SGTL1 towards Q3G, the Johnson group decided first to examine 
the possibility of interaction between Q3G and SGLT1 (Gee et al. 2000). Using a rat jejunal everted 
sac model, they found that the SGLT1-mediated uptake of galactose was reduced in the presence 
of Q3G, suggesting that Q3G might bind to SGLT1 and consequently inhibit the uptake of 
galactose. However, considering that phlorizin also binds to SGLT1, but phlorizin per se is not 
transported across the membrane, these data only suggest that Q3G might recognize and bind to 
SGLT1, but do not necessarily suggest that it is transported by SGLT1 into the circulation. 
A common way to study the specificity of an enzyme is to use enzyme inhibitors. Phlorizin is 
a potent competitive inhibitor of SGLT1 and was used by Walle’s group (Walgren et al. 2000), the 
Ader group (Wolffram et al. 2002) and the Williamson group (Day et al. 2003). However, as 
pointed out by the Hollman group (Arts et al. 2002), phlorizin is also a potent inhibitor for LPH. 
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As SGLT1 and LPH are both hypothesized to be involved in the uptake of QGs, the idea of using 
phlorizin as an exclusive inhibitor of SGLT1 fails to differentiate if the absorption is mediated by 
SGLT or LPH. Therefore, results obtained from those phlorizin experiments (Walgren et al. 2000; 
Wolffram et al. 2002; Day et al. 2003) are of concerns.  
Fortunately, there are other approaches that differentiate SGLT1 and LPH pathways. For 
instance, one way is to use specific inhibitors for LPH. N-butyl-deoxygalactonojirimycin (NB-
DGJ) is a selective LPH inhibitor and was used by the Willamson group (Day et al. 2003) and the 
Hollman groups (Sesink et al. 2003). Both of these studies have shown that NB-DGJ greatly 
decreased the total quercetin content in circulation (plasma or serosal fluid) following 
administration of Q3G. These data suggest that the hypothesis about Q3G being deglycosylated 
by LPH and then absorbed holds true. 
The question then became whether LPH is the only pathway involved in the uptake of Q3G or 
if the SGLT1-CBG pathway also occurs in addition to the LPH pathway. The ratio of Q3G uptake 
inhibited by NB-DGJ (i.e. the LPH pathway) was then examined: 75% was reported by the 
Hollman group (Sesink et al. 2003), and 67% by the Williamson group (Day et al. 2003). The ratio 
of the LPH pathway from these two independent studies are remarkably consistent. Whether the 
remaining 25-33% of Q3G uptake is attributed to the SGLT1-CBG pathway however, is still 
debated. 
In a study carried out by the Ader group (Wolffram et al. 2002), the dependence on  Na+ was 
utilized to differentiate SGLT1 and LPH pathways: SGLT1 is sodium dependent, whereas LPH is 
sodium independent (Arts et al. 2002). With this approach, they found 37% of the disappearance 
of mucosal Q3G was reduced by the absence of Na+, indicating that 37% of the uptake of Q3G 
was attributable to the SGLT1 pathway (assuming that SGLT1 is the only sodium dependent 
23 
 
transporter in the small intestinal membrane). The ratio of SGLT1 pathway (37%) suggested in 
this study matches well with the LPH-unexplained ratio of Q3G intake (25-33%). 
However, the study by the Willamson group showed contrary results (Day et al. 2003). They 
found that phlorizin, which was considered to inhibit both LPH and SGLT1 (Arts et al. 2002), had 
no effect on Q3G uptake. One possible explanation is that the low concentration of phlorizin used 
in this study might only inhibit SGLT1 (Arts et al. 2002). If this were true, these data would suggest 
that the SGLT1 pathway is not involved in the uptake of Q3G at all, which is in contradiction to 
our previous discussion. The other experiment in this study further showed that the inhibition on 
the uptake of Q3G by phlorizin and NB-DGJ together was the same level as that by NB-DGJ alone. 
These results further supported that only the LPH pathway is involved in the uptake of Q3G.  
To summarize, at least 67-75% of the uptake of Q3G is due to luminal deglycosylation by LPH 
and is followed by absorption of released quercetin aglycone. Whether the uptake of Q3G is 
involved with the SGLT1-CBG pathway remained unknown because results obtained from 
different groups are inconsistent. However, it is reported that Q3G might recognize and bind to 
SGLT1. 
(2) Q4’G 
The Walle group (Walgren et al. 2000) was the first to provide direct evidence for uptake of 
Q4’G by SGLT1 using the Caco-2 cell model. Notably, LPH expression is low in Caco-2 cells; 
therefore, phlorizin might be used as an exclusive inhibitor of SGLT1 in this model. The authors 
first argued that the absence of any observed uptake of Q4’Gs was due to the masking effect of the 
efflux protein, multidrug resistance-associated protein 2 (MRP2), which constantly pumps any 
absorbed QGs back into the lumen. By using a MRP2 inhibitor (MK-571), they found a great 
enhancement of uptake of Q4’G into Caco-2 cells.  Further, they showed that the uptake was 
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mediated by SGLT1, because both the absence of Na+ and the presence of phlorizin greatly reduced 
the uptake. Moreover, their data show that the uptake of Q4’G in G6D3 cells (a SLGT1-transfected 
Chinese hamster ovary, CHO cell line) is 4-fold higher than that in the parental CHO cell line, 
clearly suggesting the SGLT1 is involved in the uptake of Q4’G. 
The specificity of SGLT1 towards Q4’G was also studied by the Williamson group (Day et al. 
2003). If one continues to assume that the phlorizin used in this study only inhibited SGLT1, as 
considered by the authors, the data suggest that Q4’G uptake is involved with both the LPH 
pathway (46-63%, inhibited by NB-DGJ) and the SGLT1 pathway (38-64%, inhibited by 
phlorizin). However, again, the inhibition on the uptake of Q4’G by phlorizin and NB-DGJ 
together was the same level as that by NB-DGJ alone, suggesting that SGLT1 was not involved, 
which is inconsistent with the author’s previous statement. If phlorizin is assumed to inhibit both 
SGLT1 and LPH, it is more likely that SGLT1 is not involved in the uptake of Q4’G. Despite the 
controversial statements about SGLT1 in this study, it appears that the clear conclusion is that LPH 
is involved in the uptake of Q4’G. 
In summary, at least 46-63% of the uptake of Q4’G is due to luminal deglycosylation by LPH, 
which is followed by absorption of released quercetin aglycone. Whether Q4’G is absorbed intact 
by SGLT1 remains unknown because of inconsistent results. However, it is reported that SGLT1 
transports intact Q4’G across the epithelium in in vitro models.  
(3) Rutin 
Approach 1 studies show that rutin is not absorbed in the small intestine in humans, but likely 
absorbed intact in rats. Because rutin is not a substrate for either CBG or LPH showed by Approach 
2 studies (Day et al. 1998), that explains why the rutin was found in the intact form in the 
circulation.  However, one study reported that rutin did not interact with SGLT1 using a jejunal ex 
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vivo model in rats (Gee et al. 1998). This indicates that there might be other transporter systems 
apart from SGLT1 for uptake of rutin. This idea is supported by a study (Chen et al. 2007), where 
another transporter protein, the glucose transporter 2 (GLUT2), was identified as able to transport 
QGs across the epithelium. However, this hypothesis requires confirmation in future studies. 
To summarize the review of absorption of QGs, the debate on whether QG is absorbed intact 
or after deglycosylation fails to reach an agreeable conclusion due to the inconsistent and divergent 
results. We consider that the absorption of QGs is greatly dependent on the nature of the glycosides 
under study (the type, position and numbers of the glycoside moieties attached to quercetin), as 
discussed above. Most of current literature about Approach 2 focus on SGLT1, however, other 
possible transporters should also be investigated. Furthermore, the current tool to study the SGLT1 
specificity toward QGs are limited to several inhibitors, such as phlorizin, which is also an inhibitor 
of LPH. Therefore, a specific and potent inhibitor of SGLT1 should be developed. After a mature 
methodology about the transporter studies has been established, other common QGs from dietary 
sources, such as quercetin-3-O-sophoriside in broccoli, should also be included, and this system 
could be extended to other flavonoid glycosides. 
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2.5 Tables and Figures 
Table 2.1. Summary of Approach 1 studies about quercetin-3-O-glucoside (Q3G). 
Reference Subject Model Sample type 
Analytical 
method 
Measured 
as 
Results 
Absorbed 
in SI? 
Intact in 
the 
circulation? 
Morand et 
al. 2000 
Rats In vivo: feeding 
Plasma (0, 3.5, 7, 
11, 24h) 
HPLC-ECD Q3G, Q, I, T 
Absence of intact Q3G; 
presence of Q in 3.5h-
plasma 
Cannot tell 
if it’s SI or 
colon 
Not intact 
Spencer et 
al. 1999 
Rats 
Ex vivo: jejunal 
and ileal 
perfusion 
Serosal & 
mucosal fluid 
HPLC-UV 
with and 
without 
enzymatic 
hydrolysis 
Q, Q3G, 
QGA 
Presence of intact Q3G, Q 
and QGA in serosal fluid 
Yes Intact 
Gee et al. 
2000 
Rats 
Ex vivo: jejunal 
everted sac 
Serosal fluid HPLC-UV Q3G, QGA 
Absence of intact Q3G, 
several QGAs and QGA-
sulfates in serosal fluid 
Yes Not intact 
Wolffram 
et al. 2002 
Rats 
Ex vivo: jejunal 
segments 
incubated in 
Ussing chamber 
Serosal & 
mucosal fluid 
HPLC-UV 
Q3G, Q, Q 
metabolites 
Mucosal disappearance of 
Q3G; but no Q3G, Q or Q 
metabolites were found in 
serosal fluid 
Yes 
(mucosal); 
No (serosal) 
/ 
Arts et al. 
2004 
Rats 
In situ: whole SI 
perfusion 
Plasma 
HPLC-ECD 
after 
enzymatic 
hydrolysis 
Q, I, T 
Presence of Q and I in 
30min-plasma 
Yes Cannot tell 
Olthof et 
al. 2000 
Human In vivo: feeding 
Plasma (0, 0.25, 
0.5, 1, 1.5, 2, 4, 
6, 8, 12, 24, 36, 
48, 60, 72h) 
HPLC-
fluorescence 
after acid 
hydrolysis 
Q, I 
Presence of Q in plasma 
as early as 0.5h 
Yes Cannot tell 
Sesink et 
al. 2001 
Human 
In vivo: same 
study as Olthof 
et al. 2000 
Plasma (30-min, 
pooled from 6 
subjects) 
HPLC-ECD 
Q3G, QGA, 
Q 
Absence of intact Q3G; 
presence of four QGAs 
and little Q 
Yes 
Not intact at 
30min; 
cannot tell 
for other 
time points 
 
SI: small intestine; Q: quercetin; I: isorhamnetin (3’-O-methylated quercetin); T: Tamarixetin (4’-O-methylated quercetin); Q3G (quercetin-3-O-
glucoside); QGA: quercetin glucuronide; ECD: electrochemical detection. 
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Table 2.2. Summary of Approach 1 studies about rutin. 
Reference Subject Model 
Sample 
type 
Analytical 
method 
Measured 
as 
Results 
Absorbed 
in SI? 
Intact in 
the 
circulation? 
Manach et 
al. 1997 
Rats 
In vivo: 
feeding 
Plasma (2, 
4, 8, 12, 
24h) 
HPLC-UV with 
and without 
enzymatic 
hydrolysis 
Rutin, Q, 
I, T 
No Q in plasma by 2h 
following ingestion (little Q at 
4h-plasma) 
No 
Cecum: not 
intact 
Carbonaro 
and Grant 
2005 
Rats 
In vivo: 
feeding 
Plasma from 
tail blood 
HPLC-UV Rutin, Q 
Intact rutin began to occur in  
1h- plasma 
Yes Intact 
Morand et 
al. 2000 
Rats 
In vivo: 
feeding 
Plasma (4h) 
HPLC-UV after 
enzymatic 
hydrolysis 
Q, I, T Q pressent in 4h-plasma 
Cannot 
tell if it’s 
from SI or 
colon 
Cannot tell 
Crespy et 
al. 1999 
Rats 
Ex vivo: 
jejunal and 
ileal perfusion 
Influent and 
effluent 
HPLC-UV after 
enzymatic 
hydrolysis 
Rutin 
No change of rutin 
concentration in influent and 
effluent 
No / 
Spencer et 
al. 1999 
Rats 
Ex vivo: 
jejunal and 
ileal perfusion 
Serosal 
&mucosal 
fluid 
HPLC-UV with 
and without 
enzymatic 
hydrolysis 
Rutin, Q 
and Q 
glucuroni
des  
Intact rutin in serosal fluid 
with absence of Q and Q 
glucuronides 
Yes Intact 
Andlauer, 
et al. 2001 
Rats 
Ex vivo: whole 
SI perfusion 
Serosal 
&mucosal 
fluid 
HPLC-ECD; 
LC-MS 
Rutin, 
rutin 
metabolite
s 
5.6% intact rutin, 2.5% rutin 
sulfate, 2.0% rutin glucuronide 
in serosal fluid; intact rutin 
occurred as early as10 min 
Yes 
Intact and 
rutin 
conjugates 
Wolffram, 
et al. 2002 
Rats 
Ex vivo: 
jejunal 
incubation 
Serosal 
&mucosal 
fluid 
HPLC-UV Rutin 
No mucosal disappearance of 
rutin 
No / 
Carbonaro 
and Grant 
2005 
Rats 
Ex vivo: 
jejunal 
incubation 
Mucosal 
fluid 
HPLC-UV Rutin 
Rutin disappeared in mucosal 
fluid as early as 0.5min 
Yes Cannot tell 
Hollman 
et al. 1995 
Human 
ileostomy 
patients 
In vivo: 
feeding 
Urine 
HPLC- 
fluorescence 
after acid 
hydrolysis 
Total Q 
Presence of Q in the urine Yes Cannot tell 
Hollman 
et al. 1997 
Human 
In vivo: 
feeding 
Plasma, 
urine 
Q began to occur at 1h-plasma 
Yes, a 
little 
Cannot tell 
Hollman 
et al. 1999 
Human 
In vivo: 
feeding 
Plasma 
No presence of Q in plasma by 
6h following ingestion 
No / 
28 
 
Table 2.2. (continued) Summary of Approach 1 studies about rutin. 
 
Mauri et 
al. 1999 
Human 
In vivo: 
feeding (in 
tomato) for 2 
weeks 
Plasma LC-MS Rutin 
Presence of intact rutin 
(only one sample and the 
time point not given) 
Cannot tell 
if it’s SI or 
colon 
Intact 
Erlund et 
al. 2000 
Human 
In vivo: 
feeding 
Plasma 
(0.25, 0.5, 1, 
2, 4, 6, 8, 
12, 24, 32h) 
HPLC-ECD 
Rutin, total 
Q 
No intact rutin at all time 
points; 
presence of little Q during 0-
2h 
Yes, a little Not intact 
Graefe et 
al. 2001 
Human 
In vivo: 
feeding 
Plasma 
HPLC-ECD with 
and without 
enzymatic 
hydrolysis 
Rutin, rutin 
metabolites, 
Q, Q 
metabolites 
No intact rutin (the time 
point not given); 
presence of little Q during 0-
2h 
Yes, a little Not intact 
Jaganath 
et al. 2006 
Human 
(healthy 
and 
ileostomy 
patients) 
In vivo: 
feeding in 
tomato soup 
Plasma 
(every 1h 
until 8h) 
LC-MS 
Rutin, Q, Q 
metabolites 
Nothing during 0-3h; 
presence of glucuronides in 
4-8h plasma; 
(nothing in plasma & urine 
sample of ileostomy 
patients) 
No / 
 
SI: small intestine; Q: quercetin; I: isorhamnetin (3’-O-methylated quercetin); T: Tamarixetin (4’-O-methylated quercetin); ECD: electrochemical 
detection. 
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Figure 2.1. Main hydrolysis products of glucoraphanin. 
 
 
 
 
 
 
 
 
 
Figure 2.2. Metabolism of sulforaphane via mercapturic acid pathway; modified from 
Higdon et al. 2017.  
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Quercetin-3-O-glucoside (Q3G) Quercetin-4’-O-glucoside (Q4’G) 
  
Quercetin-3, 4’-O-diglucoside (Q3,4’-diG) Quercetin-3-O-rutinoside (rutin) 
 
 
Figure 2.3. Structure of common quercetin glycosides 
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CHAPTER 3: Dietary Broccoli Alters Rat Cecal Microbiota to Improve Glucoraphanin 
Hydrolysis to Bioactive Isothiocyanates 1 
3.1 Introduction 
Broccoli belongs to the glucosinolate (GSL)-containing family of brassica vegetables. The 
major GSL in broccoli is glucoraphanin (GRP) which, upon hydrolysis, produces the bioactive 
isothiocyanate (ITC) sulforaphane (SFN), shown to slow or prevent cancer in humans (Bauman et 
al. 2016). One major mechanism of action of SFN is upregulation of several phase II detoxification 
enzymes, including NAD(P)H: quinone oxidoreductase 1 (NQO1) (Dinkova-Kostova et al. 2007). 
Here we use increased NQO1 levels as a measure of broccoli-induced bioactivity. 
The formation of SFN from GRP is catalyzed by the plant enzyme myrosinase, active during 
chewing or crushing when broccoli is consumed raw or lightly steamed (Angelino and Jeffery 
2014). When broccoli and other brassica vegetables are cooked more vigorously, the plant 
myrosinases are inactivated and, thus, are unable to hydrolyze GSLs (Wang et al. 2012). Even 
though many US consumers prefer cooked broccoli, epidemiological studies suggest that 
frequent consumption of brassica vegetables decreases the risk for a number of cancers, 
including breast, colon, and prostate cancers (Jeffery and Araya 2009). This suggests that GSLs 
undergo hydrolysis to ITC following ingestion, in the absence of active plant myrosinase. 
Several microorganisms isolated from the mammalian gut, including lactic acid bacteria (Llanos 
Palop et al. 1995), Enterobacteriaceae (Mullaney et al. 2013), Bifidobaicterium spp. (Cheng et 
al. 2004), and Bacteroides spp. (Elfoul et al. 2001), appear to have myrosinase-like glycoside 
hydrolases that cleave GSL. 
1 This chapter appeared in its entirety in Nutrients: Liu, X., Wang, Y., Hoeflinger, J.L., Neme, 
B.P., Jeffery, E.H. and Miller, M.J., 2017. Dietary broccoli alters rat cecal microbiota to improve 
glucoraphanin hydrolysis to bioactive isothiocyanates. Nutrients, 9(3), p.262. This article is 
reprinted with permission from the publisher and can be found in Appendix A. 
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 However, although research shows direct evidence for GRP hydrolysis ex vivo and in vivo to 
bioactive SFN by cecal microbiota, SFN is only found in trace amounts (Lai et al. 2010). 
Comparatively inactive nitriles (Matusheski and Jeffery 2001; Matusheski et al. 2006), not 
bioactive ITC, are typically reported as products of microbial GSL hydrolysis ex vivo, as reviewed 
in (Angelino and Jeffery 2014), and ingestion of cooked broccoli typically provides only about 
one tenth the amount of SFN as that from raw broccoli hydrolyzed by plant myrosinase during 
digestion (Conaway et al. 2000; Oliviero et al. 2014; Fahey et al. 2015). These findings suggest 
that if hydrolysis to SFN by microbiota could be enhanced, consumers might obtain greater health 
benefits from cooked broccoli. Although microbial glycoside hydrolase has been shown to be 
involved in the degradation of GSL with the pathogenic Escherichia coli O157:H7 (Cordeiro et al. 
2015) and a soil Citrobacter spp. (Albaser et al. 2016), it is not yet clear which gut commensal 
microorganism(s) are responsible for GSL conversion to ITC. In addition, why most ex vivo 
studies identify nitriles, rather than ITC, as the product of hydrolysis is also unknown. 
Furthermore, while there have been some studies that have evaluated the impact of broccoli on the 
gut microbiome (Paturi et al. 2010, 2012), no correlation studies relating gut microbial community 
composition and GRP hydrolysis have been reported. Our hypothesis is that frequent consumption 
of broccoli will promote a change in the gut microbial community resulting in increased microbial 
SFN production, with increased NQO1 activity in the host tissues, such as the colon and liver.  
In this study, the effect of feeding broccoli and GRP on the composition of rat cecal microbiota 
was analyzed using Illumina 16S rRNA sequencing. We also determined changes in GRP 
hydrolytic activity ex vivo by cecal microbiota and NQO1 activity in rat colonic mucosa and liver.  
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3.2 Materials and Methods 
Animals and Diets 
Animal use for Project Protocol 15042 was approved on 20 March 2015 by the Illinois 
Institutional Animal Care and Use Committee according to National Institutes of Health 
guidelines. Fischer 344 rats weighing 120-140 g, were purchased from Harlan (Colony 217, 
Indianapolis, IN; Colony 208, Frederick, MD, USA) and housed individually in cages with food 
and water ad libitum. Rats from two colonies were used to evaluate the impact on broccoli 
hydrolysis of reported differences in microbial composition among colonies (Hufeldt et al. 2010). 
Rats were acclimated to a powdered AIN93G diet (Table 3.1) for five days prior to transition to 
experimental diets. All diets were balanced to provide similar macronutrient content to the 
AIN93G diet (Table 3.1) according to the USDA National nutrient database.   
Commercially available pre-cooked, frozen broccoli (cooked broccoli; CB) was freeze-dried 
before incorporation into the diets. The CB was confirmed free of both myrosinase activity and 
SFN. A raw broccoli (RB) diet was prepared by freeze-drying commercial fresh broccoli. 
Glucoraphanin-free broccoli was prepared by the addition of excess exogenous myrosinase 
(thioglucosidase from Sinapis alba, Sigma-Aldrich , Carlsbad, CA, USA) to cooked broccoli, then 
incubating for 8 h at room temperature to complete hydrolysis (hydrolyzed cooked broccoli; CB-
H), followed by additional freeze drying; some SFN but no GRP remained. A GRP-rich powder 
was prepared from broccoli seed raffinate (SFN glucosinolate broccoli raffinate, CS Health, 
Louisville, KY, USA) as previously described (Lai et al. 2008), and was added to the GRP diet 
(0.41% w/w) to achieve the same GRP concentrations as that found in the CB diet (10% broccoli 
w/w). All rats were anaesthetized with ketamine/xylazine (87 and 13 mg/mL, respectively), blood 
drawn, and then killed by cervical dislocation. The ceca were ligated anteriorly and distally, 
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surgically removed, and immediately transferred to an anaerobic chamber to remove the 
microbiome for DNA isolation and for GRP hydrolysis ex vivo.  
Experimental Design 
Rats from Colonies 208 and 217 were used in Study 1 and only rats from Colony 217 were used 
in Studies 2 and 3. Study 1: 18 rats from Colony 208 were acclimated to AIN93G (control; CON) 
diet, randomized to six groups of three and fed the CB diet ad libitum for 0, 1, 2, 4, 7, or 14 days; 
the study was then repeated with another 18 rats, but from colony 217. Study 2: To separate the 
effects of GRP and non-GRP components of broccoli, 32 rats from Colony 217 were randomized 
into four treatment groups (n = 8) and fed; (1) CON diet; (2) CB diet; (3) GRP diet; or (4) CB-H 
diet (containing no GRP), for four days. Study 3: To examine the effects of raw broccoli feeding 
and of withdrawal from broccoli, 9 rats (Colony 217) were divided into three groups of three and 
fed; (1) CON diet; (2) RB diet for four days; or (3) RB diet for four days then the CON diet for 
three days. 
Total DNA was extracted from 40 mg of cecal contents using QIAmp DNA stool Mini Kit 
(Qiagen, Alameda, CA, USA ) with bead-beating (Barry et al. 2009; Yu and Morrison 2004). 
Concentration and quality of DNA was measured using NanoDrop (Thermo Scientific, Franklin, 
MA , USA). The 16S rRNA sequencing was performed by the DNA Sequencing Group at the Roy 
J. Carver Biotechnology Center, University of Illinois. The V3-V5 variable regions of the 16S 
rDNA were amplified using primers (forward F357: 5′-CCTACGGGAGGCAGCAG-3′ and 
reverse R926: 5′-CCGTCAATTCMTTTRAGT-3′). The quality of the PCR products was analyzed 
using an Agilent 2100 BioAnalyzer. 
Paired-end reads were generated with the Illumina® MiSeq platform for each sample, at a read 
length of 250 nt. The reads were demultiplexed and quality-filtered using Trimmomatic (Bolger et 
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al. 2014; version 0.30, USADELLAB.org, Worringerweg, Aachen, Germany) with a Phred score 
cut-off of 33. Data analysis was performed through the QIIME pipeline including chimera removal 
(version 1.9.0, Scikit-bio™, Boulder, CO, USA). Operational taxonomical unit (OTU)-picking 
was performed by searching the Greengenes 16S rRNA gene database. Prior to analysis of the 16S 
amplicon sequencing data, rarefaction was used to standardize the number of sequences per 
sample, thus facilitating comparisons among groups. Principal Component Analysis (PCA) was 
performed on all of the groups based on unweighted Unifrac tables. The x- and y- coordinate values 
of the data points were extracted by WebPlotDigitizer from the PCA plots of each colony generated 
in R (package FactoMineR) and were re-plotted in Microsoft Excel 2010. 
Metabolism of GRP by Microbiome Ex Vivo 
Cecal contents were diluted 1 to 25 with PBS and mixed 1:1 (v/v) with reinforced clostridial 
medium (RCM; BD Difco™, Franklin Lakes, NJ , USA), which was found in our earlier studies 
to be suitable for GRP hydrolysis ex vivo (Lai et al. 2010). Glucoraphanin dissolved in water (final 
concentration 183 μM) or PBS control were added to the bacterial slurry. The mixture was 
incubated anaerobically at 37 °C for 120 min. Each sample was centrifuged for 1 min at 4 °C, 
filtered (0.22 μm), and flash-frozen in liquid nitrogen. Colon and liver tissue were also surgically 
removed and processed at necropsy. The first five centimeters of the colon were flushed with cold 
PBS, slit open lengthwise, and scraped rapidly using a histology slide on ice. The collected 
mucosal scrapings of the colon and known weights of the liver were snap-frozen in liquid nitrogen. 
All samples were stored at -80 °C until use. 
Total ITC Quantification 
Hydrolysis of GRP to ITC (SFN and erucin) by rat cecal samples was quantified using the 
cyclocondensation method (Zhang 2012), as previously described (Cramer and Jeffery 2011). 
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Briefly, samples were incubated with potassium phosphate buffer (25 mM) and 1,2-benzenedithiol 
(10 mM) for 2 h at 65 °C. After cooling to room temperature, the mixture was centrifuged at 16,000 
× g for 10 min. The supernatant was analyzed by HPLC, using a C18 reverse-phase column (ODS-
3, 5 μm, 250 × 4.6 mm, ES Industries Marvel, West Berlin, NJ, USA) attached to a Waters HPLC 
system (Waters Corp., Milford, MA, USA). The solvent system was operated isocratically with 
80% methanol/20% water at a flow rate of 1.0 mL/min, with 10 min column washing between 
sample runs. The cyclocondensation product, 1,3-benzodithiole-2-thione, was detected by 
absorption at 365 nm. For quantification, the peak area of 1,3-benzodithiole-2-thione (eluting 
between 10 and 11 min) was integrated using Empower PRO software (Waters Corp.) and 
compared to a standard developed by reacting known concentrations of pure SFN with 1,2-
benzenedithiol. 
NAD(P)H: Quinone Oxidoreductase (NQO1) Activity 
The NQO1 activity was measured using a spectrophotometric assay as described previously 
(Hwang and Jeffery 2004) with slight modifications. For tissue preparation, rat colonic mucosa 
and liver were homogenized in buffer (0.05 M Tris-HCl, 1.15% KCl, 1 mM EDTA, pH 7.4) before 
centrifugation at 12,000× g for 20 min at 4 °C. Supernatants were centrifuged at 100,000× g for 1 
h at 4 °C to separate microsomal and cytosolic fractions. The cytosolic fractions were snap-frozen 
in liquid nitrogen and stored at -80 °C. The cytosolic fraction was mixed (1:4 v/v) with the reaction 
mixture (25 mM Tris-HCl buffer, 0.67 mg/mL BSA, 0.01% Tween-20 (v/v), 0.03 mM NADP+, 1 
mM glucose-6-phosphate, 5 μM FAD, 2 unit/mL glucose-6-phosphate dehydrogenase, and 0.72 
mM 3-(4,-5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 50 μM menadione 
(added immediately before reaction)). The product was measured every 50 s over 5 min at 610 nm 
in a μQuant plate reader (BioTek, Winooski, VT, USA). The reaction was quenched by the 
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addition of 50 μL of 0.3 mM dicumarol in 25 mM Tris buffer (pH 7.4). The absorbance was 
measured continuously for another 5 min to correct for non-NQO1 specific activity (background). 
The protein concentrations were determined using the BioRad assay (Bradford 1976) with BSA as 
the standard. The enzyme specific activity was reported as nmol MTT reduced/min/mg protein. 
Statistical Analysis 
The nonparametric Kruskal-Wallis test was performed to compare the effect of multiple diets 
(CON, CB, GRP, CB-H) on the abundance of rat cecal microbial taxa (p < 0.05, false discovery 
rate < 0.1) as previously described (Ludvigsen et al. 2016). One-tail Student’s t-tests were 
performed to compare the difference between short-term (<4 days) and long-term (>4 days) cooked 
broccoli feeding on rat cecal microbial communities, and to compare both the GRP hydrolysis ex 
vivo and the NQO1 activities between the treated and control groups. 
3.3 Results 
Alteration in the Cecal Microbiota Community and GRP Hydrolysis Following 1-14 Days of 
A Cooked Broccoli Diet; Study 1 
The cecal microbiota was profiled to determine changes in bacterial taxa following 
consumption of CB or CON diets. Illumina® MiSeq resulted in an average of 64,678 paired-end 
high-quality reads per sample. Initial PCA analysis revealed a significant shift in the cecal 
microbiota between two and four days on diet (Figure 3.1). Therefore, the cecal microbiota was 
reanalyzed separately for short-term (0-2 days) and long-term (4-14 days) broccoli feeding. 
Metrics of alpha diversity revealed a significant increase in the number of OTUs, Chao1, 
Shannon, and Simpson indices in rats fed cooked broccoli for ≥4 days (Table 3.2). Additional beta 
diversity analysis revealed six genera, mostly from the order Clostridiales (Blautia, Clostridium, 
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Dorea, Ruminococcaceae (family, genus not assigned) and Oscillospira) significantly changed in 
abundance after CB feeding for four days or longer (Table 3.3).  
In addition to the change in the microbiome, we also evaluated the myrosinase-like activity ex 
vivo of the cecal microbiota. Cecal samples were incubated anaerobically with excess GRP. The 
GRP hydrolyzing activity of the cecal microbiota increased as rats fed for longer periods, up to 
four days (Figure 3.2). Feeding rats the broccoli diet for 4 days increased ex vivo GRP hydrolysis 
activity by 25-fold over that from rats fed no broccoli (CON diet) (p < 0.001). The enhanced GRP 
hydrolysis remained high throughout the feeding study (7 and 14 days). In animals receiving only 
the control diet, neither the microbiome community nor the GRP hydrolysis activity changed, 
regardless of days on the diet, data not shown. 
Increased NQO1 Activity in Rat Colonic Mucosa Following 1–14 Days of Cooked Broccoli 
Diet 
To assess the chemopreventive effects of CB on the host, the NQO1 activity in rat colon mucosa 
and liver was measured. As the rats were fed for longer periods, the colonic NQO1 activity 
increased gradually over 7 and 14 days (Figure 3.3).   
Effects of GRP on Both Cecal Microbiota Composition and GRP Hydrolysis; Study 2  
Study 2 was designed to investigate whether the increased cecal microbial hydrolysis of GRP 
seen in Study 1 was due to the daily presence of GRP and/or non-GRP component(s) of broccoli. 
To this end, the composition of cecal microbiota was compared across rats fed for four days either 
CON, CB, GRP, or CB-H diets. On average, over 15,000 high-quality paired-end sequences per 
sample were obtained from Illumina® MiSeq. The total numbers of OTUs and Chao1 index were 
greater in the CB-H group than in any other groups (p < 0.05; Table 3.4). 
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We performed phylogenetic beta diversity calculations to examine the dissimilarity between 
microbiome communities. The differences in the abundance of genera are shown as relative 
proportions (Table 3.5). Although the Shannon and Simpson indices were not different between 
any treatments (Table 3.4), phylogenetic beta diversity calculations showed that the abundance of 
several cecal bacterial taxa were impacted by the treatments (Table 3.5).  
  An understudied genus from the S24-7 family was found to be in greatest abundance (>15% 
total genera) in all groups, including from control-fed rats. The composition of the cecal microbiota 
from rats receiving the CB diet was quite distinct from the other groups, as observed by 
phylogenetic clustering (Figure 3.4a) and PCA analysis (Figure 3.4b). Conversely, in the same 
analysis the cecal microbiota of the CON and GRP groups were indistinguishable. Unlike those 
from other dietary groups, the microbiome from the CB-H group formed two unique clusters by 
both distance metrics. The ITC production ex vivo was similar in the CON and CB-H groups. 
However, production in the CB and GRP groups was greater than in either the CON or CB-H 
groups (Figure 3.5; p < 0.05). 
Effect of A Raw Broccoli Diet and Its Withdrawal on GRP Hydrolytic Potential; Study 3 
To determine the impact of a raw broccoli diet and its removal, we fed rats either CON diet for 
four days, RB diet for four days, or the RB diet for four days, followed by three days of the control 
diet (RB/CON). As with the cooked broccoli diet, the total ITCs produced ex vivo from cecal 
microbiota of rats fed raw broccoli for four days increased (p < 0.05) compared to ITC production 
by microbiota from rats on the control diet (Figure 3.6). However, when raw broccoli was 
withdrawn from the diet for three days and replaced with CON, the total ITCs production 
decreased, but remained greater than the CON group (p < 0.05). 
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3.4 Discussion 
 
Impact of Different Diets on The Cecal Microbiota Communities 
In this study, the cecal microbial communities from rats fed CB and CB-H diets were similar, 
yet different, from the CON-fed group (Figure 3.4b). Since CB contained GRP and CB-H did not, 
although both had a broccoli base, this indicates that non-GRP component(s) of broccoli are 
responsible for the new cecal microbial community structure. Further supporting the concept that 
GRP was not responsible for the changes seen in community structure, the cecal microbial 
communities from rats fed CON and GRP were similar. However, given the technical limitations 
of 16S rRNA sequencing, such as the short read length, the identification of bacterial changes at 
the species- and strain-level were not determined. Future research employing the examination of 
microorganisms at the species and strain level may provide further insights into the changes in the 
microbiome related to GRP hydrolysis. 
In addition to GRP, broccoli contains several other components that may impact the 
microbiome (Kurilich et al. 1999; Plumb et al. 1997). For example, broccoli is a rich source of 
fiber, which can modulate the gut microbial community and improve health (Kaczmarczyk et al. 
2012). In the present study, fiber as a percent of the diet was maintained across all diets, although 
the type of fiber varied (Table 3.1). The flavonoids quercetin and kaempferol are also present in 
broccoli. These were not balanced across diets and could impact the microbiome. For example, in 
a study where rats were fed a high-fat high-sucrose diet, oral administration of quercetin decreased 
the abundance of Erysipelotrichaceae and Bacillus bacteria in the Firmicutes phylum (Etxeberria 
et al. 2015). 
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GRP Hydrolysis 
Early pharmacokinetic studies (Conaway et al. 2000; Shapiro et al. 1998) reported that 
glucosinolate hydrolysis can occur during digestion, in the absence of myrosinase, but at a fraction 
of the rate of that in the presence of myrosinase. Here we show that daily broccoli feeding to rats 
greatly enhanced this hydrolytic rate, causing as much as a 25-fold increase in the capacity of the 
gut microbiota to hydrolyze GRP to bioactive SFN (Figure 3.2). A key finding is that it is 
specifically the presence of GRP in the diet that enhances microbial hydrolysis rates, since when 
GRP was fully hydrolyzed to SFN prior to feeding, the broccoli had no impact on rates of 
exogenous GRP hydrolysis (Figure 3.5). However at this time, we are not able to determine which 
bacteria perform the hydrolysis or even whether the increased rate is due to an increased number 
of active bacteria or to upregulation of a bacterial hydrolyzing enzyme. In a recent study (Luang-
In et al. 2014), two bacteria isolated from human feces, Escherichia coli VL8 and Enterococcus 
casseliflavus CP1, were evaluated for glucosinolate metabolism. Less than 10% of the metabolized 
glucosinolate could be detected as ITC (6% as erucin produced, with 65% GRP loss in 8 h 
incubation with Escherichia coli VL8 and less that 1% of the starting GRP level as SFN produced 
vs. 53% of GRP degraded after 8 h incubation with Enterococcus casseliflavus CP1). It would be 
interesting to determine if feeding broccoli or other brassica increases the presence of these 
microbes or the possible reductase these authors identified. In our study, a three-day withdrawal 
from the broccoli diet decreased GRP hydrolysis ex vivo, suggesting that frequent broccoli 
ingestion may be essential for this improved microbial GRP hydrolysis. Recent studies have shown 
that desulfoglucosinolates can be substrates for beta hydrolase, resulting in formation of nitriles 
(Luang-In et al. 2016). It will be interesting to see if there are bacterial N-sulfatase enzymes that 
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are able to generate desulfoglucosinolates and whether these, by forming inactive nitriles and not 
reactive isothiocyanates, can protect the bacterium from glucosinolate toxicity. 
In the present study, we used the cyclocondensation reaction to estimate total ITC, rather than 
GC or LC-MS methods that measure individual compounds, which can be summed to determine 
the total product formed. The cyclocondensation method is both accurate and rapid, when total 
metabolites are of interest, but does not provide identification of specific ITC forms. The 
cyclocondensantion reaction relies on the thiol compound benzene dithiol to bind to ITC and ITC 
metabolites. Since ITC is highly reactive, we previously proposed that ITC products of microbial 
hydrolysis might be bound to protein cysteines and possibly unavailable for estimation by GC or 
LC-MS. Using excess GSH, we were able to pull out and identify SFN and its reduced congener 
erucin, not seen when we performed LC-MS directly (Angelino et al. 2015). Many studies 
(Mullaney et al. 2013; Lai et al. 2010; Li et al. 2011; Saha et al. 2012) evaluating glucosinolate 
metabolism by microbiota ex vivo have identified disappearance of glucosinolate substrate and/or 
appearance of nitriles. Since nitriles are not electrophilic, and thus not bound to protein sulfhydryls, 
it is possible that this is why nitriles are available for direct measurement in many studies where 
ITCs, such as sulforaphane, were not detected.  
Bioactivity 
Increased colonic mucosal NQO1 activity was observed after 7 and 14 days of cooked broccoli 
feeding. Our data clearly suggest that by frequent feeding of cooked broccoli to rats, not only the 
capacity of the microbiota for GRP hydrolysis was improved, but also that the ultimate NQO1 
activity in rat colon was increased (Figure 3.3), indicating the improved potential for cancer 
chemopreventative activity of the host. However, no significant differences were observed in 
hepatic NQO1 activity (data not shown). In our previous study (Lai et al. 2008), we gavaged rats 
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with different doses of GRP (30, 60, and 120 mg/kg) for four days, and observed a significant 
dose-dependent increase in NQO1 activity in the colon, whereas there was only a slight increase 
in hepatic NQO1 activity with the highest dose of GRP. The present results are consistent with our 
previous finding that colonic mucosa had a NQO1 response at lower doses than liver, suggesting 
that the dose here was sufficient to provide a local or topical effect on the gut wall, but not large 
enough to impact the liver.  
The stimulation of colonic NQO1 activity by CB was delayed compared to the increase in GRP 
hydrolysis (Figures 3.2 and 3.3). It would be interesting to know whether microbial hydrolysis or 
mucosal wall upregulation of NQO1 is the limiting step. Since GRP was essential for increased 
microbial hydrolysis, and because hydrolysis was increased in the microbiome from rats fed raw 
broccoli, this shows for the first time that some of the GRP in raw broccoli travelled to the cecum 
for bacterial hydrolysis rather than being completely hydrolyzed by broccoli myrosinase in the 
upper gut.  
3.5 Conclusions 
Broccoli feeding changed the composition of the rat cecal microbiota, increased glucoraphanin 
hydrolysis to ITC ex vivo, and increased host colonic NQO1 activity. Glucoraphanin from broccoli 
was responsible for the increase in the hydrolysis to ITC, whereas broccoli component(s), other 
than GRP, altered the cecal microbiome composition. Furthermore, withdrawal from the broccoli 
diet caused loss of the broccoli-enhanced GRP hydrolysis, suggesting that frequent broccoli 
ingestion is required to ensure optimal microbial glucosinolate hydrolysis. 
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3.6 Tables and Figures 
 
Table 3.1. Diet Compositions (%). 
Ingredients 
AIN93G 
(CON) Diet 
(%) 
10% Cooked 
Broccoli (CB) 
Diet (%) 
10% GRP-Free 
Broccoli (CB-H) 
Diet (%) 
GRP Diet 
(%) 
Casein 20.00 17.37 17.37 19.92 
Cornstarch 39.75 37.56 37.56 39.58 
Maltodextrin 13.20 12.30 12.30 13.14 
Sucrose 10.00 9.32 9.32 9.96 
Cellulose 5.00 2.57 2.57 4.98 
Mineral mix 1 3.50 2.69 2.69 3.49 
Vitamin mix 1.00 1.00 1.00 1.00 
L-cysteine 0.30 0.30 0.30 0.30 
Choline bitartrate 0.25 0.25 0.25 0.25 
Soybean oil 7.00 6.66 6.66 6.97 
Cooked broccoli 0 10.00 0 0 
Hydrolyzed broccoli 0 0 10.00 0 
GRP-rich powder 0 0 0 10.00 
Calculated GRP 2 (μmol/g diet) 0 0.26 0 0.28 
Calculated SFN 2 (μmol/g diet) 0 0 0.17 0 
1The total mineral content are equal in all of the diet. Standard deviation < 0.01. 
 
 
Table 3.2. Analysis of rat cecal microbiota following 0-14 days of cooked broccoli diet, 
study 1. 
Treatment 1 OTUs 2 Chao1 Shannon Simpson 
<4 days 1393.4 a ± 84.7 3582.6 a ± 337.4 8.58 a ± 0.31 0.988 a ± 0.005 
≥4 days 1481.3 b ± 105.0 3803.4 b ± 416.9 8.87 b ± 0.23 0.992 b ± 0.003 
p-value 0.005 0.045 0.002 0.016 
1Microbiota from rats (n = 36, see Figure 1) fed cooked broccoli for fewer than four days or four days and 
more. 2 Microbial analysis by Illumina® 16S rRNA sequencing (V3–V5 hypervariable region). Values 
within columns with the same letter are not different (p < 0.05). p-values are reported as one-tailed Student’s 
t-test. Rarefaction was calculated based on 4900 seqs per sample when the maximum number of OTUs 
were observed in all groups. 
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Table 3.3. Changes in the abundance of bacterial genera in cecal microbiome of rats (n = 6) 
fed up to 14 days of cooked broccoli diet; Study 1.  
Genus 
Abundance 1 (% Total Genera) 
p-Value <4 days ≥4 days 
Mean SEM Mean SEM 
Akkermansia 0.001 0.001 0.008 0.003 0.007 
Blautia 0.429 0.078 0.123 0.024 0.000 
Clostridium 0.388 0.065 0.127 0.017 0.000 
Dorea 1.073 0.150 0.482 0.050 0.003 
f__Ruminococcaceae; 
Other 
0.287 0.036 0.497 0.040 0.000 
Oscillospira 9.576 0.709 14.296 1.171 0.003 
1 False discovery rate < 0.1. Student t-test showing genera increased (bolded) and decreased (underlined) 
in abundance of bacterial genera from rats fed cooked broccoli for four days or more, compared to bacteria 
from rats fed for fewer than four days of cooked broccoli diet (p < 0.05). p-values are reported as the one-
tailed student’s t-test. 
 
 
Table 3.4. Analysis of rat cecal microbiota following four days of treatment diets; Study 2 1. 
Diet 
Reads Obtained 
from MiSeq 
(Min~Max) 
Median Seqs per 
Sample after 
Quality Filtering 
(Min~Max) 
% OTUs 
Assigned 
Chao1 Observed OTUs 
CON 13,242~45,673 10,917~37,747 99.88 ± 0.07 3627.1 a ± 366.6 1573.0 a ± 77.9 
CB 11,516~29,303 9,447~24,029 99.89 ± 0.07 3847.5 a ± 208.8 1576.1 a ± 23.1 
GRP 14,829~29,988 11,900~24,483 99.91 ± 0.05 3783.7 a ± 442.5 1557.4 a ± 122.1 
CB-H 12,761~116,686 10,441~96,729 99.92 ± 0.04 3968.5 b ± 172.1 1663.6 b ± 57.4 
1 Microbial analysis by Illumina® 16S rRNA sequencing (V3–V5 hypervariable region). Rats (n = 32) fed 
four days of control (CON), cooked broccoli (CB), GRP, or GRP-free (CB-H) diet. Values within columns 
with the same letter are not different (p < 0.05). Rarefaction was performed based on 7410 sequences per 
sample when the maximum number of OTUs were observed in all groups. 
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Table 3.5. Abundance of bacterial genera (>0.1% total) of cecal contents of rats, study 2 1. 
Genus 
Abundance 2 (% Total Genera) 
p-Value CON CB GRP CB-H 
Mean SEM Mean SEM Mean SEM Mean SEM 
Clostridium 0.148 0.012 0.324 0.055 0.185 0.027 0.109 0.017 0.007 
Coprococcus 1.840 0.517 1.392 0.407 0.623 0.105 0.674 0.092 0.005 
Dorea 1.229 0.150 0.357 0.046 0.772 0.095 0.598 0.117 0.000 
f__Lachnospiraceae; Other 1.680 0.143 1.574 0.121 1.056 0.157 0.875 0.073 0.001 
f__Ruminococcaceae; Other 1.272 0.200 1.693 0.156 0.611 0.093 1.130 0.130 0.001 
f__S24-7;g__ 15.477 1.346 13.612 1.133 15.759 1.203 19.665 0.706 0.007 
Prevotella 0.119 0.049 0.163 0.083 0.420 0.077 0.737 0.285 0.003 
rc4-4 0.965 0.165 0.214 0.035 1.063 0.159 0.592 0.081 0.000 
1 Rat were fed four days of control (CON), cooked broccoli (CB), GRP, or GRP-removed (CB-H) diet. 2 
False discovery rate < 0.1, Student t-test showing genera increased (bolded) and decreased (underlined) in 
abundance compared to the control group (p < 0.05). p-values are reported as the Kruskal-wallis test. 
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Figure 3.1. PCA-individual factor map describing the rat cecal microbial communities 
following 10% cooked broccoli feeding (0-14 days) from two different rat colonies. PCA 
analysis was performed on each colony independently and plotted on the same graph. Dim 1 = 
14.47%, Dim 2 = 7.66% for rats from Colony 217 (“1”, Indianapolis IN, closed symbols) and Dim 
1 = 16.48%, Dim 2 = 8.26% for rats from Colony 208 (“2”, Fredrick MD, open symbols). 
 
 
 
 
Figure 3.2. Rats (n = 6) were fed 10% cooked broccoli diet for 0-14 days. Concentrations of 
total isothiocyanate (ITC) in rat cecal supernatant after incubating ex vivo with GRP for 120 min. 
Values with similar letters are not different (p < 0.05). 
  
57 
 
 
 
Figure 3.3. Activity of NQO1 in rat colonic mucosal tissue following cooked broccoli feeding 
(0-14 days; n = 6). Results are nmol MTT/min/mg protein. Data are mean ± SE. ** indicates 
significantly different from control (Day 0) (p < 0.01). 
 
 
 
Figure 3.4. Impact of GRP and other broccoli components on rat cecal microbial 
communities. Rats were fed with a 10% cooked broccoli (CB), GRP-rich powder (GRP), broccoli 
pre-hydrolyzed using myrosinase (CB-H) or the control diet (CON) for four days (n = 8). (a) 
Phylogenic tree describing the clustering of cecal microbial communities; and (b) PCA-individual 
factor map describing the cecal microbial communities. 
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Figure 3.5. Rats were fed a 10% cooked broccoli (CB), GRP-rich powder (GRP), broccoli 
pre-hydrolyzed using myrosinase (CB-H) or the control diet (CON) for four days (n = 8). 
Concentrations of total isothiocyanate (ITC) were measured in rat cecal supernatant after 
incubation ex vivo with GRP (183 μM) for 120 min. Data are mean ± SE. Values with similar 
letters are not different (p < 0.05). 
 
 
 
 
 
 
Figure 3.6. Reversibility of the impact of dietary broccoli on microbial GRP hydrolysis. Rats 
were fed with the control diet (CON), a 10% raw broccoli (RB) diet, or a 10% RB diet for four 
days, then the control diet four three days (RB/CON) (n = 3). Concentrations of total isothiocyanate 
(ITC) in rat cecal microbiota after incubation ex vivo with GRP for 120 min. Results are mean ± 
SE. Values with similar letters are not different (p < 0.05). 
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CHAPTER 4: Lightly Cooked Broccoli Is as Effective as Raw Broccoli in Mitigating 
Dextran Sulfate Sodium-Induced Colitis in Mice1 
4.1 Introduction 
Accumulating research frequently suggests a role for chronic inflammation as a key mechanism 
within a myriad of life-threatening diseases, including cardiovascular disease (CVD), cancer, 
diabetes, and obesity. Among these is inflammatory bowel disease (IBD), which is associated with 
severe chronic inflammation in the gut. This is a common disease, affecting over 1% of US adults 
(~3 million in 2015) (Dahlhamer et al. 2016). Not only is the incidence of IBD increasing 
(Dahlhamer et al. 2016), but untreated IBD can progress to colon cancer. 
Many research articles suggest that sulforaphane (SF) from broccoli, one of the most studied 
phytochemicals, is among several key anti-inflammatory dietary components that may benefit 
those suffering from such diseases (Wagner et al. 2013; Moon et al. 2009; Yehuda et al. 2012; 
Jeffery and Araya 2009). In the dextran sulfate sodium (DSS) mouse model, which is a 
commonly used animal model for IBD, SF has been found to attenuate DSS-induced colitis, 
evidenced by a decreased disease activity index (DAI), minimized weight loss, reduced loss of 
colon length, and less monocyte infiltration (Wagner et al. 2013). Moreover, a molecular level 
investigation confirmed that expression of the pro-inflammatory cytokine IL-6 was decreased 
by SF in DSS-treated mice, and that the expression of several Nrf2 target genes was increased. 
This suggests that the anti-inflammatory bioactivity of SF might be mediated through the Nrf2 
pathway (Wagner et al. 2013).  
 
1 This chapter appeared in its entirety in Nutrients: Wang, Y., Jeffery, E., Miller, M., Wallig, M. 
and Wu, Y., 2018. Lightly Cooked Broccoli Is as Effective as Raw Broccoli in Mitigating Dextran 
Sulfate Sodium-Induced Colitis in Mice. Nutrients, 10(6), p.748. This article is reprinted with 
permission from the publisher and can be found in Appendix B. 
65 
 
In recent years, not only SF, but also whole broccoli has shown promising anti-inflammatory 
activity.Using the mdr1a-/- IBD mouse model, a diet containing 10% fresh broccoli was shown to 
alter the gut microbiota and attenuate colitis, evidenced by an increase in the colon crypt length 
and in the number of goblet cells present in the colonic epithelium (Paturi et al. 2012). In contrast, 
in an AOM/DSS model a glucosinolate-enriched fresh broccoli diet was reported to induce Nrf2 
target genes effectively while failing to protect the host from colitis or carcinogenesis (Lippmann 
et al. 2014).  
In these studies, however, only fresh broccoli or SF was investigated. It has been widely 
acknowledged that the cooking conditions for broccoli greatly impact its efficacy. The hydrolysis 
from glucoraphanin (GRP), the parent compound of SF, is mediated by a heat-sensitive enzyme in 
broccoli, myrosinase (EC 3.2.1.147). In fully cooked broccoli, the myrosinase is likely to be 
inactivated by heat, resulting in failure to produce bioactive SF. Researchers have shown that the 
gut microbiome is also capable of hydrolyzing glucoraphanin (GRP) within dietary broccoli to 
release bioactive SF, although the yield is quite low (Lai et al. 2010).  Compared to fully cooked 
broccoli, the study of lightly cooked broccoli has become appealing to many researchers 
(Rungapamestry et al. 2007; Wang, Farnham, and Jeffery 2012) as it provides the taste/flavor that 
consumers find more acceptable than raw broccoli, while still retaining some myrosinase activity. 
In the present study, we compared the efficacy of raw broccoli and lightly cooked broccoli in terms 
of protecting mice from DSS-induced colitis, as a model of IBD.  
Although the etiology of IBD is unknown, it has been proposed that it is related to a “leaky 
gut”: increased gut permeability to luminal pathogens and their by-products, including endotoxin 
(Poritz et al. 2007; Johansson et al. 2014).  One common method to determine gut barrier 
permeability is to assess plasma lipopolysaccharide (LPS) concentration; LPS is a large molecule 
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in the outer membrane of gram-negative bacteria, not able to pass across the intact gut barrier 
(Lambert 2009). Another way is to determine the urinary excretion of orally ingested sucralose 
(Lambert 2009), a non-digestible sweetener that similarly cannot penetrate the intact gut barrier.  
However, if the integrity of the gut barrier is compromised and gut leakage occurs, LPS and 
sucralose enter the circulatory system. Therefore, in the present study, plasma LPS and urinary 
sucralose were used as indicators of gut barrier function. In addition, it is reported that the breach 
of the gut barrier, through destruction of colonocyte tight junction proteins, might be one of the 
mechanisms of IBD. Therefore, both mRNA expression of selected tight junction proteins and 
protein expression of two barrier proteins, ZO-1 and Claudin-1 were also assessed. Moreover, 
mRNA expression of selected pro-inflammatory cytokines was investigated here, to identify any 
inflammatory role within the molecular mechanism of broccoli protection of the host from DSS 
induced colitis.  
In this study, our results clearly show that even with far less myrosinase activity, lightly cooked 
broccoli is essentially as effective as raw broccoli in suppressing damage by DSS, for most of the 
endpoints. In addition, we proposed here that broccoli protection against DSS-induced colitis may 
be through halting the transition from acute to chronic inflammation through SF-Nrf2 inhibition 
of the IL-6 trans-signaling pathway.  
4.2 Materials and Methods  
Diet preparation 
AIN-93M diet ingredients were purchased from Harlan-Teklad Laboratories (Madison, WI). 
Fresh broccoli was purchased from a local grocery market.  Half of the broccoli was lightly cooked 
by microwave for 3 min and cooled on ice, as described in our previous study (Wang, Farnham, 
and Jeffery 2012). Both broccoli preparations were then freeze dried and ground into powder, 
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using a coffee grinder. Raw or lightly cooked broccoli powder (10% by weight) was incorporated 
into the raw broccoli diet (RB) or lightly cooked broccoli diet (CB), respectively. RB and CB were 
balanced to the AIN93M diet (CON) for micro- and macro-nutrients, including fiber (Table 4.1). 
Animal use and experimental design 
8 to 10 week old male C57BL/6 mice (N=54, BW 20-25g) were maintained under a 12-hour 
light/dark cycle at 22°C and 60% humidity. All animal care followed the protocol approved by the 
Institutional Animal Care and Use Committee at the University of Illinois, Urbana-Champaign. 
After 4 days’ acclimation to the AIN-93M diet, mice were divided into 3 groups and provided with 
AIN-93M diet (CON), RB or CB for 14 days, until the end of the study. Diet was provided ad 
libitum and replaced fresh daily. On the 7th day of diet treatment, mice from each diet treatment 
group were divided randomly into two halves (n=9). One half of the mice from each group received 
normal tap water (Water) and the other half received 2.5% DSS (40-50 kDa, Affymetrix, Santa 
Clara, CA) dissolved in tap water from day 7 to day 14, the completion of the study. The six 
treatment groups are abbreviated as Water/CON, Water/RB, Water/CB, DSS/CON, DSS/RB, and 
DSS/CB.  
Diet analysis 
Myrosinase activity in the broccoli diets was measured as SF formation in vitro, based on our 
previously published protocol (Dosz et al. 2014). Briefly, 400 mg freeze-dried RB or CB diet was 
incubated in 1.5mL of water for different time periods (up to 8 hours) with thorough vortexing in 
the middle of the incubation period.  Samples were then centrifuge at 4℃ for 3min. After 
centrifugation an aliquot of supernatant (0.5 mL) was spiked with an internal standard of benzyl 
isothiocyanate, then immediately extracted into dichloromethane (DCM, 0.5 mL), centrifuged for 
3 min at 16,000 x g and analyzed for SF formation, by GC-FID.  The GC program was as follows: 
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briefly, 1 μL of DCM extract was injected, using an Agilent model 7683B series autosampler, onto 
an Agilent 6890N gas chromatography system equipped with a single flame ionization detector 
(Agilent Technologies, Santa Clara, CA, USA). Samples were separated using a 30 m × 0.32 mm 
J&W HP-5 capillary column (Agilent Technologies). After an initial hold at 40 °C for 2 min, the 
oven temperature was increased by 10 °C/min to 260 °C and held for 10 min. Injector temperature 
was 200 °C; detector temperature was 280 °C. Helium carrier gas flow rate was 25 mL/min. Data 
were quantified against a standard curve of SF (LKT Laboratories, St. Paul, MN, USA). 
Tissue collection 
Mice were anesthetized using ketamine/xylazine (87 mg/mL and 13 mg/mL, respectively, at 
0.1 mL/100g BW). After blood was taken by cardiac puncture into EDTA-coated vessels, mice 
were killed by cervical dislocation. The colon, from immediately distal to the cecum to the anus 
(including the rectum; ~3-6 cm) was removed and immediately flushed with ice-cold PBS. After 
the length was measured, 16% of the length immediately distal to the midpoint was removed and 
fixed in 10% neutral buffered formalin. After ~24 h, sections were transferred into 80% ethanol 
for slide preparation by the Veterinary Diagnostic Laboratory (University of Illinois, Urbana, IL). 
The remaining colon was scraped to collect mucosa for western blot (stored at -80°C) and qPCR 
analysis (placed into RNALater and frozen).  
Disease activity index  
Mice were monitored each day for observable changes in colitis symptoms. The disease activity 
index (DAI) was calculated by daily summing the colitis clinical scores, including percent weight 
loss, stool formation and presence of stool blood; scoring was adapted from reported protocol(Kim 
et al. 2012) as follows:  (i) body weight loss: 0, none; 1, 1-5%; 2, 5-10%; 3, > 10%; (ii) stool 
formation: 0, normal pellet; 1, loose stool (mild); 2, loose stool (moderate); 3, watery diarrhea; and 
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(iii) fecal bleeding: 0, negative; 1, blood in stool (mild); 2, blood in stool (moderate); 3, gross 
bleeding. Mice were given a score of 0-3 for each of the three categories and the sum of scores 
was used as a measure of the degree of colitis as follows: 1-4: Mild colitis, 5-7: Moderate colitis, 
8-9: Severe colitis. 
Plasma LPS determination  
Fresh, EDTA-treated blood was centrifuged at 500 x g at 4°C for 15min, to yield plasma. The 
plasma LPS concentration was assayed using QCL-1000™ Limulus Amebocyte Lysate (LAL, 
Lonza) according to the manufacturer’s instructions, where plasma samples were diluted 10-fold 
and heated for 10 min at 70 °C. The results were quantified at 405 nm using a μQuant microplate 
reader (Bio-Tek Instruments, Winooski, VT). LPS concentrations are expressed as EU/mL.  
Urinary sucralose determination  
Three mice from each group received 30 mg/mL sucralose by gavage 24 h prior to euthanisa 
(0.2 mL/25g BW). Mice were provided food and water ad libitum for the next 6 hours, and then 
placed individually into stainless steel metabolic cages for urine collection, uncontaminated by 
feces. A sample jar was placed under each cage to collect urine from 6-24 hours which was then 
freeze dried and reconstituted in 0.8 mL distilled water for sucralose analysis after conversion of 
sucralose to its alditol acetate derivatives according to Shaikh and colleagues (Shaikh et al. 2015) 
with minor modifications. Briefly, myo-inositol (9 μL of 10mg/mL) was added to 100 μL urine 
sample as internal standard, then 500 μL 20 mg sodium borodeuteride /mL DMSO was added 
slowly while mixing and heated to 40 °C for 90 min. After cooling, 0.2 mL glacial acetic acid was 
added slowly while mixing, then 100 μL 1-methylimidazole and 1 mL acetic anhydride were added 
and the sample stored for 10 min at room temperature, before 4 mL water and 1 mL methylene 
chloride were added to the mixture and vortexed. The bottom layer was transferred to a new tube. 
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The extraction was repeated three times, and the combined methylene chloride layers washed with 
4 mL of water, removed into a fresh tube and dried under a stream of nitrogen. Finally, 0.5 mL 
acetone was added to the dried residue, vortexed, and the resulting solution analyzed by GC. 
Gas chromatography was performed using a 6890N (Agilent Technologies) equipped with a 
N10149 autosampler and a flame ionization detector. The column used was a 30 m HP-5 capillary 
column (0.32 mm id, 0.25 μm), with helium as the carrier gas. The analytical program was 
according to Shaikh and colleagues (Shaikh et al. 2015) with some modifications. Briefly, the 
temperatures of the detector and the injector were 280 °C and 250 °C, respectively; the initial 
column temperature was 100 °C. After holding for 2 min, the temperature was raised to 180 °C at 
a rate of 10 °C/min, held for 2 min, then raised to a final temperature of 240 °C at a rate of 4 
°C/min, and held for 15 min. The injection volume was 1 μL. 
mRNA expression of tight junction proteins and pro-inflammatory cytokines 
Colonic RNA was extracted using an E.Z.N.A.® Total RNA Kit II (Omega Bio-tek, GA, USA) 
according to the manufacturer’s instructions. Extracted RNA was further purified by Lithium 
chloride and sodium acetate to remove any remaining DSS, which was reported to interfere with 
PCR amplification efficiency (Viennois et al. 2013). RNA was then quantified using a NanoDrop 
spectrophotometer and converted to cDNA using a High-Capacity cDNA Reverse Transcription 
kit (Applied Biosystems).  Primers for the genes (Table 4.2) were designed using the online 
Primer3-BLAST system from NCBI, and were tested for amplification efficiency and specificity 
with the use of the SYBR Green PCR Master Mix (Applied Biosystems) and an ABI 7900HT Fast 
Real-Time PCR System (Applied Biosystems) according to the manufacturer’s instructions.  All 
cDNA samples and pairs of primers were submitted to the Roy J. Carver Biotechnology Center 
(University of Illinois, Urbana, IL, USA) for gene expression profiling using a Fluidigm Dynamic 
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Array and Biomarker HD high-throughput amplification system (Fluidigm, South San Francisco, 
CA, USA) following 12 cycles of pre-amplification. The copy number for each gene was 
calculated using standard curves and normalized to the housekeeping gene Hprt1 for each sample. 
Protein expression of tight junctions 
The colonic mucosal scrapings were homogenized with 0.2 ml RIPA lysis buffer (0.15 M NaCl, 
5 mM EDTA, 10 mM Tris-HCl [pH 7.4], 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 
5 mM DTT) with Protease Inhibitor Cocktail (ROCHE) to prevent protein degradation. Protein 
concentration was measured using a Bio-Rad protein assay kit (Bio-Rad Laboratories). Mucosal 
samples were separated by SDS-PAGE (Bio-Rad) and transferred to a nitrocellulose membrane 
(GE Health Care) then at 60 V for 60 min (for Claudin-1) or 15 V overnight at 4 °C (for ZO-1, 
which is a larger molecule). After blocking in 5% nonfat dried milk, membranes were incubated 
with affinity purified rabbit anti-mouse ZO-1 (Invitrogen, 225kDa, 1: 500) or mouse anti-mouse 
Claudin-1(Life Science, 22kDa, 1:2500) overnight at 4 °C. After washing with TBST, membranes 
were incubated with either anti-rabbit secondary antibody (KPL (MD, USA), 1:5000) or anti-
mouse secondary antibody (Santa Cruz, TX, USA, 1:4000), at room temperature for 1 h. Enhanced 
chemiluminescence of the immunocomplex was evaluated using a detection kit (GE Health Care). 
Chemiluminescence was visualized using ImageQuant LAS 4000 and IQTL software (GE Health 
Care). The image was quantified using Quantity One software (Bio-Rad). Band intensities of ZO-
1 and Claudin-1 were normalized by the intensity of Ponceau Red staining, used as a loading 
control (Romero-Calvo et al. 2010; Sirois et al. 2011), as the DSS was reported to alter the colonic 
expression of most commonly used loading control proteins including β-actin and GAPDH in 
DSS-induced mice (Eissa et al. 2016). 
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Histology 
The formalin-fixed specimens of the middle one-third of the colon from each mouse were 
trimmed for longitudinal sectioning, with the mucosal surfaces placed face down in the cassette to 
give full-length profiles of the colonic wall.  Following routine processing through graded 
alcohols, the tissues were embedded in paraffin and sectioned at 4 µm, stained and reviewed in 
blinded fashion by a board-certified veterinary pathologist (M. Wallig).  The slides were scored, 
using a simplified version of a previous scoring system (Dieleman et al. 1994).  A severity scale 
system was used to grade the severity of erosive/ulcerative colitis (EC) and its reparative 
consequences (persistence/diminution of inflammation; crypt regeneration).  A score of 0 indicated 
no lesions; 1, mild decrease in crypt density&/or mild mucosal edema with mild inflammation, 
indicative of prior mild damage and/or a repaired lesion with residual inflammation and 
regenerated/regenerating crypts; 2, focal erosion with mucosal collapse and inflammation affecting 
<20% of the section, with moderate lymphohistiocytic cellular infiltrates and advanced crypt 
regeneration along the margins of the erosion; 3, multifocal to locally extensive erosions and 
mucosal collapse affecting up to 50% of the section, generally with marked lymphohistiocytic 
infiltration mixed with neutrophils and minimal early marginal crypt regeneration; 4, extensive 
erosions and mucosal collapse affecting >50% of the mucosa with heavy mixed lymphohistiocytic 
and neutrophilic infiltrates; 5, ulceration with extension into submucosa and muscularis and 
accompanying severe neutrophilic inflammation with no marginal regeneration of lost crypts. 
Statistical analysis 
The effect of DSS and the interaction between diet and DSS were determined by two-way 
ANOVA (except for DAI and histological data). Where an interaction was indicated, the effect of 
DSS was determined by comparing CON diet groups (Water/CON vs DSS/CON) using Welch's 
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unequal variance t-test, instead. The effect of diet was determined separately in water and DSS 
groups, using one-way ANOVA, followed by Tukey's post hoc test (adjusted for family-wise type 
I error), where differences were indicated.  For DAI and histological data, which are non-
continuous quantifications and do not fit normal distribution, the non-parametric ANOVA 
(Kruskal’s test) was used to determine the effect of diet in the water groups and DSS groups, 
separately; this was followed by the Wilcoxon rank sum test where differences were indicated. For 
histological score (EC), Wilcoxon rank sum test with continuity correction was used to determine 
the effect of DSS in the CON groups (Water/CON vs DSS/CON). The Pearson’s correlation was 
used to determine any linear correlation between the EC score and mRNA expression of pro-
inflammatory cytokines. For all tests, significance was reported when p<0.05; all tests were carried 
out using R.  
4.3 Results 
Formation of SF during diet hydrolysis in vitro 
In this study, we compared the efficacy of diets containing a single broccoli preparation, either 
raw or lightly cooked, for protecting the host from DSS-induced colitis. The lightly cooked 
broccoli was prepared by microwave heating for 3 min, which retained weak myrosinase activity, 
as shown in Figure 4.1. When RB was incubated in water (400 mg diet/ 1.5 mL water), SF formed 
rapidly and was complete within 1 min, whereas when CB was treated similarly, SF started to form 
as late as 30 min after initiating the incubation and reached a similar maximum SF production but 
not until 4-8 h later (Figure 4.1), indicating that CB had much less myrosinase activity, releasing 
SF at a much slower rate. 
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Disease activity index 
Mice were monitored daily during DSS treatment (day 8-14), scored for weight loss, stool 
formation and fecal bleeding. The addition of these scores is the DAI. Weight loss was partly 
mitigated by RB and CB diets, with 53% and 58% decrease in weight loss, respectively, by the 
completion of the study, compared to weight loss in mice receiving the CON diet (Figure 4.2a). 
The RB and CB diets were more effective at mitigating those symptoms most directly related to 
the colon, i.e. stool formation and fecal bleeding (Figures 4.2a, c).  By the completion of the study, 
mice receiving either RB or CB showed a 100% or 92% reduction in the extent of damage to stool 
formation, respectively, and 77% or 75% reduction in fecal bleeding, respectively, compared to 
mice receiving the CON diet.   
As a general pattern (Figure 4.2d), the DAI increased over the period of DSS treatment in CON 
mice, whereas mice receiving RB and CB exhibited slower increases in scores for damage in all 
three parameters. The DAIs for RB- and CB-fed mice were significantly different from the DAI 
for CON mice, starting from day 12 (5 full days of DSS treatment; Figure 4.2d).  After 7 days of 
DSS treatment, RB and CB mice showed a 77% and 71% lower DAI, respectively, compared to 
CON mice. Taken together, these data suggest that feeding mice either RB or CB alleviated the 
clinical symptoms of colitis, particularly symptoms directly related to colon health. 
Colon length 
In mice receiving RB or CB but no DSS (healthy controls), neither diet had any effect on colon 
length (Figure 4.3). When given DSS daily for 7 consecutive days, the colon length decreased by 
21% (DSS-CON vs Water-CON). In DSS-treated mice, the colon length of those mice receiving 
RB or CB were 24% and 17% longer than those of CON mice, respectively. 
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Gut barrier permeability 
Plasma LPS concentration was low in the water groups, regardless of the diet (Figure 4.4a). 
When DSS was given to CON mice daily for 7 days, the plasma LPS increased 4-fold. This 
increase was far less in plasma LPS from mice receiving either RB or CB (p<0.01 and p<0.05, 
respectively). This suggests that RB and CB effectively mitigated the DSS-induced damage to gut 
wall integrity, responsible for DSS-induced gut leakage of LPS. 
Similarly, the sucralose level in the urine, which was low in all three water groups, increased 
3-fold when CON mice were given DSS daily for 7 days (Figure 4.4b). Urinary sucralose was 
substantially lower following RB (p<0.05) and trended toward lower following CB. Taken 
together, our data suggest that RB and CB prevented the DSS-induced elevation in plasma LPS 
level. The RB also greatly reduced urinary sucralose compared to that seen in DSS-treated mice 
receiving the CON, but variability in response in the CON group masked any CB effect. 
Tight junction expression 
Among the selected eight genes involved in the production of tight junction proteins, the mRNA 
expression of two genes (CLDN2 and OCLN) were significantly decreased by DSS treatment 
(p<0.001 and p<0.05, respectively; Figures 4.4c, d). The broccoli diets appeared unable to reverse 
the effect of DSS. The mRNA expression of the other six genes examined (CLDN1, CLDN3, 
CLDN4, CLDN5, CLDN8 and TJP1) was not impacted by DSS and the different diets (data not 
shown).  
The expression of two tight junction proteins (Claudin-1 and ZO-1) was also investigated. The 
DSS treatment decreased expression of ZO-1(p<0.01; Figure 4.4e), but had no effect on Claudin-
1 (data not shown). Broccoli diets had no impact on levels of either tight junction protein.  
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mRNA expression of pro-inflammatory cytokines 
 Among the nine selected pro-inflammatory markers, the expressions of five genes (IL1β, IL6, 
CCL2, CCR2 andVCAM1) were significantly increased by DSS treatment (Figure 4.5). Notably, 
the expression of the CCL2 gene was increased 27-fold in DSS mice (DSS/CON vs Water/CON, 
Figure 4.5a).  These results suggest that most of the selected pro-inflammatory genes responded 
to DSS treatment. Looking into the effect of diet in healthy (no DSS) mice, gene expression was 
not affected by diet in the water groups, suggesting that neither RB nor CB had any effect on the 
expression of these pro-inflammatory genes in healthy, control mice.  However, the diet did 
influence the expression of three pro-inflammatory genes that had been upregulated by DSS 
treatment: IL6, CCR2, and VCAM1 (Figures 4.5b, d, e). Specifically, the expression of IL6 in 
DSS/RB and DSS/CB mice was 3.4-fold and 1.8-fold lower, respectively, compared to expression 
in DSS/CON mice. A post-hoc test showed that the expressions of genes IL6, CCR2 and VCAM1, 
from DSS/RB were different from DSS/CON, although values from tissue of mice receiving 
DSS/CB were not. 
Histology 
Representative photography of HE stained colon sections from mice receiving the water control 
and from the three groups receiving DSS are shown in Figures 4.6a-d, and the scores for erosive/ 
ulcerative colitis for each group are shown in Figure 4.6e. Histology from mice receiving Water 
and RB or Water and CB were not different from water and control diet (data not shown). 
Figure 4.6a shows a typical normal and healthy colon (scored 0), with tall columnar surface 
colonocytes (Co), abundant goblet cells (GC, arrows), long crypts (Cr) of uniform depth, and an 
inconspicuous lamina propria (LP), giving the mucosa a densely cellular appearance. Submucosa 
(SM) is thin and peripheral muscularis (M) is composed almost entirely of densely packed smooth 
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muscle cells. In contrast, Figure 4.6b, a section of colon from a DSS/CON mouse (scored 4), 
shows severe mucosal collapse, with the disappearance of colonocytes (bold arrows) and goblet 
cells. Moreover, throughout the tissue there is intensive leukocyte infiltration (predominantly 
neutrophils [encircled] and some histiocytes [monocytes which have left the circulation and 
entered the lamina propria]). The submucosa is edematous (star) as evidenced by its expanded size 
between mucosa and muscularis. All these changes suggest severe and ongoing inflammation in 
colons from DSS/CON mice, with no regeneration evident. 
In Figure 4.6c, a colon from a mouse treated with DSS and RB (scored 2), there are elongated, 
newly regenerating crypts (RCr) and the surface is covered by regenerated colonocytes. A few 
goblet cells have reappeared. Portions of the lamina propria not fully repopulated by crypts, but 
there is less edema and only residual neutrophils (circled) and histiocytes (arrowheads), suggesting 
some recovery from damage. These changes suggest that RB mitigated DSS-induced colonic 
damage. In Figure 4.6d, a colon from a mouse given DSS and CB (scored 1), there is even further 
regeneration to almost normal structures of both crypts and colonocytes are similar to normal colon 
(Figure 4.6a). There is very little infiltration by neutrophils and monocytes, and the submucosa is 
thin with minimal edema. Goblet cells are more numerous, although most are small due to 
incomplete replenishment of mucin. The lamina propria is almost completely repopulated by 
crypts. These changes indicate almost complete regeneration. These data suggest that CB is able 
to attenuate mucosal damage. In Figure 4.6e, a substantial difference was observed between the 
EC score of Water/CON and DSS/CON (p<0.05), suggesting a strong response to DSS. Both RB 
and CB were able to decrease colitis as scored from histology, compared to tissues from mice 
receiving only DSS, but only when removing scores for one DSS/CON mouse (#18) that did not 
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respond to DSS. In total, the histologic data confirmed that both RB and CB are effective at 
mitigating DSS-induced ulceration in colon. 
4.4. Discussion 
Site of SF absorption 
In this study, we prepared the lightly cooked broccoli by microwaving for 3min. The broccoli 
was shown to still retain a low level of myrosinase activity (Figure 4.1). Heating broccoli for short 
periods or at low temperatures can increase maximum SF production, by destroying the heat-
sensitive epithiospecifier protein (ESP), a myrosinase-associated protein that irreversibly directs 
hydrolysis away from ITC formation toward inactive nitrile formation (Matusheski and Jeffery 
2001). Alternatively, a longer cooking time or higher cooking temperature begins to destroy 
myrosinase, adversely impacting the efficacy of a broccoli meal (Rungapamestry et al. 2006). 
Temperature and timing for ESP inhibition without loss of myrosinase is not readily predicted, 
since the exact heat sensitivity of ESP and myrosinase may vary with the broccoli variety (Wang, 
Farnham, and Jeffery 2012). Therefore, it is always crucial to determine the remaining myrosinase 
activity when using cooked broccoli in a study. 
 In this study, little myrosinase activity remained in CB, but the rate of SF formation was greatly 
diminished, compared to RB. It takes only around 1h for food to begin entering the small intestine 
following ingestion (Padmanabhan et al. 2013). Therefore, by the time the broccoli diets entered 
the small intestine (~1h), only ~30% of GRP from CB  was hydrolyzed, whereas ~100% of the 
GRP from RB would have been hydrolyzed and absorbed, based on the in vitro data from Figure 
4.1. The extent of hydrolysis in CB might have been even less in vivo, where the hydrolysis was 
in a dynamic situation and might be interfered with by other factors such as chewing efficiency, 
and other food components, leaving the majority of GRP (~70%) remaining intact. Because the 
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myrosinase and other proteins are expected to be digested in small intestine, we propose that the 
majority of GRP from CB reaches the cecum intact, where microbiota can slowly hydrolyze the 
GRP to SF. Consequently, compared to RB, where SF is rapidly formed and released during 
passage through mouth and stomach, the SF from CB is slowly released, but in cecum and colon, 
the primary site for colitis.  
Protection from DSS colitis: comparing CB and RB 
We compared the efficacy of RB and CB for their ability to protect the host from DSS-induce 
colitis. Our results show that CB was essentially as effective as RB in suppressing damage by DSS, 
for most of the endpoints, such as DAI (Figure 4.2), colon length (Figure 4.3), and lesion severity 
as assessed by histopathology (Figure 4.6). The exceptions were gut barrier integrity (Figure 4.4) 
and mRNA expression of pro-inflammatory cytokines (Figure 4.5).   
RB lessened DSS-increased gut permeability, as measured by plasma LPS concentration and 
urinary sucralose excretion, whereas CB only decreased plasma LPS concentration (Figures 4a, 
b). Neither broccoli diet induced changes in mRNA or protein expression of tight junction 
proteins (Figures 4.4c, d, e). Three pro-inflammatory cytokines (IL6, CCR2 and VCAM-1) were 
identified via mRNA expression as affected by diet. RB reversed DSS-mediated increase in mRNA 
expression in all three of these cytokines, whereas CB did not. However, CB did have a tendency 
to decrease the mRNA expression of these genes, especially for VCAM-1 (p=0.054). The failure 
to detect any difference between the mRNA expression of these cytokines among CB- and CON- 
fed DSS mice, might be attributable to the smaller sample size of CB (n=3) compared RB (n=4). 
Interestingly, whereas there was no difference between CB and CON in DSS mice, there was also 
no difference between CB and RB for the gene expression data either. 
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There are several possible explanations for why CB, with far less myrosinase activity, is 
essentially as effective as RB. Firstly, although the myrosinase activity in CB is far less, CB has 
an advantage of a topical effect on the gut wall. As we discussed earlier, compared to RB, where 
SF is rapidly formed and released during mouth or stomach, the SF from CB is slowly released, 
but right in cecum and colon, the primary site of damage by colitis. Therefore, the SF from CB is 
more likely to directly impact colitis than SF from RB, where the SF is formed earlier and has to 
travel via the blood stream to reach the colon. Secondly, although the myrosinase content is far 
less in CB, we find that the myrosinase-like activity of  the gut microbiota is greatly increased after 
4 or more days of CB intake (Liu et al. 2017). Therefore, increased formation of SF by the gut 
microbiota after 14 days of CB intake might be sufficient to protect the mice from colitis, as 
effectively as a larger, but systemic, dose of SF from RB. 
However, we also keep open to the possibility that the efficacy of RB and CB might be 
independent of SF in this study. It is possible that other compounds in broccoli such as quercetin 
sophorosides, alone or in combination with SF, might play a role in mitigating the colitis. 
Gut barrier integrity 
Emerging evidence has suggested that gut barrier dysfunction is closely related to the etiology 
of IBD (Poritz et al. 2007; Johansson et al. 2014). In this study, gut barrier integrity was assessed 
by gut permeability (plasma LPS concentration and urinary sucralose excretion) and expression of 
tight junction proteins. Both RB and CB mitigated DSS-induced elevations of plasma LPS 
concentrations (Figure 4.4a). RB was associated with a decrease in the urinary sucralose 
excretion, whereas CB only showed a tendency toward decreased urinary excretion (p=0.07, 
Figure 4.4b). Consistent with these gut permeability tests, histologic evaluation of H&E stained 
colon sections also suggests that RB and CB were able to protect the integrity of the gut barrier, 
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as evidenced by milder damage, enhanced regeneration and less disruption of crypt structure than 
for CON/DSS mice (Figures 4.6c, d). 
Gut barrier typically consists of colonocyte plasma membrane tight junctions, secreted mucus, 
and mucosal immune cells (Lambert 2009).  It is reported that the destruction of the tight junctions 
is one possible mechanism for the breached gut barrier in DSS-treated mice (Poritz et al. 2007). In 
order to investigate whether protection by RB and CB against increased gut permeability is through 
effects on tight junctions, mRNA expression of genes involved in the production of tight junction 
proteins, as well as protein expression of two tight junction proteins was determined. However, 
although both RB and CB showed a tendency to reverse the DSS-induced downregulation of 
mRNA expression of CLDN2 gene and protein expression of ZO-1, there was no significant 
impact. Interestingly, for the two tight junction proteins examined (Claudin-1 and ZO-1), DSS had 
no effect on their mRNA expression (CLDN1 or TJP1 genes; data not shown), and DSS only 
affected protein expression of ZO-1. These results suggest that further research about the function 
of different tight junction proteins is needed, but that maybe broccoli protection of the gut barrier 
is not through maintenance or preservation of tight junctions.  
Inflammation 
Colonic inflammation in DSS mice was evaluated by both gene expression of pro-inflammatory 
cytokines and by histology.  We investigated gene expression of the three key pro-inflammatory 
cytokines that mediate inflammation [23], interleukin-1 (IL-1β), interleukin-6 (IL-6) and tumor 
necrosis factor alpha (TNFα). Gene expression of IL-1β and IL-6 (Figures 4.5a, b) were greatly 
increased by DSS. TNFα is also an important pro-inflammatory cytokine, but we did not observe 
any increase in gene expression of TNFα by DSS in this study (data not shown), indicating that 
DSS-induced colitis might not involve TFNα. 
82 
 
Although both broccoli diets decreased IL-6 expression in DSS mice (Figure 4.5b), IL-1β 
expression was not impacted by diet. IL-1β is a potent pro-inflammatory cytokine and plays a 
central role in mediating the inflammatory response (Turner et al. 2014). In this study, a significant 
increase (10-fold) in gene expression of IL-1β was observed in DSS treated mice (p<0.01, Figure 
4.5a), suggesting that DSS-induced colitis involves the IL-1 signaling family. It also indicates a 
role for gut microbiota (presumably LPS) in DSS colitis, as IL-1β is mainly induced by microbial 
products (Turner et al. 2014), consistent with appearance of LPS in plasma in this study (Figure 
4.4a).  However, neither CB nor RB was able to reverse this induction. Furthermore, SF formed 
in the lower gut from CB had no greater impact than SF formed and absorbed in the upper gut 
from RB. Interestingly, the expression of other genes from the IL-1 family, including TLR2, TLR4 
and NF-kB, were not impacted by DSS in this study (data not shown).  
Accumulating evidence suggests that IL-6 is much more than a marker or product of 
inflammation. It appears to play a pivotal role in both recovery from acute inflammation and the 
transition from acute inflammation to prolonged/chronic inflammation (Gabay 2006). In the initial 
phase of inflammation, the endothelial cells are triggered by microbial products, IL-1β or TNFα, 
to release IL-6 as well as a series of chemokines (Scheller et al. 2011). Together, these cytokines 
recruit neutrophils to the local injury site, the infiltration of which is one important hallmark of 
acute inflammation (Gabay 2006). The membrane-bound receptor of IL-6 (mIL6R) found on only 
a few cell types including hepatocytes and some leukocytes (Rose-John 2012) can be then shed as 
a soluble receptor, sIL6R, freely traveling to combine with IL-6 and complex with gp130, present 
on multiple cell types. This induces a switch from upregulation of neutrophil-attracting 
chemokines to upregulation of monocyte-attracting cytokines, including CCL2 (MCP-1)/CCR2, 
as well as promoting apoptosis of neutrophils and the differentiation of monocytes to form 
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macrophages, hallmarks of chronic inflammation (Gabay 2006). Typically, acute inflammation is 
considered beneficial, as it is one of the ways that the body responds to stress, whereas prolonged 
chronic inflammation may enhance a series of severe diseases. The beneficial acute inflammatory 
response mediated by IL-6/mIL6R is termed IL-6 classic signaling; whereas the prolonged 
inflammatory response mediated by the IL-6/sIL6R complex is termed IL-6 trans-signaling 
(Scheller et al. 2011) (Figure 4.7).  In addition, cell adhesion molecules including VCAM-1 are 
induced by IL-6 trans-signaling, to increase vascular permeability for monocyte infiltration 
(Scheller et al. 2011; Mudter and Neurath 2007; Kaplanski 2003) 
We report here that gene expressions of IL-6 (p<0.001), CCL2 (p<0.01), CCR2 (p<0.01), and 
VCAM-1 (p<0.01) were increased in DSS mice (Figures 4.5b, c, d and e, respectively), 
suggesting that chronic inflammation was triggered by IL-6 trans-signaling. Moreover, our data 
show that RB decreased the upregulation of IL-6, CCR2 and VCAM-1 expression in DSS mice 
(p<0.05, Figures 4.5b, d and e, respectively). Notably, as seen in Figure 4.5c, there was an 
obvious difference between the mRNA expression of CCL2 of mice fed DSS/CON and 
DSS/broccoli diets. However, we failed to detect a statistical difference, due to the large variation 
in the DSS/CON group. Interestingly, if mouse #18 (the DSS non-responder, as described earlier) 
is removed from the DSS/CON group, both RB and CB showed a significant decrease in the 
mRNA expression of CCL2 (p<0.01). Also, a positive correlation between the gene expression of 
CCL2 and the histological EC score was observed (R=0.717, p<0.001, Figure 4.6f). As described 
earlier, the chemokine CCL2 (also referred as monocyte chemoattractant protein 1, MCP1) recruits 
monocytes, playing an important role in the transition from acute to chronic inflammation.  The 
EC score reflects the degree of ulcerative colitis in the tissue. The positive correlation between 
CCL2 and EC suggests that the gene expression of CCL2 might be a good marker of colitis. 
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We propose that broccoli may be able to halt the transition from acute to chronic inflammation, 
through the IL-6 trans-signaling pathway. That SF and other brassica ITC inhibit inflammation has 
been known for a long time, but the exact mechanism is unclear. A recent study proposed a detailed 
mechanism for the anti-inflammatory effect of Nrf2 (Kobayashi et al. 2016). The study found that 
Nrf2 binds the IL-6 gene to physically interrupt RNA Polymerase II recruitment, effectively 
inhibiting transcription of IL-6. Moreover, this inhibition involves direct binding of Nrf2 to the 
gene and is independent of the typical pathway of Nrf2-ARE activation. Given the fact that SF 
from broccoli is a potent Nrf2 inducer, we propose that the mechanism of broccoli protection may 
be through direct Nrf2 inhibition of IL-6 expression, leading to suppression of the IL-6 trans-
signaling pathway. Consequently, the mRNA expression of genes involved in the IL-6 trans-
signaling pathway, IL-6, CCL2/CCR2 and VCAM-1, is inhibited and the transition from acute to 
chronic inflammation is halted (Figure 4.7).  
Interestingly, whereas our gene expression data clearly show that the tissue from DSS/CON 
mice was undergoing a switch from acute inflammation where neutrophils predominate to chronic 
inflammation where monocytes predominate, the histological data do not support this. Histology 
showed that neutrophils were still the predominant leukocytes in DSS/CON mice. Nevertheless, 
the histology data do show that both RB and CB were able to mitigate ulceration in the colon, 
evidenced by elongated crypts, regenerating colonocytes, and infiltration of fewer neutrophils and 
monocytes, compared to tissues from DSS/CON mice. This indicates that RB and CB may support 
a more rapid regeneration of colonocytes and restoration of colonic epithelium, in addition to 
inhibition of the IL-6 trans-signaling pathway.  
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4.5. Conclusions 
In conclusion, our results clearly show that even with far less myrosinase activity, CB was 
essentially as effective as raw broccoli in suppressing damage by DSS, for most of the endpoints, 
including DAI, colon length, gut barrier integrity as assessed by plasma LPS concentration, and 
colon lesion severity as assessed by histopathology. Moreover, the pro-inflammatory gene 
expression data suggest that broccoli protection may be through halting the transition from acute 
to chronic inflammation through SF-Nrf2 inhibition of the IL-6 trans-signaling pathway. Future 
studies are needed to test this hypothesis that inhibition of inflammation by SF or broccoli is 
dependent upon Nrf2 inhibition of IL-6 synthesis and subsequent disruption of IL-6 trans-signaling 
by Nrf2. 
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4.6 Tables and Figures 
Table 4.1. Diet composition 
Ingredients (g/100g diet) 
AIN-93M 
(CON) 
10% raw 
broccoli (RB) 
10% lightly cooked 
broccoli (CB) 
Freeze-dried raw broccoli powder 0 10.0 0 
Freeze-dried lightly cooked broccoli powder 0.0 0 10.0 
Casein 14.0 11.4 11.4 
Cornstarch 46.6 44.4 44.4 
Maltodextrin 15.5 14.6 14.6 
Sucrose 10.0 9.3 9.3 
Cellulose 5.0 2.6 2.6 
Mineral mix 3.5 2.7 2.7 
Vitamin mix 1.0 1.0 1.0 
L-cysteine 0.2 0.2 0.2 
Choline bitartrate 0.3 0.3 0.3 
Soybean oil 4.0 4.0 4.0 
 
Table 4.2. Primer list 
Gene 
NCBI Reference 
Sequence 
Forward Primer Reverse Primer 
Tight Junction 
 
  
CLDN1 NM_016674.4 TGTGGATGGCTGTCATTGGGG ATTCATACCTGGCATTGATGGGGG 
CLDN2 NM_016675.4 ACGGCTCCGTTTTCTAGATGCC CGTTTGGCTGCTGCTCTTGC 
CLDN3 NM_009902.4 AGCCCTCATCGTGGTGTCCA GGCCGTCTCGTCTTGTACGC 
CLDN4 NM_009903.2 GAGCCGTGTTCATCGTGGCA CCCAGCCGACGTAAAGCGAG 
CLDN5 NM_013805.4 GTGCGTGGTGCAGAGTACCG GAGCGCCGGTCAAGGTAACA 
CLDN8 NM_018778.3 ATGCACGGGGGACGATGAGA TGAGCACAACCAAGCCGGTG 
OCLN NM_008756.2 ACGGTCCTCCTGGCTCAGTT GATAAGCGAACCTTGGCGGC 
TJP1 NM_001163574.1 TGTTTATGCGGACGGTGGCG TCCATTGCTGTGCTCTTAGCGG 
Inflammation 
 
  
CCL2 NM_011333.3 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT 
CCR2 NM_009915.2 ATAAAGGAGCCATACCTGTAAATGC CATGTGGTGAATCCAATGCCCT 
IL1B NM_008361.4 TGCCACCTTTTGACAGTGATGAGA TGTTGATGTGCTGCTGCGAGA 
IL6 NM_031168.2 TAGTCCTTCCTACCCCAATTTCC TTGGTCCTTAGCCACTCCTTC 
TLR2 NM_011905.3 AGGAGGTGCGGACTGTTTCCT ATTTGACGCTTTGTCTGAGGTTTCG 
TLR4 NM_021297.3 TCCCTGCATAGAGGTAGTTCCTA TTCAAGGGGTTGAAGCTCAGA 
TNF NM_001278601.1 TCGGTCCCCAAAGGGATGAGA GGTGGTTTGTGAGTGTGAGGGT 
VCAM1 NM_011693.3 ACGTGGACATCTACTCTTTCCCCA CTTGACCGTGACCGGCTTCC 
NFKB1  NM_008689.2 CTGCCATGTCTGCTGCTGCT CGTGGGCATCACCCTCCAGA 
Housekeeping 
 
  
HPRT NM_013556.2 TCCCAGCGTCGTGATTAGCG TCGAGCAAGTCTTTCAGTCCTGT 
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Figure 4.1. Sulforaphane production by 10% raw broccoli (RB) diet and 10% lightly cooked 
broccoli (CB) diet after in vitro hydrolysis. Hydrolysis time was 1 min, 5 min, 2 h, 8 h (RB) and 
1 min, 5 min, 30 min, 1 h, 2 h, 4 h, and 8 h (CB), respectively. Data are mean ± SE (n=3-5). 
 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 4.2. The effect of diet on (a) weight loss, (b) stool formation, (c) fecal bleeding and (d) 
the combined disease activity index in dextran sulfate sodium (DSS)-treated mice during DSS 
treatment (day 7 through day 14). The diet groups are control (CON, open squares), 10% raw 
broccoli (RB, filled triangles) and 10% lightly cooked broccoli (CB, filled circles). Data are mean 
± SE (n=9, except for RB at day 14, n=8). *, ** and *** indicate significant difference from 
DSS/CON (p<0.05, p<0.01 and p<0.001. 
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Figure 4.3. The effect of diet and dextran sulfate sodium (DSS) on colon length. Diet 
groups are tap water and control (Water/CON), tap water and 10% raw broccoli (Water/RB), 
tap water and 10% lightly cooked broccoli (Water/CB), DSS and control (DSS/CON), DSS 
and 10% raw broccoli (DSS/RB), DSS and 10% lightly cooked broccoli (DSS/CB). Data are 
mean ± SE (n=6, except for DSS/RB, n=5). *** indicates a significant effect of DSS, p<0.001. 
The presence of letters indicates a significant effect of diet for Water groups or DSS groups 
(p<0.05). Values with the same letter are not different (p<0.05).   
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
Figure 4.4. The effect of diet and dextran sulfate sodium (DSS) on gut barrier function. (a) plasma 
lipopolysaccharide (LPS) concentration, n=3, except for DSS/RB (n=4); (b) urinary sucralose 
excretion, n=3, except for DSS/CON and DSS/RB (n=2); (c) mRNA expression of CLDN2, 
normalized by HPRT, n=3, except for DSS/RB (n=4); (d) mRNA expression of OCLN, normalized by 
HPRT, n=3, except for DSS/RB (n=4); (e) protein expression of ZO-1, n=3, except for DSS/CB (n=2). 
Diet groups are tap water and control (Water/CON), tap water and 10% raw broccoli (Water/RB), tap 
water and 10% lightly cooked broccoli (Water/CB), DSS and control (DSS/CON), DSS and 10% raw 
broccoli (DSS/RB), DSS and 10% lightly cooked broccoli (DSS/CB). Data are mean ± SE. * and *** 
indicate a significant effect of DSS (p<0.05 and p<0.001, respectively). The presence of letters 
indicates a significant effect of diet within Water groups or DSS groups (p<0.05). Values with the 
same letter are not different (p<0.05).  
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(d) 
 
(e) 
 
Figure 4.5. The effect of diet and dextran sulfate sodium (DSS) on mRNA expression of 
pro-inflammatory cytokines. Diet groups are tap water and control (Water/CON), tap water 
and 10% raw broccoli (Water/RB), tap water and 10% lightly cooked broccoli (Water/CB), 
DSS and control (DSS/CON), DSS and 10% raw broccoli (DSS/RB), DSS and 10% lightly 
cooked broccoli (DSS/CB). Data are mean ± SE, n=3, except for DSS/RB (n=4). *, ** and 
*** indicate significant effect of DSS (p<0.05, p<0.01 and p<0.001, respectively). The 
presence of letters indicates a significant effect of diet within Water groups or DSS groups 
(p<0.05). Values with the same letter are not different (p<0.05).   
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(e) 
 
(f) 
Figure 4.6. The effect of diet and dextran sulfate sodium (DSS) on histological pathology. (a), (b), (c) and 
(d) representative microscopic images (40 x magnification) of colon sections from Water/CON, DSS/CON, 
DSS/CB and DSS/RB, respectively; (e) erosive/ulcerative colitis (EC) scores; (f) the correlation between mRNA 
expression of CCL2 and EC score. Abbreviations used in microscopic images are: colonocytes (Co), goblet cells 
(GC), crypts (Cr), regenerating crypts (RCr), lamina propria (LP), submucosa (SM), and muscularis (M). 
Highlights are the disappearance of colonocytes (bold arrows), neutrophils (encircled), edematous submucosa 
(star), and residual histiocytes (arrowheads). Diet groups are tap water and control (Water/CON), tap water and 
10% raw broccoli (Water/RB), tap water and 10% lightly cooked broccoli (Water/CB), DSS and control 
(DSS/CON), DSS and 10% raw broccoli (DSS/RB), DSS and 10% lightly cooked broccoli (DSS/CB). Data are 
mean ± SE, n=6, except for Water/CON, DSS/CON and DSS/RB (n=5). *, ** and *** indicate a significant 
effect of DSS (p<0.05, p<0.01 and p<0.001, respectively). The presence of letters indicates a significant effect 
of diet within Water groups or DSS groups (p<0.05). Values with the same letter are not different (p<0.05).   
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Figure 4.7. Proposed molecular mechanism of anti-inflammatory property of broccoli is 
through the IL-6 trans-signaling pathway. 
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CHAPTER 5: Purification, Absorption and Metabolism of Quercetin-3-O-Sophoroside, the 
Major Quercetin in Brassica 
5.1 Introduction 
Flavonoids have been widely acknowledged for their nutritional values and health-promoting 
roles in many chronic diseases including cardiovascular diseases and cancers (Kris-Etherton et al. 
2002). Quercetin is one of the most commonly consumed flavonoids, abundantly present in plant-
based food and beverages, including onions, broccoli, and black tea. As with most flavonoids, 
quercetin occurs as multiple quercetin glycosides in nature. The signature quercetin glycosides in 
onions and black tea have been studied extensively (i.e. quercetin-4’-O-glucoside in onion, and 
rutin in black tea), however, little is known about the signature quercetin glycoside in broccoli: 
quercetin-3-O-sophoroside (QS; Price et al. 1998). The sophoroside that is bound to quercetin in 
QS consists of two glucose molecules, with a β-1, 2- linkage (Figure 5.1). 
Emerging evidence suggests that food components commonly interact, altering absorption, 
metabolism and activity. Recent studies suggest that the interaction between sulforaphane (SF) 
and quercetin, the major two bioactive compounds in broccoli, might result in synergy of anti-
cancer activity (Zhou et al. 2010; Srivastava et al. 2011). This raises the possibility of the 
interaction between glucoraphanin and QS, the precursors of SF and quercetin in broccoli, 
respectively. The bioavailability of SF from glucoraphanin has been well established by our lab 
and other labs (Angelino and Jeffery 2014; Conaway et al. 2000; Egner et al. 2011) whereas the 
bioavailability of quercetin from QS remains unknown. In order to understand the interaction 
between glucoraphanin and QS, it is essential to first understand the disposition of QS, such as 
where QS is absorbed, whether QS is absorbed intact or after deglycosylation to quercetin 
aglycone, and in what forms QS products circulate in the body.  
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One reason for the scarcity of studies of QS is lack of commercial QS. There was only one 
study that reported isolation of QS from fresh florets of broccoli (Price et al. 1998). However, the 
relatively low recovery (65 mg/kg fresh broccoli) and the interference of glucoraphanin in isolation 
of QS made the isolation from broccoli difficult. In the present study, we overcame this problem 
by isolating QS from an alternative plant, Apocynum venetum, which contains a high amount of 
QS and no interfering glucoraphanin (Li et al. 2017). With access to the pure QS compound, we 
were able to characterize its absorption and metabolism using an in-situ rat model. The in-situ 
model is chosen because it allows us to study the absorption at the upper gut (small intestine) and 
lower gut (cecum) separately, compared to feeding models. In addition, this model enables us to 
collect blood from the portal vein, before joining the peripheral circulation and therefore absorbed 
metabolites remain more concentrated. We have previously used this model to successfully 
investigate the disposition of vitexin-2-O-xyloside, a glycoside of apigenin (Angelino et al. 2013) 
and glucoraphanin (Lai et al. 2010).  
Our data suggest that QS is absorbed intact at the jejunum and partly methylated within 
enterocytes or the liver. The absorption of QS in the cecum is negligible. To the best of our 
knowledge, our study is the first to report the disposition of QS, this important flavonoid from 
broccoli. Our data also provide important information for future studies to understand the 
bioactivity of quercetin from broccoli, and its possible interaction with other food components 
such as sulforaphane. 
5.2 Methods 
Purification of QS from Apocynum  
Dried leaves of Apocynum venetum (sword-leaf dogbane or Luo Bu Ma) were obtained from 
Xinjiang, China. The leaves were extracted with methanol in Soxhlet extractors (200g/extractor) 
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overnight. The extracts were then dried in the hood, resuspended in water: methanol (83:17, v/v) 
and filtered through Whatman #1 filter paper to remove the solids. The separation of QS was 
performed using a Büchi Sepacore flash chromatography system (Newcastle, DE, USA) with dual 
C-605 pump modules, C-615 pump manager, C-660 fraction collector, C-635 UV photometer, 
with Sepacore Record chromatography software. The column was a 90 g SiliaSep BU C18 reverse 
phase flash column (230-400 mesh, 40-63 µm, Silicycle, Quebec, Canada).  
The column was equilibrated with 30% methanol: 70% water containing 0.5% acetic acid, at a 
flow rate of 50 mL/min. After injection of the samples (15 mL), the column was developed with a 
linear gradient to 40% methanol over 10 minutes, then to 60% methanol over the next 15 minutes. 
The column was washed with methanol between runs and re-equilibrated with 30% methanol. The 
effluent was monitored at 340 nm and there were two major peaks. Fractions from the two peaks 
were collected and run in HPLC- MS2 to identify the structures. The MS data showed that the first 
peak (29-32min) was QS and the other peak (36-40min) was quercetin-3-O-glucoside. During 
large-scale purification, fractions containing the putative QS (29-32min) were collected, and 
evaporated to remove the methanol and most of the acetic acid prior to freeze-drying to form a 
yellow powder.  
Structural confirmation of QS 
The structure of the putative QS powder was confirmed by LC-MS2, 1H and 13C nuclear 
magnetic resonance (NMR) spectra (LC-MS2 was carried out using the same method to identify 
the metabolites; see detailed parameters below). 1H and 13C NMR spectra were obtained using a 
Bruker Avance 500 spectrometer (Billerica, MA, USA) equipped with a 5mm broadband Z-
gradient probe (13C NMR, 125 MHz; 1H, 500 MHz) at 27 °C. NMR spectra were recorded in 
MeOH-d4, which served as the internal reference (13C, 49.0 ppm, 1H, 3.30 ppm). The data were 
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analyzed using the Advanced Chemistry Development, Inc., SpecManager 1D Processor (Toronto, 
ONT Canada) and the HNMR and CNMR Predictor software suite. 
Animals and surgery 
Fischer 344 rats weighing 140-160 g, were purchased from Envigo (formerly known as Harlan 
Laboratories Inc., Frederick, Maryland, USA) and housed individually in cages with food and 
water ad libitum. Upon arrival, rats were acclimated to a powdered AIN93G diet (Liu et al. 2017) 
for six days. The diet was removed 12 h prior to surgery. On surgery day, rats were anaesthetized 
with ketamine and xylazine (87 and 13 mg/mL, respectively; 0.1mL/100g BW) and kept under 
anesthesia during the surgery, then killed without recovering from anesthesia. The protocol for in 
situ surgery (Figure 5.2) was modified from published methods (Angelino et al. 2013; Shinoki et 
al. 2013). Briefly, each rat was administered QS or quercetin via either jejunal or cecal 
administration (n=3-4 for each group), and blood from the portal vein was collected and analyzed 
for the metabolite profile. For jejunal administration, a segment starting from the proximal end of 
the jejunum for approximately 20cm was closed by ligation. Then 15 𝜇mol quercetin or QS 
dissolved in 0.5 mL propylene glycol with 2% DMSO was injected at the proximal end of the 
ligated segment. Upon injection, the needle was withdrawn and the proximal end was immediately 
ligated, forming a closed jejunal segment with both ends ligated. For cecal administration, the 
whole cecum was ligated and material was introduced from the colonic (distal) end prior to 
complete ligation. 
Prior to material introduction, a catheter was inserted into the portal vein (~2cm distal to the 
liver) to collect blood. Blood (600 𝜇L) was withdrawn with a 1mL syringe containing 60 𝜇L 2% 
EDTA to prevent blood clotting, at 0 time (immediately before quercetin/QS administration), 10, 
20, and 30min after jejunal administration and 0, 60, 90, 120 and 150 min after cecal 
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administration. The time points were chosen based on preliminary data (not shown). After surgery, 
for rats with jejunal administration, the jejunal segment was removed from the body and the 
accurate length was measured (19-24cm); for rats with cecal administration, cecal contents were 
collected and kept frozen at -80℃ until analysis. Rats were then killed by cervical dislocation, 
without recovery from surgery. Blood samples were kept on ice and centrifuged for plasma 
collection immediately after the surgery.  
Preparation of plasma samples 
Plasma was prepared from blood samples by centrifugation at 2,400 rpm (500 x g) for 15min 
at 4℃ twice then kept frozen at -80℃ until analysis. Upon analysis, approximately 300 𝜇L plasma 
samples were extracted using three volumes of methanol containing 0.1% formic acid. The mixture 
was vortexed 30sec every 2min over 10min. After centrifugation at 16,100 x g for 10min, the 
supernatant (approximately 1.2 mL) was concentrated to approximately 100 𝜇L under nitrogen. 
After re-centrifugation, the volume of supernatant was measured and injected onto LC-MS2 for 
qualitative analysis and separately onto HPLC-PDA for quantitative analysis. 
Metabolite identification by LC-MS2 
Samples were run on Thermo Electron Linear Trap Quadrupole (LTQ) Orbitrap Discovery 
Mass Spectrometer: a linear ion trap (LTQ XL) MS, coupled to a high precision electrostatic ion 
trap (Orbitrap) MS with a high energy collision (HCD) cell and an Ion Max electrospray ionization 
(ESI) source, and a Thermo Scientific ACCELA series HPLC system (ACCELA 1250 UHPLC 
pump, ACCELA1 HTC cool stack autoinjector, and a ACCELA 80 Hz PDA detector) all running 
under Thermo Scientific Xcalibur 2.1.0.1140 LC-MS software. The MS was typically calibrated 
at least weekly with a standard calibration mixture recommended by Thermo Scientific and the 
signal detection optimized by running the autotune software feature as needed. The MS was run 
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with the ESI probe in the negative mode. The source inlet temperature was 300 ˚C, the sheath gas 
rate was typically set at 50 arbitrary units (AU), the auxiliary gas rate was typically set at 5 AU 
and the sweep gas rate, typically set at 2 AU. The maximal mass resolution was set at 30,000, the 
spray voltage was set at 3.0 kV, and the tube lens was set at -100 V. Other parameters are 
determined and set by the calibration and tuning process. The initial solvent system was 95% 
water: 5% acetonitrile, with 0.1% formic acid in both solvents, at a flow rate of 0.25 mL/min. After 
injection (15-25 µL) the column was developed with a linear gradient to 60% acetonitrile over 60 
min. The column effluent was monitored at 365 nm and 280 nm using a PDA detector. The 
software package was set to collect mass data between 100-2000 AMUs. Generally, the most 
significant sample ions generated under these conditions were [M-H]- and [M+HCOO]-. Three 
mass spectrometric events were programmed to run in sequence in the MS: 1) LTQ (IT)-MS full 
scan m/z 150 to 2000. 2) LTQ (IT)-MS trap most abundant ion performs CID at 35% energy. 3) 
FT-MS full scan m/z 150 to 2000.  For the evaluation of Xcalibur accurate mass data by the Cerno 
BioScience LLC MassWorks 5.0.0.0 software the FTMS was set to collect spectra at a resolution 
of 7500 and a range of m/z of 100 to 2000 and then were evaluated by sCLIPS (self Calibrating 
Line-shape Isotope Profile Search), which enhances formula ID accuracy.  
Identification of the phase II metabolites of quercetin and QS was with reference to a list of 
commonly reported quercetin metabolites (Mullen et al. 2006). Each peak identified was 
confirmed using HPLC retention time and MS2 fragmentation data (Table 5.1).  
Metabolite quantification by Shimadzu LC-20 HPLC system 
Because the UV detector in the LC-MS2 system was not sufficiently sensitive for accurate 
quantification, we carried out the quantification separately on a Shimadzu LC-20 HPLC system 
consisting of a LC-20AT quaternary pump, DGU-20A5 degasser, SIL-20A HT autosampler, and 
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a SPD M20A PDA, running under Shimadzu LCSolutions version 1.22 chromatography software 
(Columbia, MD, USA). Samples and standards were separated using an Inertsil ODS-3 reverse 
phase C-18 column (5 µm, 250 x 4.6 mm; GL Sciences, Torrance, CA) using a 50-min linear 
gradient of 5-34.7% acetonitrile containing 0.25% trifluroacetic acid, at a flow rate of 1 mL/min, 
based on a published method (Mullen et al 2006). The injection volume was 50 µL.  
The identification of quercetin-3-glucuronide, isorhamnetin-3-glucuronide, and QS was by 
reference to the retention time of standards in the Shimadzu LC-20 HPLC system as reported in 
Table 5.1. Quercetin-3-glucuronide standard was purchased from Sigma; isorhamnetin-3-
glucuronide was kindly provided by Drs. Paul Kroon and Paul Needs (Quadram Institute, Norwich, 
UK); and QS was from our purification, confirmed by LC-MS2 and NMR, as described earlier. 
The other three isomers of isorhamnetin glucuronide and isorhamnetin sophoroside were also 
identified by their elution patterns in the Shimadzu LC-20 HPLC system, which were the same as 
those in LC-MS2 system. The quantification of all these compounds was by reference to standard 
calibration curves of quercetin, based on the assumption that that the extinction coefficients of 
quercetin phase II metabolites are close to that of quercetin. Additional metabolites were not 
quantified either because of lack of exclusive absorbance peaks at 365nm or lack of the same 
elution pattern in Shimadzu LC-20 HPLC compared to the LC-MS2 system, leading to difficulty 
in identification of an absorbance peak in the Shimadzu LC-20 HPLC system. 
5.3 Results 
Isolation of QS from Apocynum 
The yield of QS from Apocynum venetum was 200 mg/kg dried leaf material and the purity 
following purification was approximately 93%, based on HPLC data (not shown). The structure 
was confirmed by LC-MS2 (Figure 5.3), 1H and 13C NMR spectra.  
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LC-MS2: The chromatogram at 365nm and ESI-MS2 detector showed a clean peak with 
retention time at 24.0min. M/z: 625.15 [M-H]- for a molecular formula of C27H29O17 with a mass 
error of 4.36 ppm; MS/MS yielded major fragment ions of 300.03 [M-sophoroside-H] -, and 445.09 
[M-glucose-H2O] -.   
1H and 13C NMR spectra further confirmed the isolate from Apocynum venetum as QS, based 
on comparison with previously published literature (Li et al. 2017; Shi et al. 2011).  Detailed data 
follow. 
1H NMR (500 MHz, CD3OD), delta, ppm: 7.68 (1H, d, J=2.0, 2'), 7.55 (1H, dd, J=8.4,2.0, 6'), 
6.90 (1H, d, J=8.5, 5'), 6.40 (1H, d, J=1.9, 8), 6.21 (1H, d, J=1.9, 6), 5.37 (1H, d, J=7.5, 1''), 4.77 
(1H, d, J=7.2, 1'''), 3.80, 3.72 (2H, 6''ab)*, 3.70, 3.54 (2H, 6'''ab)*, 3.60 (1H, t, J=8.9, 3''), 3.41 
(3H, 3''', 4'', 4'''), 3.39 (1H, 2'''), 3.33 (1H, 5'')†, 3.20 (1H, 5''')†. *, † = may be reversed.  
13C NMR (125 MHz, CD3OD), delta, ppm: 178.36 (4), 164.44 (7), 161.71 (5), 157.46 (9), 
157.07 (2), 148.37 (4'), 144.55 (3'), 133.72 (3), 121.68 (1')*, 121.65 (6')*, 116.36 (2'), 114.75 (5'), 
104.39 (10), 103.57 (1'''), 99.79 (1''), 98.42 (6), 93.26 (8), 81.47 (2''), ~76.6 (3'', 3''', 5'', 5'''), 74.14 
(2'''), 69.68 (4'')†, 69.55 (4''')†, 61.02 (6'')‡, 60.94 (6''')‡. *, †, ‡ = may be reversed. 
Based on the data from LC-MS2, 1H and 13C NMR, we conclude that the compound we isolated 
from Apocynum is the 3-O-sophoroside of quercetin. 
Absorption and metabolism of quercetin aglycone 
Quercetin aglycone was also investigated in the present study in addition to QS, not only to 
serve as a positive control of the methodology, but also because studies are lacking that directly 
compare the absorption & metabolism of quercetin at the upper gut and lower gut.  
Typical phase II metabolism of quercetin involves glucuronidation, sulfation and methylation. 
In this study, eleven phase II quercetin metabolites involving all three pathways were identified in 
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plasma following jejunal administration, as shown in Figure 5.4A and Table 5.1. These 
metabolites are isorhamnetin glucuronide sulfate (four isomers, peaks 1, 2, 3 and 5), quercetin 
glucuronide sulfate (two isomers, peaks 1 and 3), quercetin glucuronide (two isomers, peaks 3 and 
4), isorhamnetin glucuronide (four isomers, peaks 6-9), quercetin sulfate (peak 10) and quercetin 
aglycone (peak 11). Quercetin aglycone was only seen in the 30min- plasma sample from one of 
three rats using LC-MS2, and was not detected using the Shimazu HPLC system with the same 
sample, suggesting that if present, it was a minor constituent. Among these metabolites, quercetin-
3-O-glucuronide (Q3GA) and isorhamnetin glucuronides (IGA, four isomers) were quantified, as 
described in Methods. 
As Figure 5.5A shows, Q3GA and the IGAs were present in plasma as early as 10min following 
quercetin administration into the jejunum, with IGA-2 being the most abundant one among those 
quantified, suggesting a swift absorption and metabolism of quercetin at the jejunum. At 20 and 
30 min, the amount of these glucuronides had increased over time and IGA-2 was still the most 
abundant metabolite quantified (48% of the total quantified metabolites at 20min and 50% at 
30min). At 30min, the glucuronides were: IGA-2 (12 𝜇M), followed by IGA-1 (isorhamnetin-3-
O-glucuronide, 3𝜇 M), IGA-4 (3𝜇 M), Q3GA (3𝜇 M), and IGA-3 (2 𝜇 M). The total plasma 
concentration of IGA isomers was 20 𝜇 M at 30 min, suggesting intense methylation of the 
glucuronides.  
In the cecum, very little quercetin absorption and metabolism was seen during 60 min, with 
observations at 0.5, 1, 10, 30 and 60min (data not shown), therefore, we increased the surgery 
duration to 150min. Even in this case, there were few metabolites in the plasma following quercetin 
administration into the cecum (Figures 5.4B and 5.5B). In the HPLC trace from LC-MS2, only 
isorhamnetin glucuronide sulfate (two isomers) was detected (Figure 5.4B). Using the Shimazu 
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HPLC system, which had a higher resolution, Q3GA and four isomers of IGA were also found 
(Figure 5.5B).  At 60 and 90 min, only Q3GA and two isomers of IGA were detected (IGA-1 and 
IGA-3). At 120min, IGA-4 was present in the plasma sample from one rat and was not present at 
150min in any sample. IGA-2, which was the major metabolite in plasma samples following 
jejunal administration, was present at both 120 and 150min, but with less abundance. At 60, 90, 
and 120min, Q3GA was the predominant metabolite and at 150min, IGA-3 became the major 
metabolite. At 150min, the concentration of these glucuronides was: IGA-3 (0.27 𝜇M), followed 
by Q3GA (0.24 𝜇M), IGA-1 (0.23 𝜇M) and IGA-2 (0.02 𝜇M). The total concentration of IGA 
isomers was 0.5 𝜇M at 150 min.  
Absorption and metabolism of QS 
Intact QS was observed in plasma following QS administration into the jejunum, as shown in 
Table 5.1, Figures 5.4C (peak 12) and 5.6A. During purification from Apocynum, QS was 
confirmed by HPLC retention time, LC-MS2 and NMR. Here, plasma QS exhibited the same 
retention time and MS2 fragmentation patterns (NMR was not performed because purification of 
QS from plasma was difficult). We consider that peak 13 in Figure 5.4C is isorhamnetin 
sophoroside (IS: methylated QS, Table 5.1) based on the MS2 fragmentation pattern. 
Unfortunately, there is no available standard for IS, resulting in lack of further confirmation by 
retention time. Notably, apart from QS and IS, we did not detect any other QS metabolites 
(glucuronides or sulfates), or free quercetin or quercetin metabolites, indicating QS was not 
deglycosylated. 
Intact QS was present in the plasma as early as 10min following jejunal QS administration 
(Figure 5.6A). IS, although in a small amount, was also present at 10min, suggesting a rapid 
methylation in the jejunal enterocyte or liver. During the 30-min surgery, the concentration of QS 
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and IS increased over the time. The ratios of concentrations of IS and QS first increased and 
appeared to stay constant during 20-30min (IS: QS was approximately 1:5).  
Following cecal administration, only intact QS was detected in plasma during the 150min 
surgery and that was only present in plasma from two of four rats (Figure 5.4D and 5.6B). In 
addition, this cecal absorption of QS was negligible (<0.1 μM in plasma at all the time points 
analyzed), compared to 4.7 μM in 30min-plasma following jejunal administration, suggesting that 
for QS, the jejunum is a better absorptive site compared to cecum. 
5.4 Discussion 
Absorption and metabolism of quercetin  
Our data suggest that the absorption of quercetin from the cecum is much lower and slower 
than that from jejunum: a maximum plasma concentration of 0.8 μM of quantified metabolites 
from cecum (in a 120min blood sample) vs a maximum plasma concentration of 23 μM from 
jejunum (in a 30min blood sample). Besides, we found that although the types of metabolite in 
jejunum and cecum were similar, the relative abundance of each metabolite differed. For instance, 
IGA-2 (peak 7 in Table 5.1 and Figure 5.4A) was the most abundant among the quantified 
metabolites in the plasma samples following jejunal administration whereas IGA-3 (peak 8) and 
Q3GA (peak 4) were most abundant following cecal administration. These data suggest a slight 
difference in the specific phase II enzyme activities and the preferential metabolic pathways in the 
upper gut and lower gut. 
One major difference between the upper gut and lower gut is the abundance of residing 
microbiota. In the upper gut, the population of microbiota is small, therefore, the metabolism we 
observed is mainly attributed to the small intestinal enterocyte. However, with a large population 
of microbiota in cecum, the possible contribution of microbial metabolism cannot be excluded. In 
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addition to the typical phase II metabolism, catabolism of quercetin to form phenolic acids (such 
as 3-methoxy-4-hydroxyphenylacetic acid) by the microbiota is also suggested occurring in the 
lower gut (Jaganath et al. 2016).  In the present study, one of the limitations is that the potential 
catabolism by cecal microbiota (i.e. the phenolic acid analysis) was not investigated in either 
quercetin or QS studies. 
In the small intestine, quercetin aglycone once absorbed undergoes extensive phase II 
metabolism (sulfation, glucuronidation and methylation) on one or more of the five free hydroxyl 
groups, resulting in dozens of possible metabolites. Typical metabolites reported in rat models 
include quercetin glucuronide, quercetin sulfate, isorhamnetin, isorhamnetin sulfate, quercetin 
glucuronide sulfate, isorhamnetin glucuronide sulfate, and isorhamnetin glucuronide (Jones et al. 
2004; Graf et al. 2006; Kawai et al. 2009). In the present study, when evaluating absorption and 
metabolism of quercetin aglycone, we found all these metabolites with the only exceptions being 
isorhamnetin and its sulfate, suggesting that our data are consistent with the literature. This is 
important because it supports the accountability of our QS results, which unexpectedly showed 
absorption of unaltered QS. 
Absorption and metabolism of QS  
In the present study, our data clearly suggest that unlike most quercetin glycosides (QGs), QS 
is absorbed intact and partly methylated, with apparent absence of any deglycosylation. This 
observation however, challenges the conventional idea that QGs must be deglycosylated prior to 
absorption. Therefore, here we carefully examine our methodology. An important question is 
whether the QS we report is indeed quercetin-3-O-sophoroside. In the present study, QS was 
identified based on retention time in HPLC trace (Figure 5.4C), molecular weight (Table 5.1) and 
the fragmentation pattern (Table 5.1). We consider this identification as the best analytical method 
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to confirm a structure in biological samples. Another question night be whether the occurrence of 
intact QS in the plasma is due to leakage through the rat small intestinal wall. We consider it 
unlikely, based on how consistent the absorption and metabolism data are with that of the literature 
for the quercetin aglycone (Figures 5.4A and 5.5), for which we used the same in situ surgery 
model and analysis as for QS. Furthermore, the presence of IS (methylated QS) in plasma supports 
the proposal that QS is absorbed transcellularly (through the cells) rather than paracellularly 
(between the cells), because methylation occurs within the enterocyte, whereas “leakage” would 
be expected to take the paracellular route. 
In reviewing the literature on flavonoid absorption, there has been a long debate (since the 90s) 
as to whether the absorption of QGs without prior deglycosylation is possible. This question was 
discussed extensively during the decade 1995 to 2005, with contribution by many scientists, 
particularly the Hollman and Williamson groups. However, this discussion failed to reach an 
agreeable conclusion, due to inconsistent and divergent results. By reviewing studies covered by 
that debate, we find that the absorption and metabolism of QGs greatly depends upon the nature 
of the glycoside(s) under study (the type, position and numbers of the glycoside moieties attached 
to quercetin). 
For instance, researchers consistently found that quercetin-3-O-glucoside (Q3G) is absorbed in 
the small intestine and that intact Q3G does not occur in the circulation, no matter in rat or clinical 
studies (Gee et al. 2000; Sesink et al. 2001; Morand et al. 2000). The molecular explanation is that 
Q3G is deglycosylated by a luminal β-glycosidase, lactase phlorizin hydrolase (LPH) in the lumen 
of the small intestine, and that the released quercetin aglycone is then absorbed across the 
membrane by simple diffusion. However, these studies found that only 67-75% of Q3G absorption 
was accounted for by the LPH pathway, whereas the other 25-33% remained unexplained (Sesink 
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et al. 2003; Day et al. 2003). One study (Wolffram et al. 2002) reported that the unaccounted 
absorption was due to the “SGLT1-CBG pathway”: intact absorption by the membrane transporter, 
sodium dependent glucose transporter 1 (SGLT1) and subsequent deglycosylation by a cytosolic 
β-glycosidase (CBG). The extent of absorption via the SGLT1-CBG pathway reported in that study 
(37%) matched well the unexplained absorption of Q3G (25-33%). However, another group (Day 
et al. 2003) showed data suggesting that SGLT1 was not involved in the absorption of Q3G, based 
on the observation that the presence of a SGLT1 inhibitor did not reduce the absorption of Q3G.  
Rutin, another diglycoside of quercetin, shows distinct difference in absorption compared to 
Q3G. Whether rutin is absorbed in the small intestine (no matter which form) has been debated. 
Most clinical studies showed the absence of absorption (Hollman et al. 1999; Jaganath et al. 2006), 
whereas more than half of the rat studies showed presence of absorption and found intact rutin in 
the circulation (Carbonaro and Grant 2005; Spencer et al. 1999; Andlauer et al. 2001). Molecular 
investigation showed that rutin was not the substrate of any β-glycosidases (CBG and LPH, Day 
et al. 1998). With these inconsistent results obtained from rat and clinical studies, we hypothesize 
that there might be an unidentified transporter system to transport rutin across the small intestinal 
membrane in rats that is not present in human. However, future studies need to be conducted to 
confirm this. 
As with those studies that reported absorption of intact rutin in rats, QS is also shown absorbed 
intact in the small intestine in the present study. Rutin and QS are both quercetin diglycosides with 
the glycoside moiety conjugated in the 3-position. However, the type and linkage of the 
diglycosides differ. The diglycoside in rutin is a glucose conjugated with a rhamnose with a 1,6-
linkage whereas the diglycoside in QS is two glucose molecules with a 1, 2-linkage: possibly more 
likely to be a substrate of the glucose transporter system. Future studies should be conducted to 
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evaluate glucose transporters for transport of QS across the small intestinal membrane in rats and 
confirm that QS is not the substrate of β-glycosidases (LPH and CBG). The present study did not 
address the possibility that absorption may differ in clinical studies. 
5.5 Conclusions 
In conclusion, with the successful purification of QS from Apocynum venetum, and with the use 
of an in situ rat model, our data show that QS, the major flavonoid in broccoli, is absorbed intact 
in the small intestine and partly methylated to IS. Compared to the small intestine, the absorption 
of QS in the cecum appeared negligible. Therefore, future studies that address the bioactivity of 
quercetin from broccoli may need to evaluate QS and IS activity in addition to the activity of 
quercetin aglycone and its phase II metabolites. Our data also provide important information for 
future studies to understand the interaction between QS and other components in broccoli, such as 
glucoraphanin. 
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5.6 Table and Figures 
 
Table 5.1. LC-MS2 identification of metabolites of quercetin and quercetin-3-O-sophoroside (QS) detected in plasma. 
 
Fragment ions: glc: glucosyl; glcUA: glucuronyl; met: methyl; [M-H]-: negatively charged molecular ion 
*  Peak numbers and retention times refer to HPLC traces in Figures 5.4A and 5.4C 
☥ Retention time confirmed by standards 
☩ Quantification shown in Figures 5.5 and 5.6
Peak* 
Retention 
time/min* 
Metabolites 
[M-H]- 
(m/z) 
MS2 fragments ions (m/z) Source 
12 24.0☥ Quercetin-3-sophoroside (QS) ☩ 625 301([M-H]--glc-glc), 445([M-H]--glc-H2O), 463 ([M-H]--glc) QS 
1 25.7 
Isorhamnetin glucuronide sulfate 571 491([M-H]--SO3), 315 ([M-H]--SO3-glcUA) Quercetin 
Quercetin glucuronide sulfate 557 477([M-H]--SO3), 381([M-H]--glcUA), 301 ([M-H]--SO3-glcUA) Quercetin 
2 28.0 Isorhamnetin glucuronide sulfate 571 491([M-H]--SO3), 315 ([M-H]--SO3-glcUA) Quercetin 
13 28.6 Isorhamnetin sophoroside☩(IS) 639 
315 ([M-H]--glc-glc), 300([M-H]--glc-glc-met), 459([M-H]--glc-
H2O), 477([M-H]--glc) 
QS 
3 28.7 
Quercetin glucuronide sulfate 557 477([M-H]--SO3), 381([M-H]--glcUA), 301 ([M-H]--SO3-glcUA) Quercetin 
Quercetin glucuronide 477 301([M-H]--glcUA) Quercetin 
Isorhamnetin glucuronide sulfate 571 491([M-H]--SO3), 315 ([M-H]--SO3-glcUA) Quercetin 
4 29.3☥ Quercetin-3-glucuronide (Q3GA) ☩ 477 301([M-H]--glcUA) Quercetin 
5 30.8 Isorhamnetin glucuronide sulfate 571 491([M-H]--SO3), 315 ([M-H]--SO3-glcUA) Quercetin 
6 35.2☥ Isorhamnetin-3-glucuronide (IGA-1) ☩ 491 315([M-H]--glcUA) Quercetin 
7 36.1 Isorhamnetin glucuronide (IGA-2) ☩ 491 315([M-H]--glcUA) Quercetin 
8 37.0 Isorhamnetin glucuronide (IGA-3) ☩ 491 315([M-H]--glcUA) Quercetin 
9 37.8 Isorhamnetin glucuronide (IGA-4) ☩ 491 315([M-H]--glcUA) Quercetin 
10 38.6 Quercetin sulfate 381 301([M-H]--SO3) Quercetin 
11 46.1 Quercetin 301 179, 151 Quercetin 
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Quercetin Quercetin-3-O-sophoroside (QS) 
 
 
Quercetin-3-O-glucuronide (Q3GA) Isorhamnetin-3-O-glucuronide (IGA-1) 
 
 
 
Isorhamnetin-3-O-sophoroside (IS) Quercetin-3-O-glucuronide-sulfate 
 
Figure 5.1. Structure of quercetin derivatives.  
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Figure 5.2. The model of in situ surgery in rats. Each rat was administered quercetin-3-O-
sophoroside (QS) or quercetin via either jejunal or cecal administration (n=3-4 for each group), 
and blood from the portal vein was collected and analyzed for the metabolite profile. See details 
in 5.2 Methods.  
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Figure 5.3. Structure confirmation of quercetin-3-O-sophoroside by LC-MS2. M/z: 625.15 
[M-H]- for a molecular formula of C27H29O17 with a mass error of 4.36 ppm; MS/MS yielded major 
fragment ions of 300.03 [M-sophoroside-H]- and 445.09 [M-glucose-H2O]-.  
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Figure 5.4. Representative HPLC trace from LC-MS2 for identification of metabolites. (A) 
30min- plasma following jejunal administration of quercetin; (B) 150min- plasma following cecal 
administration of quercetin; (C) 30min- plasma following jejunal administration of quercetin-3-O-
sophoroside; (D) 150min- plasma following cecal administration of quercetin-3-O-sophoroside. *: 
present in sample of only one of three rats with the same treatment; †: peaks identified as 
Isorhamnetin glucuronide sulfate. 
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 A.  
 
 
B.  
 
 
Figure 5.5.  Metabolite distribution in plasma samples following jejunal (A) and cecal (B) 
administration of quercetin.  
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Figure 5.6.  Metabolite distribution in plasma samples following jejunal (A) and cecal (B) 
administration of quercetin-3-O-sophoroside.  
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CHAPTER 6: Conclusions and Future Directions 
6.1 Conclusions and Future Directions 
The overall objective of this study is to improve sulforaphane (SF) bioavailability from 
cooked broccoli (CB). The first aim was to investigate whether frequent intake of CB would alter 
gut microbiota composition and subsequently improve SF bioavailability (Chapter 3). Our data 
show that no less than 4 days of 10% CB diet significantly alters rat cecal microbiota composition, 
based on principle component analysis (PCA) of the 16s rRNA sequencing data. Also, 
consistently, no less than 4 days of 10% CB diet increased SF formation by cecal microbiota, to 
25-fold higher than that by microbiota of rats following control diet. In addition, increased colonic 
NAD(P)H: quinone oxidoreductase 1 activity (one marker of SF bioactivity) was shown to require 
no less than 7 days of feeding 10% CB diet. These pieces of evidence clearly suggest that CB-
dependent SF bioavailability and bioactivity can be increased by frequent intake of CB, through 
increased myrosinase-like activity of cecal microbiota. In addition, our data show that increased 
SF formation was lost when the 4 day CB diet was switched back to a control diet for an additional 
3 days, indicating that the enhancement of SF bioavailability might require intake of CB on a daily 
basis. 
Although these data have shown that CB alters gut microbiota composition and improves SF 
formation, we have not clearly shown which component is responsible for the effect. With the 
hypothesis that glucoraphanin (GRP, the precursor of SF in broccoli) is that component, four 
different diets were designed: control diet, control diet supplemented GRP powder, CB diet, CB 
diet with GRP converted to SF. The data show that GRP alone is sufficient to improve SF 
formation by cecal microbiota, but not sufficient to alter the microbiota composition. There are 
two possible explanations for these inconsistent results. First, GRP might change the abundance 
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of only a minor bacterial specie(s) that cannot readily be captured by 16s rRNA sequencing and 
PCA: this methodology might only reflect greater levels of change. Secondly, GRP might improve 
SF formation by enhancing the myrosinase activity of the bacteria rather than by enhancing the 
abundance of any bacteria. Future study is needed to identify the specific bacterial strains that have 
myrosinase activity, and whether myrosinase activity or abundance of myrosinase-containing 
bacteria is induced by GRP.  
 Furthermore, our data suggest that additional components in CB other than GRP alone play 
important roles in modifying the cecal microbiota composition. This could be fiber, quercetin-3-
O-sophoroside or other flavonoids in broccoli or the combination of these components together. 
Future study is needed to identify which components in broccoli cause the change in microbiota 
composition, and whether this change is responsible for any additional health implications. 
The second aim of this study (Chapter 4) was based on the conclusion from the first aim. 
Since SF bioavailability can be improved by frequent intake of CB, whether this enhanced SF 
bioavailability would provide the host with protection as effective as that of raw broccoli (RB) is 
of great interest. Therefore, we compared the protective effect of 14 day’s intake of CB and RB 
diet in a dextran sulfate sodium (DSS)-induced colitis model in mice. Our data show that CB diet 
is essentially as protective as RB diet against colitis in terms of attenuated weight loss, improved 
fecal bleeding and stool looseness, restored epithelial structure, and less leukocyte infiltration.  
Our data further show that this protection might be through mitigating gut leakage, seen as 
less lipopolysaccharide (endotoxin from gram-negative bacteria) found in serum of mice receiving 
RB and CB diet. However, tight junction protein analysis shows that neither CB nor RB diet 
improved gene and protein expression of tight junctions, indicating that the mitigated gut leakage 
might be through other components of the gut barrier other than by enhanced synthesis of tight 
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junction proteins. For instance, the inhibition of pro-inflammatory signals by the broccoli diet 
might be a possible mechanism. 
Analysis of pro-inflammatory gene expression reveals that a broccoli diet decreases the IL-6 
trans-signaling pathway in DSS mice, evidenced by decreased IL-6, CCR2 and VCAM-1 gene 
expression in colonic tissues. This is of great interest because the increased IL-6 trans-signaling 
pathway is a hallmark of chronic inflammation (Gabay 2006), which is a possible mechanism for 
aggravation many life-threatening chronic diseases, such as cancers and diabetes. Therefore, we 
hypothesize that dietary broccoli might inhibit chronic inflammation through the IL-6 trans-
signaling pathway. However, future studies are needed to confirm this hypothesis. In addition, 
which components in broccoli (SF, fiber, quercetin or others) is responsible for the mitigation of 
colitis and how such components interact with the IL-6 trans-signaling pathway require further 
investigation. 
Furthermore, the microbiota has been suggested to play an important role in the pathology of 
DSS-induced gut inflammation (Hernández-Chirlaque et al. 2016; Håkansson et al. 2015). It would 
therefore be of great interest to investigate whether transplant of microbiota from broccoli-fed 
mice to germ-free mice treated with DSS would mitigate the colitis. In addition, encroachment of 
microbiota into the mucus layer of gut barrier has been reported in colitis models (Chassaing et al. 
2017). Future study could also investigate whether dietary broccoli is able to prevent this 
encroachment of microbiota.  
The third aim of this study was to understand the absorption and metabolism of quercetin-3-
O-sophoroside (QS), the major flavonoid in broccoli (Chapter 5). Our original hypothesis was that 
QS could improve the bioavailability of SF from CB by modifying the gut microbiota composition, 
based on studies reporting synergism in anti-cancer activities between quercetin (the 
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deglycosylation product of QS) and SF (Zhou et al. 2010b; Srivastava et al. 2011b). With the 
realization that no literature exists about the health related properties of QS, we considered that in 
order to understand the interaction between QS and SF, it was essential to first understand the 
disposition of QS per se.  
With the successful purification of QS from Apocynum venetum and with the use of in situ 
rat model, our data show that QS is absorbed intact in the small intestine and partly methylated to 
isorhamnetin sophoroside. No quercetin aglycone or its typical phase II metabolites were observed. 
Therefore, future studies that address the bioactivity of quercetin from broccoli may need to 
evaluate QS and IS activity in addition to the activity of quercetin aglycone and its phase II 
metabolites. 
It has been shown that the unabsorbed quercetin or QGs in the small intestine would reach 
the lower gut and undergo deglycosylation, ring fission and catabolism into small phenolic acids 
within the colonic lumen, such as 3-methoxy-4-hydroxyphenylacetic acid  (Jaganath et al. 2006). 
In the present study, the analysis of these phenolic acids was not included. Future studies are 
needed to determine whether QS is catabolized in the lower gut and whether the formed phenolic 
acids are absorbed.  
The present study was conducted in the rat model, which allowed us to investigate the 
absorption of QS in the upper gut and lower gut separately. However, with our long-term goal to 
improve public health through a dietary approach, we foresee the importance of extending our 
current conclusion to clinical studies. We have the privilege to access the plasma and urine samples 
following broccoli consumption in a clinical study, conducted by our collaborators, Drs. Craig 
Charron and Janet Novotny at USDA. Our future studies will investigate whether QS from dietary 
broccoli is also absorbed intact in the small intestine in the human body. We hope that with these 
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important pieces of information about where and how QS is absorbed and metabolized, future 
studies will be able to study whether the intact QS improves SF bioavailability from CB and 
whether this effect, if present, is dependent on the microbiota. 
  
128 
 
6.2 References 
 
Chassaing, Benoit, Shreya M. Raja, James D. Lewis, Shanthi Srinivasan, and Andrew T. 
Gewirtz. 2017. “Colonic Microbiota Encroachment Correlates With Dysglycemia in 
Humans.” Cellular and Molecular Gastroenterology and Hepatology 4 (2): 205–21.  
Gabay, Cem. 2006. “Interleukin-6 and Chronic Inflammation.” Arthritis Research & Therapy 8 
Suppl 2: S3.  
Håkansson, Å, N. Tormo-Badia, A. Baridi, J. Xu, G. Molin, M.-L. Hagslätt, C. Karlsson, B. 
Jeppsson, C. M. Cilio, and S. Ahrné. 2015. “Immunological Alteration and Changes of 
Gut Microbiota after Dextran Sulfate Sodium (DSS) Administration in Mice.” Clinical 
and Experimental Medicine 15 (1): 107–20.  
Hernández-Chirlaque, Cristina, Carlos J. Aranda, Borja Ocón, Fermín Capitán-Cañadas, 
Mercedes Ortega-González, Juan Jesús Carrero, María Dolores Suárez, Antonio 
Zarzuelo, Fermín Sánchez de Medina, and Olga Martínez-Augustin. 2016. “Germ-Free 
and Antibiotic-Treated Mice Are Highly Susceptible to Epithelial Injury in DSS Colitis.” 
Journal of Crohn’s & Colitis 10 (11): 1324–35.  
Jaganath, Indu B., William Mullen, Christine A. Edwards, and Alan Crozier. 2006. “The 
Relative Contribution of the Small and Large Intestine to the Absorption and Metabolism 
of Rutin in Man.” Free Radical Research 40 (10): 1035–46.  
Srivastava, Rakesh K., Su-Ni Tang, Wenyu Zhu, Daniel Meeker, and Sharmila Shankar. 2011. 
“Sulforaphane Synergizes with Quercetin to Inhibit Self-Renewal Capacity of Pancreatic 
Cancer Stem Cells.” Frontiers in Bioscience (Elite Edition) 3 (January): 515–28. 
Zhou, Wei, Georgios Kallifatidis, Bernd Baumann, Vanessa Rausch, Jürgen Mattern, Jury 
Gladkich, Nathalia Giese, et al. 2010. “Dietary Polyphenol Quercetin Targets Pancreatic 
Cancer Stem Cells.” International Journal of Oncology 37 (3): 551–61. 
nutrients
Article
Dietary Broccoli Alters Rat Cecal Microbiota to
Improve Glucoraphanin Hydrolysis to
Bioactive Isothiocyanates
Xiaoji Liu 1,†, Yanling Wang 1,†, Jennifer L. Hoeﬂinger 1, Bárbara P. Neme 2, Elizabeth H. Jeffery 1
and Michael J. Miller 1,*
1 Department of Food Science and Human Nutrition, University of Illinois, 905 S. Goodwin Ave., Urbana,
61801 IL, USA; xiaoji2@illinois.edu (X.L.); ywang436@illinois.edu (Y.W.); jlwinric@illinois.edu (J.L.H.);
ejeffery@illinois.edu (E.H.J.)
2 Department of Food Technology, Federal Rural University of Rio de Janeiro, 23.897-000 Seropédica, Brazil;
barbara.neme@hotmail.com
* Correspondence: mille216@illinois.edu; Tel.: +1-217-244-1973; Fax: +1-217-265-0925
† These authors contributed equally to this work.
Received: 9 February 2017; Accepted: 7 March 2017; Published: 10 March 2017
Abstract: Broccoli consumption brings many health beneﬁts, including reducing the risk of cancer
and inﬂammatory diseases. The objectives of this study were to identify global alterations in
the cecal microbiota composition using 16S rRNA sequencing analysis and glucoraphanin (GRP)
hydrolysis to isothiocyanates ex vivo by the cecal microbiota, following different broccoli diets. Rats
were randomized to consume AIN93G (control) or different broccoli diets; AIN93G plus cooked
broccoli, a GRP-rich powder, raw broccoli, or myrosinase-treated cooked broccoli. Feeding raw or
cooked broccoli for four days or longer both changed the cecal microbiota composition and caused a
greater production of isothiocyanates ex vivo. A more than two-fold increase in NAD(P)H: quinone
oxidoreductase 1 activity of the host colon mucosa after feeding cooked broccoli for seven days
conﬁrmed the positive health beneﬁts. Further studies revealed that dietary GRP was speciﬁcally
responsible for the increasedmicrobial GRP hydrolysis ex vivo, whereas changes in the cecal microbial
communities were attributed to other broccoli components. Interestingly, a three-day withdrawal
from a raw broccoli diet reversed the increased microbial GRP hydrolysis ex vivo. Findings suggest
that enhanced conversion of GRP to bioactive isothiocyanates by the cecal microbiota requires four or
more days of broccoli consumption and is reversible.
Keywords: broccoli; glucoraphanin; isothiocyanate; rat; gut microbiome
1. Introduction
Broccoli?belongs?to?the?glucosinolate?(GSL)-containing?family?of?brassica?vegetables.?The?major?
GSL?in?broccoli?is?glucoraphanin?(GRP)?which,?upon?hydrolysis,?produces?the?bioactive?isothiocyanate?
(ITC)?sulforaphane?(SFN),?shown?to?slow?or?prevent?cancer?in?humans?[1].?One?major?mechanism?
of?action?of?SFN? is?upregulation?of?several?phase? II?detoxiﬁcation?enzymes,? including?NAD(P)H:?
quinone? oxidoreductase? 1? (NQO1)? [2].? Here?we? use? increased?NQO1? levels? as? a?measure? of?
broccoli-induced?bioactivity.
The?formation?of?SFN?from?GRP?is?catalyzed?by?the?plant?enzyme?myrosinase,?active?during?
chewing?or?crushing?when?broccoli? is?consumed? raw?or? lightly?steamed? [3].? When?broccoli?and?
other?brassica?vegetables?are?cooked?more?vigorously,? the?plant?myrosinases?are? inactivated?and,?
thus,?are?unable?to?hydrolyze?GSLs?[4].? Even?though?many?US?consumers?prefer?cooked?broccoli,?
epidemiological? studies? suggest? that? frequent? consumption? of?brassica?vegetables?decreases? the
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risk for a number of cancers, including breast, colon, and prostate cancers [5]. This suggests that
GSLs undergo hydrolysis to ITC following ingestion, in the absence of active plant myrosinase.
Several microorganisms isolated from the mammalian gut, including lactic acid bacteria [6],
Enterobacteriaceae [7], Biﬁdobaicterium spp. [8], and Bacteroides spp. [9], appear to have myrosinase-like
glycoside hydrolases that cleave GSL. However, although research shows direct evidence for GRP
hydrolysis ex vivo and in vivo to bioactive SFN by cecal microbiota, SFN is only found in trace
amounts [10]. Comparatively inactive nitriles [11,12], not bioactive ITC, are typically reported as
products of microbial GSL hydrolysis ex vivo, as reviewed in [3], and ingestion of cooked broccoli
typically provides only about one tenth the amount of SFN as that from raw broccoli hydrolyzed
by plant myrosinase during digestion [13–15]. These ﬁndings suggest that if hydrolysis to SFN by
microbiota could be enhanced, consumers might obtain greater health beneﬁts from cooked broccoli.
Although microbial glycoside hydrolase has been shown to be involved in the degradation of GSL
with the pathogenic Escherichia coli O157:H7 [16] and a soil Citrobacter spp. [17], it is not yet clear
which gut commensal microorganism(s) are responsible for GSL conversion to ITC. In addition, why
most ex vivo studies identify nitriles, rather than ITC, as the product of hydrolysis is also unknown.
Furthermore, while there have been some studies that have evaluated the impact of broccoli on the
gut microbiome [18,19], no correlation studies relating gut microbial community composition and
GRP hydrolysis have been reported. Our hypothesis is that frequent consumption of broccoli will
promote a change in the gut microbial community resulting in increased microbial SFN production,
with increased NQO1 activity in the host tissues, such as the colon and liver.
In this study, the effect of feeding broccoli and GRP on the composition of rat cecal microbiota
was analyzed using Illumina 16S rRNA sequencing. We also determined changes in GRP hydrolytic
activity ex vivo by cecal microbiota and NQO1 activity in rat colonic mucosa and liver.
2. Materials and Methods
2.1. Animals and Diets
Animal use for Project Protocol 15042 was approved on 20 March 2015 by the Illinois Institutional
Animal Care and Use Committee according to National Institutes of Health guidelines. Fischer 344
rats weighing 120–140 g, were purchased from Harlan (Colony 217, Indianapolis, IN, USA; Colony 208,
Frederick, MD, USA) and housed individually in cages with food and water ad libitum. Rats from two
colonies were used to evaluate the impact on broccoli hydrolysis of reported differences in microbial
composition among colonies [20]. Rats were acclimated to a powdered AIN93G diet (Table 1) for ﬁve
days prior to transition to experimental diets. All diets were balanced to provide similar macronutrient
content to the AIN93G diet (Table 1) according to the USDA National nutrient database [21].
Commercially available pre-cooked, frozen broccoli (cooked broccoli; CB) was freeze-dried before
incorporation into the diets. The CB was conﬁrmed free of both myrosinase activity and SFN. A raw
broccoli (RB) diet was prepared by freeze-drying commercial fresh broccoli. Glucoraphanin-free
broccoli was prepared by the addition of excess exogenous myrosinase (thioglucosidase from
Sinapis alba, Sigma-Aldrich, Carlsbad, CA, USA) to cooked broccoli, then incubating for 8 h at room
temperature to complete hydrolysis (hydrolyzed cooked broccoli; CB-H), followed by additional
freeze drying; some SFN but no GRP remained. A GRP-rich powder was prepared from broccoli
seed rafﬁnate (SFN glucosinolate broccoli rafﬁnate, CS Health, Louisville, KY, USA) as previously
described [22], and was added to the GRP diet (0.41% w/w) to achieve the same GRP concentrations as
that found in the CB diet (10% broccoli w/w). All rats were anaesthetized with ketamine/xylazine
(87 and 13 mg/mL, respectively), blood drawn, and then killed by cervical dislocation. The ceca were
ligated anteriorly and distally, surgically removed, and immediately transferred to an anaerobic
chamber to remove the microbiome for DNA isolation and for GRP hydrolysis ex vivo.
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Table 1. Diet Compositions (%) 1.
Ingredients AIN93G (CON)Diet (%)
10% Cooked Broccoli
(CB) Diet (%)
10% GRP-Free Broccoli
(CB-H) Diet (%)
GRP Diet
(%)
Casein 20.00 17.37 17.37 19.92
Cornstarch 39.75 37.56 37.56 39.58
Maltodextrin 13.20 12.30 12.30 13.14
Sucrose 10.00 9.32 9.32 9.96
Cellulose 5.00 2.57 2.57 4.98
Mineral mix 1 3.50 2.69 2.69 3.49
Vitamin mix 1.00 1.00 1.00 1.00
L-cysteine 0.30 0.30 0.30 0.30
Choline bitartrate 0.25 0.25 0.25 0.25
Soybean oil 7.00 6.66 6.66 6.97
Cooked broccoli 0 10.00 0 0
Hydrolyzed
broccoli 0 0 10.00 0
GRP-rich powder 0 0 0 10.00
Calculated GRP 2
(μmol/g diet)
0 0.26 0 0.28
Calculated SFN 2
(μmol/g diet)
0 0 0.17 0
1 The total mineral content are equal in all of the diet. 2 Standard deviation <0.01.
2.2. Experimental Design
Rats from Colonies 208 and 217 were used in Study 1 and only rats from Colony 217 were used in
Studies 2 and 3. Study 1: 18 rats from Colony 208 were acclimated to AIN93G (control; CON) diet,
randomized to six groups of three and fed the CB diet ad libitum for 0, 1, 2, 4, 7, or 14 days; the study
was then repeated with another 18 rats, but from colony 217. Study 2: To separate the effects of GRP
and non-GRP components of broccoli, 32 rats from Colony 217 were randomized into four treatment
groups (n = 8) and fed; (1) CON diet; (2) CB diet; (3) GRP diet; or (4) CB-H diet (containing no GRP),
for four days. Study 3: To examine the effects of raw broccoli feeding and of withdrawal from broccoli,
9 rats (Colony 217) were divided into three groups of three and fed; (1) CON diet; (2) RB diet for four
days; or (3) RB diet for four days then the CON diet for three days.
2.3. Cecal Microbiota Proﬁling by 16S rRNA Sequencing
Total DNA was extracted from 40 mg of cecal contents using QIAmp DNA stool Mini Kit
(Qiagen, Alameda, CA, USA) with bead-beating [23,24]. Concentration and quality of DNA was
measured using NanoDrop (Thermo Scientiﬁc, Franklin, MA, USA). The 16S rRNA sequencing was
performed by the DNA Sequencing Group at the Roy J. Carver Biotechnology Center, University of
Illinois. The V3-V5 variable regions of the 16S rDNA were ampliﬁed using primers (forward F357:
5′-CCTACGGGAGGCAGCAG-3′ and reverse R926: 5′-CCGTCAATTCMTTTRAGT-3′). The quality of
the PCR products was analyzed using an Agilent 2100 BioAnalyzer.
Paired-end reads were generated with the Illumina® MiSeq platform for each sample, at a
read length of 250 nt. The reads were demultiplexed and quality-ﬁltered using Trimmomatic [25]
(version 0.30, USADELLAB.org, Worringerweg, Aachen, Germany) with a Phred score cut-off of 33.
Data analysis was performed through the QIIME pipeline including chimera removal (version 1.9.0,
Scikit-bio™, Boulder, CO, USA). Operational taxonomical unit (OTU)-picking was performed by
searching the Greengenes 16S rRNA gene database [26]. Prior to analysis of the 16S amplicon
sequencing data, rarefaction was used to standardize the number of sequences per sample, thus
facilitating comparisons among groups. Principal Component Analysis (PCA) was performed on
all of the groups based on unweighted Unifrac tables. The x- and y- coordinate values of the data
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points were extracted by WebPlotDigitizer [27] from the PCA plots of each colony generated in R
(package FactoMineR) and were re-plotted in Microsoft Excel 2010.
2.4. Metabolism of GRP by Microbiome Ex Vivo
Cecal contents were diluted 1 to 25 with PBS and mixed 1:1 (v/v) with reinforced clostridial
medium (RCM; BD Difco™, Franklin Lakes, NJ, USA), which was found in our earlier studies to
be suitable for GRP hydrolysis ex vivo [10]. Glucoraphanin dissolved in water (ﬁnal concentration
183 μM) or PBS control were added to the bacterial slurry. The mixture was incubated anaerobically at
37 ◦C for 120 min. Each sample was centrifuged for 1 min at 4 ◦C, ﬁltered (0.22 μm), and ﬂash-frozen
in liquid nitrogen. Colon and liver tissue were also surgically removed and processed at necropsy.
The ﬁrst ﬁve centimeters of the colon were ﬂushed with cold PBS, slit open lengthwise, and scraped
rapidly using a histology slide on ice. The collected mucosal scrapings of the colon and known weights
of the liver were snap-frozen in liquid nitrogen. All samples were stored at −80 ◦C until use.
2.5. Total ITC Quantiﬁcation
Hydrolysis of GRP to ITC (SFN and erucin) by rat cecal samples was quantiﬁed using the
cyclocondensation method [28], as previously described [29]. Brieﬂy, samples were incubated with
potassium phosphate buffer (25 mM) and 1,2-benzenedithiol (10 mM) for 2 h at 65 ◦C. After cooling
to room temperature, the mixture was centrifuged at 16,000× g for 10 min. The supernatant was
analyzed by HPLC, using a C18 reverse-phase column (ODS-3, 5 μm, 250 × 4.6 mm, ES Industries
Marvel, West Berlin, NJ, USA) attached to a Waters HPLC system (Waters Corp., Milford, MA,
USA). The solvent system was operated isocratically with 80% methanol/20% water at a ﬂow rate
of 1.0 mL/min, with 10 min column washing between sample runs. The cyclocondensation product,
1,3-benzodithiole-2-thione, was detected by absorption at 365 nm. For quantiﬁcation, the peak area
of 1,3-benzodithiole-2-thione (eluting between 10 and 11 min) was integrated using Empower PRO
software (Waters Corp.) and compared to a standard developed by reacting known concentrations of
pure SFN with 1,2-benzenedithiol.
2.6. NAD(P)H: Quinone Oxidoreductase (NQO1) Activity
The NQO1 activity was measured using a spectrophotometric assay as described
previously [21,30] with slight modiﬁcations. For tissue preparation, rat colonic mucosa and liver
were homogenized in buffer (0.05 M Tris-HCl, 1.15% KCl, 1 mM EDTA, pH 7.4) before centrifugation
at 12,000× g for 20 min at 4 ◦C. Supernatants were centrifuged at 100,000× g for 1 h at 4 ◦C to
separate microsomal and cytosolic fractions. The cytosolic fractions were snap-frozen in liquid
nitrogen and stored at −80 ◦C. The cytosolic fraction was mixed (1:4 v/v) with the reaction
mixture (25 mM Tris-HCl buffer, 0.67 mg/mL BSA, 0.01% Tween-20 (v/v), 0.03 mM NADP+,
1 mM glucose-6-phosphate, 5 μM FAD, 2 unit/mL glucose-6-phosphate dehydrogenase, and
0.72 mM 3-(4,-5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 50 μM menadione
(added immediately before reaction)). The product was measured every 50 s over 5 min at 610 nm in
a μQuant plate reader (BioTek, Winooski, VT, USA). The reaction was quenched by the addition of
50 μL of 0.3 mM dicumarol in 25 mM Tris buffer (pH 7.4). The absorbance was measured continuously
for another 5 min to correct for non-NQO1 speciﬁc activity (background). The protein concentrations
were determined using the BioRad assay [31] with BSA as the standard. The enzyme speciﬁc activity
was reported as nmol MTT reduced/min/mg protein.
2.7. Statistical Analysis
The nonparametric Kruskal-Wallis test was performed to compare the effect of multiple diets
(CON, CB, GRP, CB-H) on the abundance of rat cecal microbial taxa (p < 0.05, false discovery rate < 0.1)
as previously described [32]. One-tail Student’s t-tests were performed to compare the difference
between short-term (<4 days) and long-term (>4 days) cooked broccoli feeding on rat cecal microbial
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communities, and to compare both the GRP hydrolysis ex vivo and the NQO1 activities between the
treated and control groups.
3. Results
3.1. Alteration in the Cecal Microbiota Community and GRP Hydrolysis Following 1–14 Days of A Cooked
Broccoli Diet; Study 1
The cecal microbiota was proﬁled to determine changes in bacterial taxa following consumption
of CB or CON diets. Illumina® MiSeq resulted in an average of 64,678 paired-end high-quality reads
per sample. Initial PCA analysis revealed a signiﬁcant shift in the cecal microbiota between two and
four days on diet (Figure 1). Therefore, the cecal microbiota was reanalyzed separately for short-term
(0–2 days) and long-term (4–14 days) broccoli feeding.
Figure 1. PCA-individual factor map describing the rat cecal microbial communities following 10%
cooked broccoli feeding (0–14 days) from two different rat colonies. PCA analysis was performed on
each colony independently and plotted on the same graph. Dim 1 = 14.47%, Dim 2 = 7.66% for rats
from Colony 217 (“1”, Indianapolis IN, closed symbols) and Dim 1 = 16.48%, Dim 2 = 8.26% for rats
from Colony 208 (“2”, Fredrick MD, open symbols).
Metrics of alpha diversity revealed a signiﬁcant increase in the number of OTUs, Chao1, Shannon,
and Simpson indices in rats fed cooked broccoli for ≥4 days (Table 2).
Table 2. Analysis of rat cecal microbiota following 0–14 days of cooked broccoli diet, study 1.
Treatment 1 OTUs 2 Chao1 Shannon Simpson
<4 days 1393.4 a ± 84.7 3582.6 a ± 337.4 8.58 a ± 0.31 0.988 a ± 0.005
≥4 days 1481.3 b ± 105.0 3803.4 b ± 416.9 8.87 b ± 0.23 0.992 b ± 0.003
p-value 0.005 0.045 0.002 0.016
1 Microbiota from rats (n = 36, see Figure 1) fed cooked broccoli for fewer than four days or four days and more.
2 Microbial analysis by Illumina® 16S rRNA sequencing (V3–V5 hypervariable region). Values within columns
with the same letter are not different (p < 0.05). p-values are reported as one-tailed Student’s t-test. Rarefaction was
calculated based on 4900 seqs per sample when the maximum number of OTUs were observed in all groups.
Additional beta diversity analysis revealed six genera, mostly from the order Clostridiales
(Blautia, Clostridium, Dorea, Ruminococcaceae (family, genus not assigned) and Oscillospira) signiﬁcantly
changed in abundance after CB feeding for four days or longer (Table 3).
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Table 3. Changes in the abundance of bacterial genera in cecal microbiome of rats (n = 6) fed up to
14 days of cooked broccoli diet; Study 1.
Genus
Abundance 1 (% Total Genera)
p-Value<4 Days ≥4 Days
Mean SEM Mean SEM
Akkermansia 0.001 0.001 0.008 0.003 0.007
Blautia 0.429 0.078 0.123 0.024 0.000
Clostridium 0.388 0.065 0.127 0.017 0.000
Dorea 1.073 0.150 0.482 0.050 0.003
f__Ruminococcaceae; Other 0.287 0.036 0.497 0.040 0.000
Oscillospira 9.576 0.709 14.296 1.171 0.003
1 False discovery rate < 0.1. Student t-test showing genera increased (bolded) and decreased (underlined) in
abundance of bacterial genera from rats fed cooked broccoli for four days or more, compared to bacteria from rats
fed for fewer than four days of cooked broccoli diet (p < 0.05). p-values are reported as the one-tailed Student’s t-test.
In addition to the change in the microbiome, we also evaluated the myrosinase-like activity
ex vivo of the cecal microbiota. Cecal samples were incubated anaerobically with excess GRP. The GRP
hydrolyzing activity of the cecal microbiota increased as rats fed for longer periods, up to four days
(Figure 2).
Figure 2. Rats (n = 6) were fed 10% cooked broccoli diet for 0–14 days. Concentrations of total
isothiocyanate (ITC) in rat cecal supernatant after incubating ex vivo with GRP for 120 min. Values
with similar letters are not different (p < 0.05).
Feeding rats the broccoli diet for 4 days increased ex vivo GRP hydrolysis activity by 25-fold over
that from rats fed no broccoli (CON diet) (p < 0.001). The enhanced GRP hydrolysis remained high
throughout the feeding study (7 and 14 days). In animals receiving only the control diet, neither the
microbiome community nor the GRP hydrolysis activity changed, regardless of days on the diet [33].
3.2. Increased NQO1 Activity in Rat Colonic Mucosa Following 1–14 Days of Cooked Broccoli Diet
To assess the chemopreventive effects of CB on the host, the NQO1 activity in rat colon mucosa
and liver was measured. As the rats were fed for longer periods, the colonic NQO1 activity increased
gradually over 7 and 14 days (Figure 3).
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Figure 3. Activity of NQO1 in rat colonic mucosal tissue following cooked broccoli feeding (0–14 days;
n = 6). Results are nmol MTT/min/mg protein. Data are mean ± SE. ** indicates signiﬁcantly different
from control (Day 0) (p < 0.01).
The colonic NQO1 activity increased more than two-fold compared to day 0 (control diet) by
day 7 (p = 0.004) and 3.3-fold by day 14 (p = 0.002). There was no increase in hepatic NQO1 activity
compared to the activity in liver from rats fed the CON diet, even by 14 days of CB feeding [33].
3.3. Effects of GRP on Both Cecal Microbiota Composition and GRP Hydrolysis; Study 2
Study 2 was designed to investigate whether the increased cecal microbial hydrolysis of GRP seen
in Study 1 was due to the daily presence of GRP and/or non-GRP component(s) of broccoli. To this
end, the composition of cecal microbiota was compared across rats fed for four days either CON, CB,
GRP, or CB-H diets. On average, over 15,000 high-quality paired-end sequences per sample were
obtained from Illumina® MiSeq. The total numbers of OTUs and Chao1 index were greater in the
CB-H group than in any other groups (p < 0.05; Table 4).
Table 4. Analysis of rat cecal microbiota following four days of treatment diets; Study 2 1.
Diet
Reads
Obtained from
MiSeq
(Min~Max)
Median Seqs per
Sample after
Quality Filtering
(Min~Max)
% OTUs
Assigned Chao1 Observed OTUs
CON 13,242~45,673 10,917~37,747 99.88 ± 0.07 3627.1 a ± 366.6 1573.0 a ± 77.9
CB 11,516~29,303 9,447~24,029 99.89 ± 0.07 3847.5 a ± 208.8 1576.1 a ± 23.1
GRP 14,829~29,988 11,900~24,483 99.91 ± 0.05 3783.7 a ± 442.5 1557.4 a ± 122.1
CB-H 12,761~116,686 10,441~96,729 99.92 ± 0.04 3968.5 b ± 172.1 1663.6 b ± 57.4
1 Microbial analysis by Illumina® 16S rRNA sequencing (V3–V5 hypervariable region). Rats (n = 32) fed four days
of control (CON), cooked broccoli (CB), GRP, or GRP-free (CB-H) diet. Values within columns with the same letter
are not different (p < 0.05). Rarefaction was performed based on 7410 sequences per sample when the maximum
number of OTUs were observed in all groups.
We performed phylogenetic beta diversity calculations to examine the dissimilarity between
microbiome communities. The differences in the abundance of genera are shown as relative proportions
(Table 5). Although the Shannon and Simpson indices were not different between any treatments
(Table 4), phylogenetic beta diversity calculations showed that the abundance of several cecal bacterial
taxa were impacted by the treatments (Table 5).
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Table 5. Abundance of bacterial genera (>0.1% total) of cecal contents of rats, study 2 1.
Genus
Abundance 2 (% Total Genera)
p-ValueCON CB GRP CB-H
Mean SEM Mean SEM Mean SEM Mean SEM
Clostridium 0.148 0.012 0.324 0.055 0.185 0.027 0.109 0.017 0.007
Coprococcus 1.840 0.517 1.392 0.407 0.623 0.105 0.674 0.092 0.005
Dorea 1.229 0.150 0.357 0.046 0.772 0.095 0.598 0.117 0.000
f__Lachnospiraceae; Other 1.680 0.143 1.574 0.121 1.056 0.157 0.875 0.073 0.001
f__Ruminococcaceae; Other 1.272 0.200 1.693 0.156 0.611 0.093 1.130 0.130 0.001
f__S24-7; g__ 15.477 1.346 13.612 1.133 15.759 1.203 19.665 0.706 0.007
Prevotella 0.119 0.049 0.163 0.083 0.420 0.077 0.737 0.285 0.003
rc4-4 0.965 0.165 0.214 0.035 1.063 0.159 0.592 0.081 0.000
1 Rat were fed four days of control (CON), cooked broccoli (CB), GRP, or GRP-removed (CB-H) diet. 2 False
discovery rate <0.1, Student t-test showing genera increased (bolded) and decreased (underlined) in abundance
compared to the control group (p < 0.05). p-values are reported as the Kruskal-wallis test.
An understudied genus from the S24-7 family was found to be in greatest abundance (>15% total
genera) in all groups, including from control-fed rats. The composition of the cecal microbiota from rats
receiving the CB diet was quite distinct from the other groups, as observed by phylogenetic clustering
(Figure 4a) and PCA analysis (Figure 4b). Conversely, in the same analysis the cecal microbiota of the
CON and GRP groups were indistinguishable. Unlike those from other dietary groups, the microbiome
from the CB-H group formed two unique clusters by both distance metrics. The ITC production ex
vivo was similar in the CON and CB-H groups. However, production in the CB and GRP groups was
greater than in either the CON or CB-H groups (Figure 5; p < 0.05).
Figure 4. Impact of GRP and other broccoli components on rat cecal microbial communities. Rats
were fed with a 10% cooked broccoli (CB), GRP-rich powder (GRP), broccoli pre-hydrolyzed using
myrosinase (CB-H) or the control diet (CON) for four days (n = 8). (a) Phylogenic tree describing the
clustering of cecal microbial communities; and (b) PCA-individual factor map describing the cecal
microbial communities.
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Figure 5. Rats were fed a 10% cooked broccoli (CB), GRP-rich powder (GRP), broccoli pre-hydrolyzed
using myrosinase (CB-H) or the control diet (CON) for four days (n = 8). Concentrations of total
isothiocyanate (ITC) were measured in rat cecal supernatant after incubation ex vivo with GRP (183 μM)
for 120 min. Data are mean ± SE. Values with similar letters are not different (p < 0.05).
3.4. Effect of A Raw Broccoli Diet and Its Withdrawal on GRP Hydrolytic Potential; Study 3
To determine the impact of a raw broccoli diet and its removal, we fed rats either CON diet for
four days, RB diet for four days, or the RB diet for four days, followed by three days of the control diet
(RB/CON). As with the cooked broccoli diet, the total ITCs produced ex vivo from cecal microbiota
of rats fed raw broccoli for four days increased (p < 0.05) compared to ITC production by microbiota
from rats on the control diet (Figure 6). However, when raw broccoli was withdrawn from the diet for
three days and replaced with CON, the total ITCs production decreased, but remained greater than
the CON group (p < 0.05).
Figure 6. Reversibility of the impact of dietary broccoli on microbial GRP hydrolysis. Rats were fed
with the control diet (CON), a 10% raw broccoli (RB) diet, or a 10% RB diet for four days, then the
control diet four three days (RB/CON) (n = 3). Concentrations of total isothiocyanate (ITC) in rat cecal
microbiota after incubation ex vivo with GRP for 120 min. Results are mean ± SE. Values with similar
letters are not different (p < 0.05).
4. Discussion
4.1. Impact of Different Diets on The Cecal Microbiota Communities
In this study, the cecal microbial communities from rats fed CB and CB-H diets were similar, yet
different, from the CON-fed group (Figure 4b). Since CB contained GRP and CB-H did not, although
both had a broccoli base, this indicates that non-GRP component(s) of broccoli are responsible for
the new cecal microbial community structure. Further supporting the concept that GRP was not
responsible for the changes seen in community structure, the cecal microbial communities from rats fed
CON and GRP were similar. However, given the technical limitations of 16S rRNA sequencing, such
as the short read length, the identiﬁcation of bacterial changes at the species- and strain-level were not
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determined. Future research employing the examination of microorganisms at the species and strain
level may provide further insights into the changes in the microbiome related to GRP hydrolysis.
In addition to GRP, broccoli contains several other components that may impact the
microbiome [34,35]. For example, broccoli is a rich source of ﬁber, which can modulate the gut
microbial community and improve health [36]. In the present study, ﬁber as a percent of the diet
was maintained across all diets, although the type of ﬁber varied (Table 1). The ﬂavonoids quercetin
and kaempferol are also present in broccoli. These were not balanced across diets and could impact
the microbiome. For example, in a study where rats were fed a high-fat high-sucrose diet, oral
administration of quercetin decreased the abundance of Erysipelotrichaceae and Bacillus bacteria in the
Firmicutes phylum [37].
4.2. GRP Hydrolysis
Early pharmacokinetic studies [13,38] reported that glucosinolate hydrolysis can occur during
digestion, in the absence of myrosinase, but at a fraction of the rate of that in the presence of myrosinase.
Here we show that daily broccoli feeding to rats greatly enhanced this hydrolytic rate, causing as
much as a 25-fold increase in the capacity of the gut microbiota to hydrolyze GRP to bioactive SFN
(Figure 2). A key ﬁnding is that it is speciﬁcally the presence of GRP in the diet that enhances microbial
hydrolysis rates, since when GRP was fully hydrolyzed to SFN prior to feeding, the broccoli had
no impact on rates of exogenous GRP hydrolysis (Figure 5). However at this time, we are not able
to determine which bacteria perform the hydrolysis or even whether the increased rate is due to an
increased number of active bacteria or to upregulation of a bacterial hydrolyzing enzyme. In a recent
study [39], two bacteria isolated from human feces, Escherichia coli VL8 and Enterococcus casseliﬂavus
CP1, were evaluated for glucosinolate metabolism. Less than 10% of the metabolized glucosinolate
could be detected as ITC (6% as erucin produced, with 65% GRP loss in 8 h incubation with Escherichia
coli VL8 and less that 1% of the starting GRP level as SFN produced vs. 53% of GRP degraded after 8 h
incubation with Enterococcus casseliﬂavus CP1). It would be interesting to determine if feeding broccoli
or other brassica increases the presence of these microbes or the possible reductase these authors
identiﬁed. In our study, a three-day withdrawal from the broccoli diet decreased GRP hydrolysis ex
vivo, suggesting that frequent broccoli ingestion may be essential for this improved microbial GRP
hydrolysis. Recent studies have shown that desulfoglucosinolates can be substrates for beta hydrolase,
resulting in formation of nitriles [40]. It will be interesting to see if there are bacterial N-sulfatase
enzymes that are able to generate desulfoglucosinolates and whether these, by forming inactive nitriles
and not reactive isothiocyanates, can protect the bacterium from glucosinolate toxicity.
In the present study, we used the cyclocondensation reaction to estimate total ITC, rather than GC
or LC-MS methods that measure individual compounds, which can be summed to determine the total
product formed. The cyclocondensation method is both accurate and rapid, when total metabolites are
of interest, but does not provide identiﬁcation of speciﬁc ITC forms. The cyclocondensantion reaction
relies on the thiol compound benzene dithiol to bind to ITC and ITC metabolites. Since ITC is highly
reactive, we previously proposed that ITC products of microbial hydrolysis might be bound to protein
cysteines and possibly unavailable for estimation by GC or LC-MS. Using excess GSH, we were able
to pull out and identify SFN and its reduced congener erucin, not seen when we performed LC-MS
directly [41]. Many studies [7,10,42,43] evaluating glucosinolate metabolism by microbiota ex vivo
have identiﬁed disappearance of glucosinolate substrate and/or appearance of nitriles. Since nitriles
are not electrophilic, and thus not bound to protein sulfhydryls, it is possible that this is why nitriles are
available for direct measurement in many studies where ITCs, such as sulforaphane, were not detected.
4.3. Bioactivity
Increased colonic mucosal NQO1 activity was observed after 7 and 14 days of cooked broccoli
feeding. Our data clearly suggest that by frequent feeding of cooked broccoli to rats, not only the
capacity of the microbiota for GRP hydrolysis was improved, but also that the ultimate NQO1 activity
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in rat colon was increased (Figure 3), indicating the improved potential for cancer chemopreventative
activity of the host. However, no signiﬁcant differences were observed in hepatic NQO1 activity [33].
In our previous study [22], we gavaged rats with different doses of GRP (30, 60, and 120 mg/kg) for
four days, and observed a signiﬁcant dose-dependent increase in NQO1 activity in the colon, whereas
there was only a slight increase in hepatic NQO1 activity with the highest dose of GRP. The present
results are consistent with our previous ﬁnding that colonic mucosa had a NQO1 response at lower
doses than liver, suggesting that the dose here was sufﬁcient to provide a local or topical effect on the
gut wall, but not large enough to impact the liver.
The stimulation of colonic NQO1 activity by CB was delayed compared to the increase in GRP
hydrolysis (Figures 2 and 3). It would be interesting to know whether microbial hydrolysis or mucosal
wall upregulation of NQO1 is the limiting step. Since GRP was essential for increased microbial
hydrolysis, and because hydrolysis was increased in the microbiome from rats fed raw broccoli, this
shows for the ﬁrst time that some of the GRP in raw broccoli travelled to the cecum for bacterial
hydrolysis rather than being completely hydrolyzed by broccoli myrosinase in the upper gut.
5. Conclusions
Broccoli feeding changed the composition of the rat cecal microbiota, increased glucoraphanin
hydrolysis to ITC ex vivo, and increased host colonic NQO1 activity. Glucoraphanin from broccoli was
responsible for the increase in the hydrolysis to ITC, whereas broccoli component(s), other than GRP,
altered the cecal microbiome composition. Furthermore, withdrawal from the broccoli diet caused loss
of the broccoli-enhanced GRP hydrolysis, suggesting that frequent broccoli ingestion is required to
ensure optimal microbial glucosinolate hydrolysis.
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Abstract: Dietary broccoli is anti-inflammatory. Past studies have typically investigated raw broccoli,
even though most consumers prefer cooked broccoli, where the plant myrosinase is inactivated
by heat, resulting in failure of formation of the anti-inﬂammatory bioactive compound
sulforaphane (SF). This study compareed efﬁcacy of lightly cooked broccoli (CB) containing greatly
diminished myrosinase activity, with raw broccoli (RB), in mitigating colitis in dextran sulfate
sodium (DSS)-treated mice. Male C57BL/6 mice were fed for two weeks on a 10% RB, 10% CB or
control diet, all based on the AIN-93M diet. Half (n = 9) of each group received drinking water,
half received 2.5% DSS in water for one week, starting from Day 7 of the diet. Even with far
less plant myrosinase activity, CB was essentially as effective as RB in lessening damage by DSS,
evidenced by decreased disease activity index, attenuated colon length shrinkage, less endotoxin
(lipopolysaccharide) leakage into blood, and less severe colon lesions as assessed by histopathology.
mRNA expression of pro-inﬂammatory cytokines indicated that broccoli anti-inﬂammatory action
may be through inhibition of the IL-6 trans-signaling pathway, as evidenced by reversal of the
DSS-increased expression of IL-6, CCR2 and vascular cell adhesion molecule 1 (VCAM-1).
Keywords: lightly cooked broccoli; dextran sulfate sodium; gut barrier; IL-6 trans-signaling pathway
1. Introduction
Accumulating research frequently suggests a role for chronic inﬂammation as a key mechanism
within a myriad of life-threatening diseases, including cardiovascular disease (CVD), cancer, diabetes,
and obesity. Among these is inﬂammatory bowel disease (IBD), which is associated with severe chronic
inﬂammation in the gut. This is a common disease, affecting over 1% of US adults (~3 million in
2015) [1]. Not only is the incidence of IBD increasing [1], but untreated IBD can progress to colon cancer.
Many research articles suggest that sulforaphane (SF) from broccoli, one of the most studied
phytochemicals, is among several key anti-inﬂammatory dietary components that may beneﬁt those
suffering from such diseases [2–5]. In the dextran sulfate sodium (DSS) mouse model, which is
a commonly used animal model for IBD, SF has been found to attenuate DSS-induced colitis, evidenced
by a decreased disease activity index (DAI), minimized weight loss, reduced loss of colon length,
and less monocyte inﬁltration [2]. Moreover, a molecular level investigation conﬁrmed that expression
of the pro-inﬂammatory cytokine IL-6 was decreased by SF in DSS-treated mice, and that the expression
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of several Nrf2 target genes was increased. This suggests that the anti-inﬂammatory bioactivity of
SF might be mediated through the Nrf2 pathway [2]. In recent years, not only SF, but also whole
broccoli has shown promising anti-inﬂammatory activity. Using the mdr1a-/-IBD mouse model, a diet
containing 10% fresh broccoli was shown to alter the gut microbiota and attenuate colitis, evidenced
by an increase in the colon crypt length and in the number of goblet cells present in the colonic
epithelium [6]. In contrast, in an AOM/DSS model, a glucosinolate-enriched fresh broccoli diet
was reported to induce Nrf2 target genes effectively while failing to protect the host from colitis or
carcinogenesis [7].
In these studies, however, only fresh broccoli or SF was investigated. It has been widely
acknowledged that the cooking conditions for broccoli greatly impact its efﬁcacy. The hydrolysis from
glucoraphanin (GRP), the parent compound of SF, is mediated by a heat-sensitive enzyme in broccoli,
myrosinase (EC 3.2.1.147). In fully cooked broccoli, the myrosinase is likely to be inactivated by heat,
resulting in failure to produce bioactive SF. Researchers have shown that the gut microbiome is also
capable of hydrolyzing glucoraphanin (GRP) within dietary broccoli to release bioactive SF, although
the yield is quite low [8]. Compared to fully cooked broccoli, the study of lightly cooked broccoli
has become appealing to many researchers [9,10] as it provides the taste/ﬂavor that consumers ﬁnd
more acceptable than raw broccoli, while still retaining some myrosinase activity. In the present study,
we compared the efﬁcacy of raw broccoli and lightly cooked broccoli in terms of protecting mice from
DSS-induced colitis, as a model of IBD.
Although the etiology of IBD is unknown, it has been proposed that it is related to a “leaky gut”:
increased gut permeability to luminal pathogens and their by-products, including endotoxin [11,12].
One common method to determine gut barrier permeability is to assess plasma lipopolysaccharide
(LPS) concentration; LPS is a large molecule in the outer membrane of gram-negative bacteria, not able
to pass across the intact gut barrier [13]. Another way is to determine the urinary excretion of orally
ingested sucralose [13], a non-digestible sweetener that similarly cannot penetrate the intact gut barrier.
However, if the integrity of the gut barrier is compromised and gut leakage occurs, LPS and sucralose
enter the circulatory system. Therefore, in the present study, plasma LPS and urinary sucralose were
used as indicators of gut barrier function. In addition, it is reported that the breach of the gut barrier,
through destruction of colonocyte tight junction proteins, might be one of the mechanisms of IBD.
Therefore, both mRNA expression of selected tight junction proteins and protein expression of two
barrier proteins, ZO-1 and Claudin-1, were also assessed. Moreover, mRNA expression of selected
pro-inﬂammatory cytokines was investigated to identify any inﬂammatory role within the molecular
mechanism of broccoli protection of the host from DSS induced colitis.
In this study, our results clearly show that even with far less myrosinase activity, lightly cooked
broccoli is essentially as effective as raw broccoli in suppressing damage by DSS, for most of the
endpoints. In addition, we propose here that broccoli protection against DSS-induced colitis may be
through halting the transition from acute to chronic inﬂammation through SF-Nrf2 inhibition of the
IL-6 trans-signaling pathway.
2. Materials and Methods
2.1. Diet Preparation
AIN-93M diet ingredients were purchased from Harlan-Teklad Laboratories (Madison, WI, USA).
Fresh broccoli was purchased from a local grocery market. Broccoli heads were cut less than 2 inches
from the crown and divided into ﬂorets of ~2-inch pieces. Half of the broccoli was lightly cooked
by microwave for 3 min and cooled on ice, as described in our previous study [10]. Both broccoli
preparations were then freeze dried and ground into powder, using a coffee grinder. Raw or lightly
cooked broccoli powder (10% by weight) was incorporated into the raw broccoli diet (RB) or lightly
cooked broccoli diet (CB), respectively. RB and CB were balanced to the AIN93M diet (CON) for
micro- and macro-nutrients, including ﬁber (Table 1). Based on USDA nutrient database, there is
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approximately 2.3 g ﬁber/100 g fresh broccoli; therefore, we added 2.6 g cellulose to each broccoli diet
to balance the 5 g cellulose in the control diets.
Table 1. Diet composition.
Ingredients (g/100 g Diet) AIN-93M(CON)
10% Raw
Broccoli (RB)
10% Lightly Cooked
Broccoli (CB)
Freeze-dried raw broccoli powder 0 10.0 0
Freeze-dried lightly cooked broccoli powder 0.0 0 10.0
Casein 14.0 11.4 11.4
Cornstarch 46.6 44.4 44.4
Maltodextrin 15.5 14.6 14.6
Sucrose 10.0 9.3 9.3
Cellulose 5.0 2.6 2.6
Mineral mix 3.5 2.7 2.7
Vitamin mix 1.0 1.0 1.0
L-cysteine 0.2 0.2 0.2
Choline bitartrate 0.3 0.3 0.3
Soybean oil 4.0 4.0 4.0
2.2. Animal Use and Experimental Design
Eight- to ten-week-old male C57BL/6 mice (n = 54, BW 20–25 g) were maintained under a 12-h
light/dark cycle at 22 ◦C and 60% humidity. All animal care followed the protocol approved by
the Institutional Animal Care and Use Committee at the University of Illinois, Urbana-Champaign.
After four days of acclimation to the AIN-93M diet, mice were divided into three groups and provided
with AIN-93M diet (CON), RB or CB for 14 days, until the end of the study. Diet was provided ad
libitum and replaced fresh daily. On the seventh day of diet treatment, mice from each diet treatment
group were divided randomly into two halves (n = 9). One half of the mice from each group received
normal tap water (Water) and the other half received 2.5% DSS (40–50 kDa, Affymetrix, Santa Clara,
CA, USA) dissolved in tap water from Day 7 to Day 14, the completion of the study. The six treatment
groups are abbreviated as Water/CON, Water/RB, Water/CB, DSS/CON, DSS/RB, and DSS/CB.
2.3. Diet Analysis
Myrosinase activity in the broccoli diets was measured as SF formation in vitro, based on our
previously published protocol [14]. Brieﬂy, 400 mg freeze-dried RB or CB diet was incubated in
1.5 mL of water for different time periods (up to 8 h) with thorough vortexing in the middle of the
incubation period. Samples were then centrifuge at 4 ◦C for 3 min. After centrifugation, an aliquot of
supernatant (0.5 mL) was spiked with an internal standard of benzyl isothiocyanate, then immediately
extracted into dichloromethane (DCM, 0.5 mL), centrifuged for 3 min at 16,000× g and analyzed for
SF formation, by GC-FID. The GC program was as follows: brieﬂy, 1 μL of DCM extract was injected,
using an Agilent model 7683B series autosampler, onto an Agilent 6890N gas chromatography system
equipped with a single ﬂame ionization detector (Agilent Technologies, Santa Clara, CA, USA).
Samples were separated using a 30 m × 0.32 mm J&W HP-5 capillary column (Agilent Technologies).
After an initial hold at 40 ◦C for 2 min, the oven temperature was increased by 10 ◦C/min to 260 ◦C
and held for 10 min. Injector temperature was 200 ◦C; detector temperature was 280 ◦C. Helium carrier
gas ﬂow rate was 25 mL/min. Data were quantiﬁed against a standard curve of SF (LKT Laboratories,
St. Paul, MN, USA).
2.4. Tissue Collection
Mice were anesthetized using ketamine/xylazine (87 mg/mL and 13 mg/mL, respectively,
at 0.1 mL/100 g BW). After blood was taken by cardiac puncture into EDTA-coated vessels, mice were
killed by cervical dislocation. The colon, from immediately distal to the cecum to the anus (including
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the rectum; ~3–6 cm) was removed and immediately ﬂushed with ice-cold PBS. After the length was
measured, 16% of the length immediately distal to the midpoint was removed and ﬁxed in 10% neutral
buffered formalin. After ~24 h, sections were transferred into 80% ethanol for slide preparation by
the Veterinary Diagnostic Laboratory (University of Illinois, Urbana, IL, USA). The remaining colon
was scraped to collect mucosa for Western blot (stored at −80 ◦C) and qPCR analysis (placed into
RNALater and frozen).
2.5. Disease Activity Index
Mice were monitored each day for observable changes in colitis symptoms. The disease activity
index (DAI) was calculated by daily summing the colitis clinical scores, including percent weight loss,
stool formation and presence of stool blood; scoring was adapted from reported protocol [15] as
follows: (i) body weight loss: 0, none; 1, 1–5%; 2, 5–10%; 3, >10%; (ii) stool formation: 0, normal pellet;
1, loose stool (mild); 2, loose stool (moderate); 3, watery diarrhea; and (iii) fecal bleeding: 0, negative;
1, blood in stool (mild); 2, blood in stool (moderate); 3, gross bleeding. Mice were given a score of
0–3 for each of the three categories and the sum of scores was used as a measure of the degree of colitis
as follows: 1–4: Mild colitis, 5–7: Moderate colitis, 8–9: Severe colitis.
2.6. Plasma LPS Determination
Fresh, EDTA-treated blood was centrifuged at 500× g at 4 ◦C for 15 min, to yield plasma.
The plasma LPS concentration was assayed using QCL-1000™ Limulus Amebocyte Lysate
(LAL, Walkersville, MD, USA) according to the manufacturer’s instructions, where plasma samples
were diluted 10-fold and heated for 10 min at 70 ◦C. The results were quantiﬁed at 405 nm using
a μQuant microplate reader (Bio-Tek Instruments, Winooski, VT, USA). LPS concentrations are
expressed as EU/mL.
2.7. Urinary Sucralose Determination
Three mice from each group received 30 mg/mL sucralose by gavage 24 h prior to euthanasia
(0.2 mL/25 g BW). Mice were provided food and water ad libitum for the next 6 h, and then
placed individually into stainless steel metabolic cages for urine collection, uncontaminated by feces.
A sample jar was placed under each cage to collect urine from 6 to 24 h which was then freeze
dried and reconstituted in 0.8 mL distilled water for sucralose analysis after conversion of sucralose
to its alditol acetate derivatives according to Shaikh and colleagues [16] with minor modiﬁcations.
Brieﬂy, myo-inositol (9 μL of 10 mg/mL) was added to 100 μL urine sample as internal standard,
then 500 μL 20 mg sodium borodeuteride /mL DMSO was added slowly while mixing and heated to
40 ◦C for 90 min. After cooling, 0.2 mL glacial acetic acid was added slowly while mixing, then 100 μL
1-methylimidazole and 1 mL acetic anhydride were added and the sample stored for 10 min at room
temperature, before 4 mL water and 1 mL methylene chloride were added to the mixture and vortexed.
The bottom layer was transferred to a new tube. The extraction was repeated three times, and the
combined methylene chloride layers washed with 4 mL of water, removed into a fresh tube and dried
under a stream of nitrogen. Finally, 0.5 mL acetone was added to the dried residue, vortexed, and the
resulting solution analyzed by GC.
Gas chromatography was performed using a 6890N (Agilent Technologies) equipped with
a N10149 autosampler and a ﬂame ionization detector. The column used was a 30 m HP-5 capillary
column (0.32 mm id, 0.25 μm), with helium as the carrier gas. The analytical program was according to
Shaikh and colleagues [16] with some modiﬁcations. Brieﬂy, the temperatures of the detector and the
injector were 280 ◦C and 250 ◦C, respectively; the initial column temperature was 100 ◦C. After holding
for 2 min, the temperature was raised to 180 ◦C at a rate of 10 ◦C/min, held for 2 min, then raised to
a ﬁnal temperature of 240 ◦C at a rate of 4 ◦C/min, and held for 15 min. The injection volume was 1 μL.
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2.8. mRNA Expression of Tight Junction Proteins and Pro-Inﬂammatory Cytokines
Colonic RNA was extracted using an E.Z.N.A.® Total RNA Kit II (Omega Bio-Tek, Norcross,
GA, USA) according to the manufacturer’s instructions. Extracted RNA was further puriﬁed by
Lithium chloride and sodium acetate to remove any remaining DSS, which was reported to interfere
with PCR ampliﬁcation efﬁciency [17]. RNA was then quantiﬁed using a NanoDrop spectrophotometer
and converted to cDNA using a High-Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Grand Island, NY, USA). Primers for the genes (Table 2) were designed using the online Primer3-BLAST
system from NCBI, and were tested for ampliﬁcation efﬁciency and speciﬁcity with the use of
the SYBR Green PCR Master Mix (Applied Biosystems) and an ABI 7900HT Fast Real-Time PCR
System (Applied Biosystems) according to the manufacturer’s instructions. All cDNA samples and
pairs of primers were submitted to the Roy J. Carver Biotechnology Center (University of Illinois,
Urbana, IL, USA) for gene expression proﬁling using a Fluidigm Dynamic Array and Biomarker HD
high-throughput ampliﬁcation system (Fluidigm, South San Francisco, CA, USA) following 12 cycles
of pre-ampliﬁcation. The copy number for each gene was calculated using standard curves and
normalized to the housekeeping gene Hprt1 for each sample.
Table 2. Primer list.
Gene NCBI ReferenceSequence Forward Primer Reverse Primer
Tight Junction
CLDN1 NM_016674.4 TGTGGATGGCTGTCATTGGGG ATTCATACCTGGCATTGATGGGGG
CLDN2 NM_016675.4 ACGGCTCCGTTTTCTAGATGCC CGTTTGGCTGCTGCTCTTGC
CLDN3 NM_009902.4 AGCCCTCATCGTGGTGTCCA GGCCGTCTCGTCTTGTACGC
CLDN4 NM_009903.2 GAGCCGTGTTCATCGTGGCA CCCAGCCGACGTAAAGCGAG
CLDN5 NM_013805.4 GTGCGTGGTGCAGAGTACCG GAGCGCCGGTCAAGGTAACA
CLDN8 NM_018778.3 ATGCACGGGGGACGATGAGA TGAGCACAACCAAGCCGGTG
OCLN NM_008756.2 ACGGTCCTCCTGGCTCAGTT GATAAGCGAACCTTGGCGGC
TJP1 NM_001163574.1 TGTTTATGCGGACGGTGGCG TCCATTGCTGTGCTCTTAGCGG
Inﬂammation
CCL2 NM_011333.3 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT
CCR2 NM_009915.2 ATAAAGGAGCCATACCTGTAAATGC CATGTGGTGAATCCAATGCCCT
IL1B NM_008361.4 TGCCACCTTTTGACAGTGATGAGA TGTTGATGTGCTGCTGCGAGA
IL6 NM_031168.2 TAGTCCTTCCTACCCCAATTTCC TTGGTCCTTAGCCACTCCTTC
TLR2 NM_011905.3 AGGAGGTGCGGACTGTTTCCT ATTTGACGCTTTGTCTGAGGTTTCG
TLR4 NM_021297.3 TCCCTGCATAGAGGTAGTTCCTA TTCAAGGGGTTGAAGCTCAGA
TNF NM_001278601.1 TCGGTCCCCAAAGGGATGAGA GGTGGTTTGTGAGTGTGAGGGT
VCAM1 NM_011693.3 ACGTGGACATCTACTCTTTCCCCA CTTGACCGTGACCGGCTTCC
NFKB1 NM_008689.2 CTGCCATGTCTGCTGCTGCT CGTGGGCATCACCCTCCAGA
Housekeeping
HPRT NM_013556.2 TCCCAGCGTCGTGATTAGCG TCGAGCAAGTCTTTCAGTCCTGT
2.9. Protein Expression of Tight Junctions
The colonic mucosal scrapings were homogenized with 0.2 mL RIPA lysis buffer (0.15 M NaCl,
5 mM EDTA, 10 mM Tris-HCl (pH 7.4), 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate,
5 mM DTT) with Protease Inhibitor Cocktail (ROCHE, Indianapolis, IN, USA) to prevent protein
degradation. Protein concentration was measured using a Bio-Rad protein assay kit (Bio-Rad
Laboratories, Indianapolis, IN, USA). Mucosal samples were separated by SDS-PAGE (Bio-Rad)
and transferred to a nitrocellulose membrane (GE Health Care, Marlborough, MA, USA) at 60 V for
60 min (for Claudin-1) or 15 V overnight at 4 ◦C (for ZO-1, which is a larger molecule). After blocking
in 5% nonfat dried milk, membranes were incubated with afﬁnity puriﬁed rabbit anti-mouse ZO-1
(Invitrogen, Grand Island, NY, USA, 225 kDa, 1:500) or mouse anti-mouse Claudin-1(Life Science,
Grand Island, NY, USA, 22 kDa, 1:2500) overnight at 4 ◦C. After washing with TBST, membranes
were incubated with either anti-rabbit secondary antibody (KPL, Milford, MD, USA, 1:5000) or
anti-mouse secondary antibody (Santa Cruz, TX, USA, 1:4000), at room temperature for 1 h. Enhanced
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chemiluminescence of the immunocomplex was evaluated using a detection kit (GE Health Care).
Chemiluminescence was visualized using ImageQuant LAS 4000 and IQTL software (GE Health Care).
The image was quantiﬁed using Quantity One software (Bio-Rad). Band intensities of ZO-1 and
Claudin-1 were normalized by the intensity of Ponceau Red staining, used as a loading control [18,19],
as the DSS was reported to alter the colonic expression of most commonly used loading control proteins
including β-actin and GAPDH in DSS-induced mice [20].
2.10. Histology
The formalin-ﬁxed specimens of the middle one-third of the colon from each mouse were
trimmed for longitudinal sectioning, with the mucosal surfaces placed face down in the cassette
to give full-length proﬁles of the colonic wall. Following routine processing through graded
alcohols, the tissues were embedded in parafﬁn and sectioned at 4 μm, stained and reviewed in
blinded fashion by a board-certiﬁed veterinary pathologist (M. A. Wallig). The slides were scored,
using a simpliﬁed version of a previous scoring system [21]. A severity scale system was used to grade
the severity of erosive/ulcerative colitis (EC) and its reparative consequences (persistence/diminution
of inﬂammation; crypt regeneration). A score of 0 indicated no lesions; 1, mild decrease in crypt
density and/or mild mucosal edema with mild inﬂammation, indicative of prior mild damage and/or
a repaired lesion with residual inﬂammation and regenerated/regenerating crypts; 2, focal erosion with
mucosal collapse and inﬂammation affecting <20% of the section, with moderate lymphohistiocytic
cellular inﬁltrates and advanced crypt regeneration along the margins of the erosion; 3, multifocal
to locally extensive erosions and mucosal collapse affecting up to 50% of the section, generally with
marked lymphohistiocytic inﬁltration mixed with neutrophils and minimal early marginal crypt
regeneration; 4, extensive erosions and mucosal collapse affecting >50% of the mucosa with heavy
mixed lymphohistiocytic and neutrophilic inﬁltrates; 5, ulceration with extension into submucosa and
muscularis and accompanying severe neutrophilic inﬂammation with no marginal regeneration of
lost crypts.
2.11. Statistical Analysis
The effect of DSS and the interaction between diet and DSS were determined by two-way
ANOVA (except for DAI and histological data). Where an interaction was indicated, the effect
of DSS was determined by comparing CON diet groups (Water/CON vs. DSS/CON) using
Welch’s unequal variance t-test, instead. The effect of diet was determined separately in water and
DSS groups, using one-way ANOVA, followed by Tukey’s post hoc test (adjusted for family-wise type
I error), where differences were indicated. For DAI and histological data, which are non-continuous
quantiﬁcations and do not ﬁt normal distribution, the non-parametric ANOVA (Kruskal’s test) was
used to determine the effect of diet in the water groups and DSS groups, separately; this was followed
by the Wilcoxon rank sum test where differences were indicated. For histological score (EC), Wilcoxon
rank sum test with continuity correction was used to determine the effect of DSS in the CON groups
(Water/CON vs. DSS/CON). The Pearson’s correlation was used to determine any linear correlation
between the EC score and mRNA expression of pro-inﬂammatory cytokines. For all tests, signiﬁcance
was reported when p < 0.05; all tests were carried out using R.
3. Results
3.1. Formation of SF during Diet Hydrolysis In Vitro
In this study, we compared the efﬁcacy of diets containing a single broccoli preparation, either raw
or lightly cooked, for protecting the host from DSS-induced colitis. The lightly cooked broccoli was
prepared by microwave heating for 3 min, which retained weak myrosinase activity, as shown in
Figure 1. When RB was incubated in water (400 mg diet/1.5 mL water), SF formed rapidly and was
complete within 1 min, whereas, when CB was treated similarly, SF started to form as late as 30 min
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after initiating the incubation and reached a similar maximum SF production but not until 4–8 h later
(Figure 1), indicating that CB had much less myrosinase activity, releasing SF at a much slower rate.
 
Figure 1. Sulforaphane production by 10% raw broccoli (RB) diet and 10% lightly cooked broccoli (CB)
diet after in vitro hydrolysis for 1 min, 5 min, 2 h, and 8 h (RB) and 1 min, 5 min, 30 min, 1 h, 2 h, 4 h,
and 8 h (CB), respectively. Data are mean ± SE (n = 3–5).
3.2. Disease Activity Index
Mice were monitored daily during DSS treatment (Days 8–14), scored for weight loss, stool
formation and fecal bleeding. The addition of these scores is the DAI. Weight loss was partly mitigated
by RB and CB diets, with 53% and 58% decrease in weight loss, respectively, by the completion of the
study, compared to weight loss in mice receiving the CON diet (Figure 2a). The RB and CB diets were
more effective at mitigating those symptoms most directly related to the colon, i.e., stool formation and
fecal bleeding (Figure 2a,c). By the completion of the study, mice receiving either RB or CB showed
a 100% or 92% reduction in the extent of damage to stool formation, respectively, and 77% or 75%
reduction in fecal bleeding, respectively, compared to mice receiving the CON diet.
As a general pattern (Figure 2d), the DAI increased over the period of DSS treatment in CON mice,
whereas mice receiving RB and CB exhibited slower increases in scores for damage in all three
parameters. The DAIs for RB- and CB-fed mice were signiﬁcantly different from the DAI for CON mice,
starting from Day 12 (ﬁve full days of DSS treatment; Figure 2d). After seven days of DSS treatment,
RB and CB mice showed 77% and 71% lower DAI, respectively, compared to CON mice. Taken together,
these data suggest that feeding mice either RB or CB alleviated the clinical symptoms of colitis,
particularly symptoms directly related to colon health.
  
(a) (b) 
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Figure 2. The effect of diet on: (a) weight loss; (b) stool formation; (c) fecal bleeding; and (d) the
combined disease activity index in dextran sulfate sodium (DSS)-treated mice during DSS treatment
(Days 8–14). The diet groups are control (CON, open squares), 10% raw broccoli (RB, ﬁlled triangles)
and 10% lightly cooked broccoli (CB, ﬁlled circles). Data are mean ± SE (n = 9, except for RB at
Day 14, n = 8). *, ** and *** indicate signiﬁcant difference from DSS/CON (p < 0.05, p < 0.01 and
p < 0.001, respectively).
3.3. Colon Length
In mice receiving RB or CB but not DSS (healthy controls), neither diet had any effect on colon
length (Figure 3). When given DSS daily for seven consecutive days, the colon length decreased by
21% (DSS-CON vs. Water-CON). In DSS-treated mice, the colon length of those mice receiving RB or
CB were 24% and 17% longer than those of CON mice, respectively.
Figure 3. The effect of diet and dextran sulfate sodium (DSS) on colon length. Diet groups are tap water
and control (Water/CON), tap water and 10% raw broccoli (Water/RB), tap water and 10% lightly
cooked broccoli (Water/CB), DSS and control (DSS/CON), DSS and 10% raw broccoli (DSS/RB), and
DSS and 10% lightly cooked broccoli (DSS/CB). Data are mean ± SE (n = 6, except for DSS/RB, n = 5).
*** indicates a signiﬁcant effect of DSS, p < 0.001. The presence of letters indicates a signiﬁcant effect of
diet for Water groups or DSS groups (p < 0.05). Values with the same letter are not different (p < 0.05).
3.4. Gut Barrier Permeability
Plasma LPS concentration was low in the water groups, regardless of the diet (Figure 4a).
When DSS was given to CON mice daily for seven days, the plasma LPS increased four-fold.
This increase was far less in plasma LPS from mice receiving either RB or CB (p < 0.01
and p < 0.05, respectively).
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Figure 4. The effect of diet and dextran sulfate sodium (DSS) on gut barrier function: (a) plasma
lipopolysaccharide (LPS) concentration, n = 3, except for DSS/RB (n = 4); (b) urinary sucralose excretion,
n = 3, except for DSS/CON and DSS/RB (n = 2); (c) mRNA expression of CLDN2, normalized by HPRT,
n = 3, except for DSS/RB (n = 4); (d) mRNA expression of OCLN, normalized by HPRT, n = 3, except for
DSS/RB (n = 4); and (e) protein expression of ZO-1, n = 3, except for DSS/CB (n = 2). Diet groups are
tap water and control (Water/CON), tap water and 10% raw broccoli (Water/RB), tap water and 10%
lightly cooked broccoli (Water/CB), DSS and control (DSS/CON), DSS and 10% raw broccoli (DSS/RB),
and DSS and 10% lightly cooked broccoli (DSS/CB). Data are mean ± SE. * and *** indicate a signiﬁcant
effect of DSS (p < 0.05 and p < 0.001, respectively). ** indicates p < 0.01; The presence of letters indicates
a signiﬁcant effect of diet within Water groups or DSS groups (p < 0.05). Values with the same letter are
not different (p < 0.05).
Similarly, the sucralose level in the urine, which was low in all three water groups, increased
three-fold when CON mice were given DSS daily for seven days (Figure 4b). Urinary sucralose was
substantially lower following RB (p < 0.05) and trended toward lower following CB.
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3.5. Tight Junction Expression
Among the selected eight genes involved in the production of tight junction proteins, the mRNA
expression of two genes (CLDN2 and OCLN) were signiﬁcantly decreased by DSS treatment (p < 0.001
and p < 0.05, respectively; Figure 4c,d). The broccoli diets appeared unable to reverse the effect of DSS.
The mRNA expression of the other six genes examined (CLDN1, CLDN3, CLDN4, CLDN5, CLDN8
and TJP1) was not impacted by DSS and the different diets [22].
The expression of two tight junction proteins (Claudin-1 and ZO-1) was also investigated. The DSS
treatment decreased expression of ZO-1(p < 0.01; Figure 4e), but had no effect on Claudin-1 [22].
Broccoli diets had no impact on levels of either tight junction protein.
3.6. mRNA Expression of Pro-Inﬂammatory Cytokines
Among the nine selected pro-inﬂammatory markers, the expressions of ﬁve genes (IL1β,
IL6, CCL2, CCR2 andVCAM1) were signiﬁcantly increased by DSS treatment (Figure 5).
Notably, the expression of the CCL2 gene was increased 27-fold in DSS mice (DSS/CON vs.
Water/CON, Figure 5a). These results suggest that most of the selected pro-inﬂammatory genes
responded to DSS treatment. Looking into the effect of diet in healthy (no DSS) mice, gene expression
was not affected by diet in the water groups, suggesting that neither RB nor CB had any effect on the
expression of these pro-inﬂammatory genes in healthy, control mice. However, the diet did inﬂuence
the expression of three pro-inﬂammatory genes that had been upregulated by DSS treatment: IL6,
CCR2, and VCAM1 (Figure 5b,d,e). Speciﬁcally, the expression of IL6 in DSS/RB and DSS/CB mice
was 3.4-fold and 1.8-fold lower, respectively, compared to expression in DSS/CON mice. A post-hoc
test showed that the expressions of genes IL6, CCR2 and VCAM1, from DSS/RB were different from
DSS/CON, although values from tissue of mice receiving DSS/CB were not.
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Figure 5. The effect of diet and dextran sulfate sodium (DSS) on mRNA expression of pro-inﬂammatory
cytokines: (a) normalized expression of IL1β; (b) normalized expression of IL6; (c) normalized
expression of CCL2; (d) normalized expression of CCR2; and (e) normalized expression of VCAM-1.
Diet groups are tap water and control (Water/CON), tap water and 10% raw broccoli (Water/RB),
tap water and 10% lightly cooked broccoli (Water/CB), DSS and control (DSS/CON), DSS and 10%
raw broccoli (DSS/RB), and DSS and 10% lightly cooked broccoli (DSS/CB). Data are mean ± SE, n = 3,
except for DSS/RB (n = 4). *, ** and *** indicate signiﬁcant effect of DSS (p < 0.05, p < 0.01 and p < 0.001,
respectively). The presence of letters indicates a signiﬁcant effect of diet within Water groups or DSS
groups (p < 0.05). Values with the same letter are not different (p < 0.05).
3.7. Histology
Representative photography of HE stained colon sections from mice receiving the water control
and from the three groups receiving DSS are shown in Figure 6a–d, and the scores for erosive/ulcerative
colitis for each group are shown in Figure 6e. Histology from mice receiving Water and RB or Water
and CB were not different from water and control diet [22].
Figure 6a shows a typical normal and healthy colon (scored 0), with tall columnar surface
colonocytes (Co), abundant goblet cells (GC, arrows), long crypts (Cr) of uniform depth,
and an inconspicuous lamina propria (LP), giving the mucosa a densely cellular appearance.
Submucosa (SM) is thin and peripheral muscularis (M) is composed almost entirely of densely
packed smooth muscle cells. In contrast, Figure 6b, a section of colon from a DSS/CON mouse
(scored 4), shows severe mucosal collapse, with the disappearance of colonocytes (bold arrows) and
goblet cells. Moreover, throughout the tissue there is intensive leukocyte inﬁltration (predominantly
neutrophils [encircled] and some histiocytes (monocytes which have left the circulation and entered
the lamina propria)). The submucosa is edematous (star) as evidenced by its expanded size between
mucosa and muscularis. All these changes suggest severe and ongoing inﬂammation in colons from
DSS/CON mice, with no regeneration evident.
In Figure 6c, a colon from a mouse treated with DSS and RB (scored 2), there are elongated,
newly regenerating crypts (RCr) and the surface is covered by regenerated colonocytes. A few goblet
cells have reappeared. Portions of the lamina propria not fully repopulated by crypts, but there is
less edema and only residual neutrophils (circled) and histiocytes (arrowheads), suggesting some
recovery from damage. These changes suggest that RB mitigated DSS-induced colonic damage.
In Figure 6d, a colon from a mouse given DSS and CB (scored 1), there is even further regeneration
to almost normal structures of both crypts and colonocytes are similar to normal colon (Figure 6a).
There is very little inﬁltration by neutrophils and monocytes, and the submucosa is thin with minimal
edema. Goblet cells are more numerous, although most are small due to incomplete replenishment
of mucin. The lamina propria is almost completely repopulated by crypts. These changes indicate
almost complete regeneration. These data suggest that CB can attenuate mucosal damage. In Figure 6e,
a substantial difference was observed between the EC score of Water/CON and DSS/CON (p < 0.05),
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suggesting a strong response to DSS. Both RB and CB were able to decrease colitis as scored from
histology, compared to tissues from mice receiving only DSS, but only when removing scores for one
DSS/CON mouse (#18) that did not respond to DSS. In total, the histologic data conﬁrmed that both
RB and CB are effective at mitigating DSS-induced ulceration in colon.
  
(a) (b) 
  
(c) (d) 
  
(e) (f) 
Figure 6. The effect of diet and dextran sulfate sodium (DSS) on histological pathology:
(a–d) representative microscopic images (40× magniﬁcation) of colon sections from Water/CON,
DSS/CON, DSS/CB and DSS/RB, respectively; (e) erosive/ulcerative colitis (EC) scores; and (f) the
correlation between mRNA expression of CCL2 and EC score. Abbreviations used in microscopic
images are: colonocytes (Co), goblet cells (GC), crypts (Cr), regenerating crypts (RCr), lamina
propria (LP), submucosa (SM), and muscularis (M). Highlights are the disappearance of colonocytes
(bold arrows), neutrophils (encircled), edematous submucosa (star), and residual histiocytes
(arrowheads). Diet groups are tap water and control (Water/CON), tap water and 10% raw broccoli
(Water/RB), tap water and 10% lightly cooked broccoli (Water/CB), DSS and control (DSS/CON),
DSS and 10% raw broccoli (DSS/RB), and DSS and 10% lightly cooked broccoli (DSS/CB). Data are
mean ± SE, n = 6, except for Water/CON, DSS/CON and DSS/RB (n = 5). *, ** and *** indicate
a signiﬁcant effect of DSS (p < 0.05, p < 0.01 and p < 0.001, respectively). The presence of letters indicates
a signiﬁcant effect of diet within Water groups or DSS groups (p < 0.05). Values with the same letter are
not different (p < 0.05).
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4. Discussion
4.1. Site of SF Absorption
In this study, we prepared the lightly cooked broccoli by microwaving for 3 min. The broccoli
was shown to still retain a low level of myrosinase activity (Figure 1). Heating broccoli for short
periods or at low temperatures can increase maximum SF production, by destroying the heat-sensitive
epithiospeciﬁer protein (ESP), a myrosinase-associated protein that irreversibly directs hydrolysis
away from ITC formation toward inactive nitrile formation [23]. Alternatively, a longer cooking time
or higher cooking temperature begins to destroy myrosinase, adversely impacting the efﬁcacy of
a broccoli meal [24]. Temperature and timing for ESP inhibition without loss of myrosinase is not
readily predicted, since the exact heat sensitivity of ESP and myrosinase may vary with the broccoli
variety [10]. Therefore, it is always crucial to determine the remaining myrosinase activity when using
cooked broccoli in a study.
In this study, little myrosinase activity remained in CB, but the rate of SF formation was greatly
diminished, compared to RB. It takes only around 1 h for food to begin entering the small intestine
following ingestion [25]. Therefore, by the time the broccoli diets entered the small intestine (~1 h),
only ~30% of GRP from CB was hydrolyzed, whereas ~100% of the GRP from RB would have been
hydrolyzed and absorbed, based on the in vitro data in Figure 1. The extent of hydrolysis in CB
might have been even less in vivo, where the hydrolysis was in a dynamic situation and might be
altered by other factors such as chewing efﬁciency, and other food components, leaving the majority
of GRP (~70%) remaining intact. Because the myrosinase and other proteins are expected to be
digested in the small intestine, we propose that the majority of GRP from CB reaches the cecum intact,
where microbiota can slowly hydrolyze the GRP to SF. Consequently, compared to RB, where SF is
rapidly formed and released during passage through mouth and stomach, the SF from CB is slowly
released, but in cecum and colon, the primary site for colitis.
4.2. Protection from DSS Colitis: Comparing CB and RB
We compared the efﬁcacy of RB and CB for their ability to protect the host from DSS-induce colitis.
Our results show that CB was essentially as effective as RB in suppressing damage by DSS, for most
of the endpoints, such as DAI (Figure 2), colon length (Figure 3), and lesion severity as assessed by
histopathology (Figure 6). The exceptions were gut barrier integrity (Figure 4) and mRNA expression
of pro-inﬂammatory biomarkers (Figure 5).
RB lessened DSS-increased gut permeability, as measured by plasma LPS concentration and
urinary sucralose excretion, whereas CB only decreased plasma LPS concentration (Figure 4a,b).
Neither broccoli diet induced changes in mRNA or protein expression of tight junction proteins
(Figure 4c–e). Three pro-inﬂammatory biomarkers (IL6, CCR2 and VCAM-1) were identiﬁed via
mRNA expression as affected by diet. RB reversed DSS-mediated increase in mRNA expression in all
three of these inﬂammatory biomarkers, whereas CB did not. However, CB did have a tendency to
decrease the mRNA expression of these genes, especially for VCAM-1 (p = 0.054). The failure to detect
any difference between the mRNA expression of these biomarkers among CB- and CON-fed DSS mice,
might be attributable to the smaller sample size of CB (n = 3) compared RB (n = 4). Interestingly,
whereas there was no difference between CB and CON in DSS mice, there was also no difference
between CB and RB for the gene expression data either.
There are several possible explanations for why CB, with far less myrosinase activity, is essentially
as effective as RB. Firstly, although the myrosinase activity in CB is far less, CB has an advantage of
a topical effect on the gut wall. As we discussed earlier, compared to RB, where SF is rapidly formed
and released during mouth or stomach, the SF from CB is slowly released, but right in cecum and colon,
the primary site of damage by colitis. Therefore, the SF from CB is more likely to directly impact colitis
than SF from RB, where the SF is formed earlier and has to travel via the blood stream to reach the colon.
Secondly, although the myrosinase content is far less in CB, we found that the myrosinase-like activity
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of rat gut microbiota is greatly increased after four or more days of CB intake [26]. Therefore, increased
formation of SF by the gut microbiota after 14 days of CB intake might be sufﬁcient to protect the mice
from colitis, as effectively as a larger, but systemic, dose of SF from RB.
However, we also keep open to the possibility that the efﬁcacy of RB and CB might be independent
of SF in this study. It is possible that other compounds in broccoli such as quercetin sophorosides,
alone or in combination with SF, might play a role in mitigating the colitis. Moreover, it is also
possible that the combination of other components in broccoli contributed to efﬁcacy, such as through
fermentation and/or modiﬁcation of the gut microbiota, as indicated in a recent mouse study
evaluating the impact of different ﬁber types on DSS-induced colitis [27]. Here, for example, although
total ﬁber content was balanced across diets (Table 1), there was doubtless a small change in ﬁber
composition, thus a possible change in fermentation and butyrate formation, noting that butyrate,
similar to sulforaphane, is known to trigger Nrf2 [28]. Therefore, whether the efﬁcacy of RB and CB
we observed is only SF-dependent or due to a more general impact of broccoli and the microbiome,
waits for further investigation.
4.3. Gut Barrier Integrity
Emerging evidence has suggested that gut barrier dysfunction is closely related to the etiology
of IBD [11,12]. In this study, gut barrier integrity was assessed by gut permeability (plasma LPS
concentration and urinary sucralose excretion) and expression of tight junction proteins. Consistent
with the results of gut permeability tests (Figure 4a,b), histologic evaluation of H&E stained colon
sections also suggests that RB and CB were able to protect the integrity of the gut barrier, as evidenced
by milder damage, enhanced regeneration and less disruption of crypt structure than for CON/DSS
mice (Figure 6c,d).
Gut barrier typically consists of colonocyte plasma membrane tight junctions, secreted mucus,
and mucosal immune cells [13]. It is reported that the destruction of the tight junctions is one possible
mechanism for the breached gut barrier in DSS-treated mice [11] and a variety of phytochemicals,
such as naringenin from citrus fruits and berberrubine from berberis, are reported to upregulate tight
junction proteins in DSS-treated mice [29,30]. To investigate whether protection by RB and CB against
increased gut permeability is through effects on tight junctions, mRNA expression of genes involved
in the production of tight junction proteins, as well as protein expression of two tight junction proteins
was determined. However, although both RB and CB showed a tendency to reverse the DSS-induced
downregulation of mRNA expression of CLDN2 gene and protein expression of ZO-1, there was no
signiﬁcant impact. Interestingly, for the two tight junction proteins examined (Claudin-1 and ZO-1),
DSS had no effect on their mRNA expression (CLDN1 or TJP1 genes [22]), and DSS only affected
protein expression of ZO-1. These results suggest that further research about the function of different
tight junction proteins is needed, but that maybe broccoli protection of the gut barrier is not through
maintenance or preservation of tight junctions.
4.4. Inﬂammation
Colonic inﬂammation in DSS mice was evaluated by both gene expression of pro-inﬂammatory
cytokines and by histology. We investigated gene expression of the three key pro-inﬂammatory
cytokines that mediate inﬂammation [31]: interleukin-1 (IL-1β), interleukin-6 (IL-6) and tumor necrosis
factor alpha (TNFα). Gene expression of IL-1β and IL-6 (Figure 5a,b) were greatly increased by DSS.
TNFα is also an important pro-inﬂammatory cytokine, but we did not observe any increase in
gene expression of TNFα by DSS in this study [22], indicating that DSS-induced colitis might not
involve TFNα.
Although both broccoli diets decreased IL-6 expression in DSS mice (Figure 5b), IL-1β expression
was not impacted by diet. IL-1β is a potent pro-inﬂammatory cytokine and plays a central role
in mediating the inﬂammatory response [31]. In this study, a signiﬁcant increase (10-fold) in gene
expression of IL-1βwas observed in DSS treated mice (p < 0.01, Figure 5a), suggesting that DSS-induced
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colitis involves the IL-1 signaling family. It also indicates a role for gut microbiota (presumably LPS)
in DSS colitis, as IL-1β is mainly induced by microbial products [31], consistent with appearance
of LPS in plasma in this study (Figure 4a). However, neither CB nor RB was able to reverse this
induction. Furthermore, SF formed in the lower gut from CB had no greater impact than SF formed
and absorbed in the upper gut from RB. Interestingly, the expression of other genes from the IL-1 family,
including TLR2, TLR4 and NF-kB, were not impacted by DSS in this study [22].
Accumulating evidence suggests that IL-6 is much more than a marker or product of
inﬂammation. It appears to play a pivotal role in both recovery from acute inﬂammation and the
transition from acute inﬂammation to prolonged/chronic inﬂammation [32]. In the initial phase of
inﬂammation, the endothelial cells are triggered by microbial products, IL-1β or TNFα, to release
IL-6 as well as a series of chemokines [33]. Together, these cytokines recruit neutrophils to the
local injury site, the inﬁltration of which is one important hallmark of acute inﬂammation [32].
The membrane-bound receptor of IL-6 (mIL6R) found on only a few cell types including hepatocytes
and some leukocytes [34] can then be shed as a soluble receptor, sIL6R, freely traveling to combine with
IL-6 and complex with gp130, present on multiple cell types. This induces a switch from upregulation
of neutrophil-attracting chemokines to upregulation of monocyte-attracting cytokines, including CCL2
(MCP-1)/CCR2, as well as promoting apoptosis of neutrophils and the differentiation of monocytes to
form macrophages, hallmarks of chronic inﬂammation [32]. Typically, acute inﬂammation is considered
beneﬁcial, as it is one of the ways that the body responds to stress, whereas prolonged chronic
inﬂammation may enhance a series of severe diseases. The beneﬁcial acute inﬂammatory response
mediated by IL-6/mIL6R is termed IL-6 classic signaling, whereas the prolonged inﬂammatory
response mediated by the IL-6/sIL6R complex is termed IL-6 trans-signaling [33] (Figure 7). In addition,
cell adhesion molecules including VCAM-1 are induced by IL-6 trans-signaling, to increase vascular
permeability for monocyte inﬁltration [33,35,36].
Figure 7. Proposed molecular mechanism of anti-inﬂammatory property of broccoli is through the IL-6
trans-signaling pathway.
We report here that gene expressions of IL-6 (p < 0.001), CCL2 (p < 0.01), CCR2 (p < 0.01),
and VCAM-1 (p < 0.01) were increased in DSS mice (Figure 5b–e, respectively), suggesting that chronic
inﬂammation was triggered by IL-6 trans-signaling. Moreover, our data show that RB decreased the
upregulation of IL-6, CCR2 and VCAM-1 expression in DSS mice (p < 0.05, Figure 5b,d,e, respectively).
Notably, as shown in Figure 5c, there was an obvious difference between the mRNA expression
of CCL2 of mice fed DSS/CON and DSS/broccoli diets. However, we failed to detect a statistical
difference, due to the large variation in the DSS/CON group. Interestingly, if mouse #18 (the DSS
non-responder, as described earlier) is removed from the DSS/CON group, both RB and CB showed
a signiﬁcant decrease in the mRNA expression of CCL2 (p < 0.01). In addition, a positive correlation
between the gene expression of CCL2 and the histological EC score was observed (R = 0.717, p < 0.001,
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Figure 6f). As described earlier, the chemokine CCL2 (also referred as monocyte chemoattractant
protein 1, MCP1) recruits monocytes, playing an important role in the transition from acute to chronic
inﬂammation. The EC score reﬂects the degree of ulcerative colitis in the tissue. The positive correlation
between CCL2 and EC suggests that the gene expression of CCL2 might be a good marker of colitis.
A correlation between the expression of CCL2 and tumor progression was previously reported [37,38],
but to the best of our knowledge, the correlation between CCL2 and EC is newly reported here.
We propose that broccoli may be able to halt the transition from acute to chronic inﬂammation,
through the IL-6 trans-signaling pathway. That SF and other brassica ITC inhibit inﬂammation has
been known for a long time, but the exact mechanism is unclear. A recent study proposed a detailed
mechanism for the anti-inﬂammatory effect of Nrf2 [39]. The study found that Nrf2 binds the IL-6
gene to physically interrupt RNA Polymerase II recruitment, effectively inhibiting transcription of IL-6.
Moreover, this inhibition involves direct binding of Nrf2 to the gene and is independent of the typical
pathway of Nrf2-ARE activation. Given the fact that SF from broccoli is a potent Nrf2 inducer,
we propose that the mechanism of broccoli protection may be through direct Nrf2 inhibition of IL-6
expression, leading to suppression of the IL-6 trans-signaling pathway. Consequently, the mRNA
expression of genes involved in the IL-6 trans-signaling pathway, IL-6, CCL2/CCR2 and VCAM-1,
is inhibited and the transition from acute to chronic inﬂammation is halted (Figure 7).
Interestingly, whereas our gene expression data clearly show that the tissue from DSS/CON
mice was undergoing a switch from acute inflammation where neutrophils predominate to chronic
inflammation where monocytes predominate, the histological data do not support this. Histology showed
that neutrophils were still the predominant leukocytes inDSS/CONmice. Nevertheless, the histology data
do show that both RB and CB were able to mitigate ulceration in the colon, evidenced by elongated crypts,
regenerating colonocytes, and infiltration of fewer neutrophils and monocytes, compared to tissues from
DSS/CON mice. This indicates that RB and CB may support a more rapid regeneration of colonocytes
and restoration of colonic epithelium, in addition to inhibition of the IL-6 trans-signaling pathway.
5. Conclusions
In conclusion, our results clearly show that, even with far less myrosinase activity, CB was
essentially as effective as raw broccoli in suppressing damage by DSS, for most of the endpoints,
including DAI, colon length, gut barrier integrity as assessed by plasma LPS concentration, and colon
lesion severity as assessed by histopathology. Moreover, the pro-inﬂammatory gene expression
data suggest that broccoli protection may be through halting the transition from acute to chronic
inﬂammation through SF-Nrf2 inhibition of the IL-6 trans-signaling pathway. Future studies are
needed to test this hypothesis that inhibition of inﬂammation by SF or broccoli is dependent upon
Nrf2 inhibition of IL-6 synthesis and subsequent disruption of IL-6 trans-signaling by Nrf2.
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